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Introduction: Household air pollution (HAP) affects one half of the world 
population, comprises 90% of global particulate exposure, and is associated with 
mortality from respiratory infections. Particulates are known to alter cellular redox 
balance, including that of the alveolar macrophage (AM). We investigate redox 
balance as a mechanism to explain the link between particulate exposure and failure 
of innate immune function. 
Methods: Bronchoalveolar lavage was performed on healthy human volunteers in 
the UK (low HAP) and Malawi (high HAP). Antioxidant capacity was determined 
(concentrations of oxidised and reduced glutathione, and antioxidant capacities of 
glutathione peroxidase and superoxide dismutase). AM function was assessed by 
capacity to phagocytose, and to produce oxidative burst and proteolysis activity 
within the phagosome using reporter-fluorophore coated silica beads. AM cytokine 
responses to lipopolysaccharide and to respirable size wood smoke particles were 
measured before and after ex vivo treatment to reduce glutathione content. Personal 
exposure to particulates was estimated by the cytoplasmic content of black carbon 
within AM. 
Results: AM glutathione was similar in UK and Malawi non-smokers (of which 
4.3% was in oxidised form). One quarter of Malawians exhibited a high oxidised 
glutathione phenotype (8.6% of total). Malawians exhibited higher levels of 
extracellular glutathione, and intracellular malondialdehyde and particulate content 
than UK volunteers. Nrf2 levels in Malawian AM were proportional to levels of 
particulate matter. We demonstrated no association between particulate matter 
content and AM cytokine responses to lipopolysaccharide or wood. Glutathione 
depletion did not consistently alter AM cytokine production. 
In vivo particulate exposure correlates with reduced AM phagosomal oxidative 
capacity, and increased cellular Nrf-2 concentration, but phagocytosis and 
phagosomal proteolysis are unaffected. 
Conclusion: Malawians have high levels of AM particulate exposure, as expected 
from HAP surveys. This is associated with evidence of oxidative stress (lipid 
peroxidation), antioxidant upregulation (raised extracellular glutathione, 
intracellular Nrf2) and a specific defect in AM function (reduced oxidative burst). 
Antibacterial function of the AM is key to preventing pulmonary infection: in a 
population subjected to high levels of household air pollution, particulate related 
defects in AM function could explain the high prevalence of infective respiratory 
illness. 
Abbreviations are explained at their first use. The following list may also be useful. 
BAL bronchoalveolar lavage 
CFU colony forming units 
CumOOH cumene hydroperoxide 
CV coefficient of variation 
DMSO dimethyl sulfoxide 
DTNB 5,5'-Dithio-bis(2-nitrobenzoic acid), Ellman’s reagent 
EDTA ethylenediaminetetraacetic acid 
ELF epithelial lining fluid 
H2DCFDA-SE 2',7'-dichlorodihydrofluorescein diacetate, succinimidyl ester 
FCS fetal calf serum 
FITC fluorescein isothiocyanate 
fMLP formyl-methionyl-leucyl-phenylalanine 
FSC forward scatter (flow cytometry) 
γ GCS γ-glutamylcysteine synthase 
GPx glutathione peroxidase 
GR glutathione reductase 
Grx glutaredoxin 
GSH reduced glutathione 
GSSG oxidised glutathione 
GST glutathione-S-transferases 
HAM human alveolar macrophage 
Hb haemoglobin 
IFNγ interferon γ 
LPS lipopolysaccharide 
LTA lipoteichoic acid 
MDA malondialdehyde 
MDM monocyte derived macrophage 
NADPH nicotinamide adenine dinucleotide phosphate 
NF-κB nuclear factor κB 
Nrf2 nuclear factor (erythroid-derived 2)-like 2 
PBS phosphate buffered saline 
PBMC peripheral blood mononuclear cell 
PE phycoerythrin 
SOD superoxide dismutase 
5-SSA 5-sulfasalicylic acid 
SSC side scatter (flow cytometry) 
TEA triethanolamine  
TBARS thiobarbituric acid reacting substance 
TNB 5-thio-2-nitrobenzoic acid 
TNFα tumour necrosis factor α 
Trx thioredoxin 
TrxR thioredoxin reductase 
ufCB ultrafine carbon black (Printex 90, Degussa, GmBH) 
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This project investigates the relationship between innate immune function, 
particularly in alveolar macrophages and redox balance in the lung. These topics are 
introduced separately below for orientation. Subsequently, their overlap and 
‘crosstalk’ is discussed. 
 
 
Pneumonia is the consequence of a failed immune response in the lung following 
entry of a pathogen into the alveolar space. This disease causes death worldwide 
particularly in the young, elderly and immunocompromised1, 2. In US cohorts the 
strongest risk factor is cigarette smoking3. In developing countries, where the 
burden of disease is highest, the most important risk factors among children for 
acute respiratory infection are: malnutrition and micronutrient deficiency4; indoor 
air pollution5, 6; lack of breastfeeding and measles immunisation; overcrowding7. 
Despite lower rates of pneumococcal infection, there is also a significant burden of 
disease in otherwise healthy adults. In the absence of systemic immunocompromise 
such as HIV, biological mechanisms of susceptibility are not well understood. 
The link between inhaled particulate exposure and respiratory disease was 
historically demonstrated by respiratory deaths during the 1952 London smog. 
Subsequent emphasis on, and funding to reduce environmental particulates within 
Western countries has been associated with significant increases in life expectancy8. 
In developing countries however, indoor air pollution in particular is widespread, 
affecting half of the world’s population9. Intense particulate exposures due to 
burning of organic material for cooking, heating and lighting are common, and 
associated with pneumonia in adults as well as children10 Recent meta-analysis 
showed a relative risk for pneumonia of 1.8 from unprocessed solid fuel burning in 
the home6. Interventions to improve indoor air quality using improved stoves for 
cooking can reduce pneumonia11. 
It is evident from these epidemiological studies that, apart from the infective agent, 
other challenges to the lung are important in predisposing individuals to disease. 
Enhancing our understanding of the effect of particulates on innate immunity, for 
example, might help to more efficiently direct or target interventions to improve 
lung health. 
 
The innate immune system comprises a group of defences against potentially 
infectious agents which are similarly implemented in wide range of organisms, 
suggesting an ancient and common origin12. These defence systems incorporate a 
number of mechanisms by which the host avoids injury. They include: avoidance, 
compromise or removal of infectious agents by a physical or chemical means; 
targeting or effecting extracellular killing responses; initiating containment and 
killing responses within specialised cells; recruiting of further innate components; 
priming the adaptive immune system to identify and react to the infective agent. A 
key feature of innate immune responses is that they are rapid, but non-specific in 
their response13, 14. Innate immune mechanisms are central to pulmonary defence 
against infection; Table 1-1 shows a summary of these strategies and effectors within 
the lung. Tolerance to a pathogen’s presence is an increasingly recognised defence 
mechanism15 which is important in limiting harm to the host caused by its own 
immune system. 
Table 1-1 Overview of the innate immune system strategies and effectors within the lung 
 
 
It is noted that a large proportion of aerosolised particles is deposited proximal to 
the terminal airways, and that likelihood of deposition changes with particle 
diameter and content22, 23; larger particles tend to be filtered in the nasopharynx and 
larger airways, whereas particles of around 1µm and less may more commonly be 
encountered in the terminal bronchioles and alveoli. 
At this level, the respiratory interface is populated mostly by epithelial cells. 
Alveolar macrophages (AM) occur at the approximate frequency of 1 per alveolus24. 
It is possible to obtain these cells in humans via a well-tolerated bronchoscopic 
procedure (bronchoalveolar lavage): isotonic fluid (normal saline) is instilled into a 
sub-segmental bronchus of the lung, and removed by suction. In healthy volunteers, 
the resulting suspension usually contains around 90% AM and, at an order of 
magnitude less frequent, lymphocytes25. Proportions of lymphocytes change with 
age: Figure 1-1illustrates normal values for differential counts of bronchoalveolar 
lavage in volunteers aged 19-36 years.  
Figure 1-1 Proportional area diagram showing the cells present in bronchoalveolar lavage 
fluid 
 
Data in Meyer et al26 
The alveolar epithelium also incorporates type 2 cells which secrete surfactant 
proteins17. Submucosal dendritic cells and other macrophages lie amongst the 
framework of blood vessels and extracellular matrix27. During inflammatory or 
ectopic processes, neutrophils and eosinophils may also be present in increased 
number and proportion28. 
 Even with intact upper airway defences, microbial pathogens due to their size may 
be deposited directly in the terminal airways29. This may occur following aerosol 
inhalation derived from another host (as for Mycobacterium tuberculosis), or from 
autologous colonisation in the upper airways (as for Streptococcus pneumoniae). 
The alveolar macrophage (AM), as part of the pulmonary innate immune system, is 
importantly placed to defend against organic and non-organic insults. As the 
primary resident macrophages in the lungs, they are key sentinel cells which have 
roles in cytokine response, neutrophil recruitment, antigen presentation and 
efferocytosis (the removal of apoptosed cells)24, 30. The following section describes 
the interaction between AM and pathogen, focussing on Streptococcus pneumoniae. 
 
S. pneumoniae is the commonest cause of mortality from pneumonia, accounting for 
1.2 million deaths per year in infants, and may well exceed this in adults31. 
Streptococcal pneumonia is necessarily preceded by nasopharyngeal colonisation. 
During childhood, rates of both disease and colonisation fall with age following 
repeated exposure to the pathogen32. It is presumed that the lungs are frequently 
challenged with colonising bacteria, but that frank pneumonia results from failure 
of the innate immune system24. 
S. pneumoniae (the pneumococcus) is a gram positive alpha haemolytic bacterium. 
Encapsulated forms are the most capable of colonisation and of causing invasive 
disease. The polysaccharide capsule inhibits phagocytosis, complement and 
immunoglobulin binding. More than 90 serotypes have been isolated. Each serotype 
has a unique variation in the composition of the polysaccharide coating which is 
recognised by antisera33. Various other virulence factors also subvert the innate 
immune response: preferential binding to epithelial surfaces (PspA); reduction of 
complement activity (cbpA); increased resistance to oxidative burst (PspA); cleavage 
of mucosal immunoglobulin (IgA protease). S. pneumoniae also secretes 
pneumolysin which damages ciliary transport and oxidative burst through cytotoxic 
effects, causes inflammation through activation of complement, and activates innate 
immune responses through the TLR4 pathway34. Pro-inflammatory signalling is also 
propagated through TLR2 receptors by lipoteichoic acid35 and internalised 
peptidoglycan by Nod –like receptor 2 (Nod2)36. 
The alveolar macrophage co-ordinates the host response in the lung, balancing the 
need for robust reaction against the potential for damage caused by excessive 
inflammation37. In early infection, AM are killed due to cytotoxicity of this 
response38, which involves: phagocytosis; internalised killing responses; antigen 
presentation; inflammatory response and recruitment. At a critical stage in the 
infection, the AM response becomes less inflammatory. This resolution phase is 
typified by alveolar macrophage apoptosis, efferocytosis (the clearance of apoptotic 
bodies) and anti-inflammatory signalling. These functions of the AM throughout the 
course of infection are summarised below. 
Phagocytosis requires co-ordinated change to the cell membrane and actin structure 
to allow internalisation of the particle and time critical maturation of the 
phagolysosome. A large number of cell surface receptors exist to facilitate uptake of 
microbes and other material. Depending on which receptor system is engaged, such 
ingested material is differently dealt with. Bacteria which have been opsonised are 
targeted for phagocytosis through specific cell surface receptors on the AM (such as 
Fcγ receptor recognises IgG, and CR3 and CR4 recognise complement protein 
C3b)39. The Fcγ receptor directs internalisation to maturing phagosome marked by 
lysosomal associated membrane protein LAMP-1. Complement deposition 
enhances, but is not necessary for this activity in alveolar macrophages40. 
Without bound IgG, alternative pathways exist which may converge on these killing 
and antigen presentation end points. This is mediated by pattern associated 
molecular pattern (PAMP) recognition receptors on the AM41. PAMPs are broadly 
phylogenetically conserved bacterial structures which afford the host an 
opportunity for bacterial recognition without relying on the cognate response i.e. 
without prior exposure. PAMP receptors are genetically encoded in the host, and 
unlike T and B cell receptors do not require somatic recombination. Alveolar 
macrophages exhibit a number of PAMP receptors including CD14, toll-like 
receptors (TLRs),“scavenger receptors” such as SR-A, MARCO, mannose receptor 
(CD163) 42, 43 which recognise bacterial and other foreign structures, and promote 
pathogen phagocytosis. There is overlap within these recognition pathways, for 
example Streptococcus pneumoniae is recognised by type A scavenger receptors, 
mannose receptor and others such as DC-SIGN44. 
Bacterial killing is enacted by progressive and carefully choreographed endosomal 
fusion45 Oxidative burst occurs relatively early in this pathway46 and is succeeded by 
other reactions such as further acidification, proteolysis and other destructive 
processes39. There are significant differences between these processes in 
macrophages and the more often studied neutrophil. 
NADPH oxidase produces the oxidative burst by catalytic formation of superoxide 
ions from molecular oxygen (see Equation 1). This enzyme is assembled from 
inactive cytosolic components as the macrophage becomes activated (see Figure 
1-2). Subunits include the membrane spanning gp91phox and p22phox proteins 
collectively termed flavocytochrome b558. Three other cytosolic proteins (p47phox, 
p67phox and Rac2) complete the active complex in macrophages47. Another protein, 
p40, is not necessary for oxidative burst but increases the affinity of p47 for the 
flavocytochrome b558 unit48. Other antibacterial functions of the phagolysosome, 
including mechanisms for trafficking the phagosome are reviewed elsewhere, and 
not discussed further here20, 49. 
Figure 1-2 Diagramatic structure of NADPH oxidase 
 
           
             
→                          
   
The AM may present bacterial peptides in association with MHC class II causing 
specific T cell responses. Viral peptides may also be presented, on MHC class I. 
Although AM are less effective antigen presenters than monocytes50, they are more 
adapted to this function than other tissue phagocytes51. The extent to which AM act 
as antigen presenting cells in pulmonary infection is not known, although lung 
macrophages can pass antigen to dendritic cells which may then migrate to regional 
lymph nodes52. 
In response to infectious agents, alveolar macrophages produce inflammatory 
cytokines such as TNFα, IL-1β, IL-8 and IFNγ. TNFα and IL-1β stimulate further 
inflammatory mediators from macrophages and epithelial cells. IL-8, a chemokine, 
operates as a chemo-attractant causing an influx of monocytes and neutrophils 
which may then themselves release pro-inflammatory mediators. IFNγ is important 
in priming immune cells for further activation53. 
Recognition of the bacteria by the AM, and subsequent signal transduction is fully 
described in a recent review54. Multiple pathways exist, but the best described are 
the Toll-like receptors (TLRs). These PAMP receptors, such as TLR2 and TLR4 
propagate intracellular inflammatory signals by multiple pathways including 
MAPK55, but are commonly dependent on the MyD88adapter molecule56 and 
converge on NF-κB upregulation. 
TLR4 recognises pneumolysin57 and, in combination with CD14, lipopolysaccharide 
(LPS). TLR2 is important in gram positive bacterial recognition due to its affinity to 
lipoteichoic acid and bacterial lipopeptides. Mice lacking TLR2 have impaired 
cytokine responses to Streptococcus pneumoniae, although lung infection resolves 
normally provided pneumolysin is present to activate TLR4 pathways58.  
Oxidative and inflammatory pathways in the macrophage are closely related (see 
Figure 1-3). NADPH oxidase can limit pro-inflammatory NF-κB related cytokine 
release through suppression of NF-κB relating to Nrf2 activation59. Pro-
inflammatory NF-κB also positively regulates the activity of NADPH oxidase 
through the gp91 subunit60, and through the TNFα mediated phosphorylation of the 
p47phox subunit61. 
Figure 1-3 Interrelationships between oxidative burst and inflammatory pathways in the 
alveolar macrophage 
 
 
Central to regulation of the inflammatory response is the balance between NF-κB and inflammatory 
signalling responses, and those of Nrf2 by which the host protects itself against oxidative stress by 
upregulation of antioxidants 
This diagram is necessarily simplified. Multiple inflammatory cytokines exist, and signals are transduced 
through multiple parallel pathways. See text for details. 
Surprisingly, in p47phox deficient mice, a lack of NADPH oxidase activity leads to 
improved microbial killing in low dose pneumococcal infection in mice62. In this 
model, increased neutrophil recruitment compensates for the loss of AM function. 
However, the exaggerated response to pro-inflammatory stimuli causes host lung 
damage63. 
Macrophages, in response to Th1 type cytokines in their environment (e.g. TNFα, 
INFγ), undergo a reversible phenotypic shift towards an “activated” phenotype 
(designated M1: see section 2.9.1 for more detail). Transcriptomic analysis of 
activated macrophages demonstrates this common host response to a broad range of 
bacteria, and involves upregulation of MHCII, increased cytokine release and 
oxidative burst activity, and down-regulation of scavenger type receptors whose 
usual function is in internalisation of inert particles64, 65. 
By these mechanisms, the pneumococcus might be both recognised, phagocytosed 
and initiate an inflammatory signalling cascade. Once controlled, the AM becomes 
key to resolving these inflammatory changes. 
AM then adopt an anti-inflammatory phenotype (M2) and undergo apoptosis. 
While programmed cell death in early infection results in poor bacterial handling, 
delayed apoptosis limits inflammation and enhances antigen presentation66-68. 
Phagocytosis of these apoptosis cells (efferocytosis) limits further release of IL-1β, 
IL-8 and TNF-α69. This reduces the potential for tissue destruction, conferring a 
survival benefit to the host70. Prolonged responses to persistent bacterial products 
are limited by down-regulating the inflammatory response by an unknown 
mechanism. Macrophages appear to preserve the ability to recruit neutrophils even 
after this tolerance develops71. 
  
 Airborne products of combustion, cigarette smoke and less commonly, inorganic 
dusts are all encountered by the AM in the alveoli. Inhaled particles are 
conventionally designated by diameter as coarse (2.5-10µm), fine (0.1 to 2.5µm) and 
ultrafine (less than 0.1µm). Real world exposures are necessarily more complex, 
with considerable variation in size, surface charge and aggregation. Nevertheless, 
upper airways and the nasopharynx filter most coarse particles (see Figure 1-4). 
Alveolar macrophages typically encounter fine and ultrafine particles. Most 
commonly, these are internalised by AM phagocytosis, although direct penetration 
into the submucosal and wider circulation may occur particularly with ultrafine 
particles72. 
Figure 1-4 Particulate size classification, and deposition in the respiratory tract 
 
Modelling data for nasal breathing subjects shows the deposition fraction for nasopharynx and alveolar 
regions. This is based on ‘ideal’ particles in non-agregated form in a human breathing nasally at normal 
tidal volumes. Adapted from Oberdorster et al73 
The toxicity of particles to the alveolar macrophage is in part caused by the 
inflammatory response which is turn is dependent on particle type74. Toxicity is 
inversely related to particle size75, 76, and is compounded by the adsorbed transition 
metals, aromatic hydrocarbons and other volatile organic compounds77. Activation 
of inflammatory signalling pathways and phagosomal activity is potentiated by 
hydrocarbons through the action of reactive oxygen species in either an autocrine or 
paracrine manner75, 78, 79. This is discussed further in 1.2.1.2. 
In this project, we focus on the particulates which are most commonly used as 
“biomass fuels” by around 2.4 billion people worldwide80. These are energy sources 
derived from living organisms. Typically, wood, charcoal, dung and crop residue 
are used for heating, lighting and cooking provide more than half of domestic 
energy in developing countries81. 
Wood smoke has many constituents including carbon monoxide, benzene, nitrogen 
oxides and polyaromatics hydrocarbons9 which may cause direct toxicity, generate 
reactive oxygen species and enhance inflammatory pathways. Endotoxins, of which 
lipopolysaccharide (LPS) is the archetypal example, also potentiate inflammation82, 
and are present in relatively high quantities in homes burning biomass fuels83.  
Table 1-2 summarises key features of the innate response to particulates, and 
supporting evidence from the literature. Considerable knowledge exists for 
concentrated ambient particles (CAP) and diesel exhaust particulates (DEP), which 
have some commonality with biomass fuels in terms of the end products of 
combustion, and their potential for toxicity. DEP and CAP are therefore included for 
comparison: this table is not exhaustive; where possible human studies are reported 
in preference to animal experiments. It should be noted that most of these studies 
model acute exposure, and not chronic or repeated particulate challenge. 
  
A number of generalisations may be made regarding particulate exposure, 
supported by evidence from Table 1-2: 
 Particulates have a pro-inflammatory effect on alveolar macrophages and 
the lung in general. This is partially mediated by endotoxin and transition 
metal content. NF-κB is central to the inflammatory response, and may be 
antagonised by Nrf2 activity. This is strongly dose and particle dependent, 
and for “clean” particles there is a threshold effect for surface area below 
which inflammation is not induced75. 
 Chronic particulate exposure may reduce baseline or maximal inflammatory 
response, although evidence is patchy.  
 Anti-inflammatory cytokine production has not been as widely assessed, 
and the effects are unknown. 
 Neutrophil influx is a common observation in acute and chronic studies 
 Phagocytosis is reduced by particulate exposure in the acute setting. This is 
unknown for chronic exposures 
 Maximal respiratory burst is reduced by particulate exposure in the acute 
setting, and in chronic wood smoke exposure 
 Microbial killing is reduced by acute exposure, but where prior exposure to 
particulates has caused an inflammatory stimulus, killing may be increased 
 Apoptosis in the alveolar macrophage is induced by particulates 
Detailed review of toxicological aspects may be found in recent peer reviewed 
articles84-86 and are not further described here. Specific constituents of wood smoke 
which have harmful effects on health are given in Naeher et al87. 
 
 Study of particulate exposure has often been limited by in vitro experiments based 
on submerged monoculture. Problems with these include: 
 difficulty establishing a model of physiological relevance, particularly for 
doses  
 particle behaviour in collection and re-suspension i.e. the effect of solvents 
on particles, agglutination 
 interaction with the cells in a non-confluent cell layer 
 in vitro study: the lack of surrounding extracellular milieu and interaction 
with other cell types 
Air-liquid interface experiments are possible, and might provide a more 
physiological laboratory apparatus for exposure and probing of cell cultures88, 89 but 
are not widely used. Co-culture models have also been developed which allow 
some assessment of the interplay between macrophage and epithelium90. Human in 
vivo exposure studies have some advantages compared with in vitro testing in terms 
of relevance of exposure and physiology, but use lower doses and shorter exposures 
to particulates than those from “natural” human exposures. Exposure chamber 
experiments have used 200–300µg/m3 PM2.5 for 4 hours91). 
A database of studies for indoor particulate levels92 shows 24 hour time weighted 
averages of PM2.5 to be in a wide range: of the 10 studies available, concentrations 
were 56.8 - 1102µg/m3 (geometric mean 391µg/m3). Meal time and 1 hour exposures 
were available in 8 cases, with time weighted average concentrations of 130 to 
27000µg/m3 PM2.5 (geometric mean 2531µg/m3). 
For these reasons, and because chronic and acute exposures have potential to differ 
widely in effect, human studies examining real-world exposures will be of key 
importance in defining our understanding of indoor air pollution.
Table 1-2 Effect of particulate exposure on the alveolar macrophage 
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Studies are models of acute exposure unless explicitly stated. 
Symbols:  Increased or upregulated;  Decreased or downregulated;  Unchanged 
Abbreviations: AA = arachidonic acid; AM = alveolar macrophage (HAM = human alveolar macrophage); BAL = bronchoalveolar lavage; IFN = interferon 
IL = interleukin; LPS = lipopolysaccharide; LTA = lipoteichoic acid; MDM = monocyte derived macrophage; MTB = Mycobacterium tuberculosis; PBMC = peripheral blood derived mononuclear 
cells; TNF = tumour necrosis factor; UFCB = ultrafine carbon black, NK = not known 
 
 Redox balance is the equilibrium between production and metabolism of oxidising 
substances within a biological system142. Such oxidants include reactive oxygen 
species (ROS) and reactive nitrogen species (RNS). Adequate antioxidant capacity is 
required to prevent their deleterious effects, and to repair damage once done. 
Inadequate physiological defences may result in downstream effects involving the 
altered function of lipids, proteins and DNA143. Cellular behaviour may be 
profoundly affected during this so called ‘oxidative stress’, but is also attenuated by 
less destructive, lower amplitude fluctuations in redox balance: so called redox 
signalling144. 
Lung tissue is uniquely vulnerable to alteration in redox balance. Exogenous factors 
such as high tissue concentrations of oxygen and inhaled particulate matter145 may 
compound endogenous production of oxidants146. Concurrently, low level bacterial 
challenge should be dealt with by the innate immune system in order to prevent 
pneumonia and invasive infection (see section 1.1.3). Where pulmonary redox 
balance is altered, so is the response to infection: oxidative stress has the potential to 
impair innate immune defences. Tight control of immune responses, inflammatory 
mediators and extracellular antioxidant buffering avoids excessive cellular 
recruitment and tissue oedema which would compromise normal lung function147. 
 
A number of terms are used to describe redox balance, and are explained in Table 
1-3. Examples have been chosen to be relevant to the text which follows. 
  
Table 1-3 Definition and explanation of terms relating to redox balance 
             →            
    →              
            →      
     →           
 As noted in Table 1-3, the cellular redox balance is not tightly defined, but describes 
the predominant redox state of the most common redox pairs. It may be derived 
mathematically if the concentrations of contributing molecules are known148, but 
methodologically this is not feasible. 
Experimental studies often therefore equate redox balance with that of the most 
abundant intracellular redox buffer: glutathione. This tripeptide (γ-GluCysGly) 
exists at concentrations of 1-10mmol/l in the cytoplasm depending on cell type150. 
This allows proxy measurement of redox state by analysis of only one component. 
This approach has been criticised by Martinovich151 who notes that it is possible for 
oxidants to preferentially oxidise specific redox pairs without affecting glutathione. 
Evidence for this has been seen in ex-vivo exposure of human epithelial lining fluid 
to nitrogen dioxide152. This is practically very uncommon, and the state of the 
glutathione redox pair both correlates well with the degree of oxidative stress, and 
has relevance to cellular behaviour148. 
Figure 1-5 shows examples of a number of intracellular redox pairs; these do not 
exist in isolation, and electrons may pass between sets of redox pairs (as seen with 
glutathione and NADPH in Table 1-3).  
Many processes contribute to redox balance. Both endogenous generators of redox 
active substances and exogenous sources are introduced below. 
Figure 1-5 Examples of redox pairs, and their relationship to intracellular redox balance 
 
 
 
Reactive oxygen species are produced endogenously in a number of ways in the 
alveolar macrophage (see Table 1-4). Usually, aerobic respiration uses oxygen as the 
final electron acceptor, resulting in carbon dioxide and water formation. However, 
during the process of electron transfer in the mitochondrial membrane, electrons 
may “leak” and react prematurely with oxygen. This occurs particularly from the 
ubiquinone component of the electron transport chain, and resulting in superoxide 
radical formation, for accounting for 1-3% of oxygen consumption153.  
 
Secondly, nicotinamide adenine dinucleotide phosphate (NADPH) is used to drive 
important cellular processes. Cytochrome P450 enzymes use NADPH to drive redox 
reactions to metabolise wide varieties of substances, and different forms exhibit 
tissue specificity. Alveolar macrophages express multiple forms including CYP2E1, 
which is known to produce the most ROS of all cytochrome P450 forms as a result of 
loss of electrons from the metabolic pathway154, predominantly as superoxide. 
 
Superoxide is also formed by the action of NADPH oxidase in generating the 
oxidative burst of phagocytes (see Equation 1 and section 1.2.1.5). 
Superoxide is extremely short lived, causing oxidation immediate to its site of 
production. It dismutes spontaneously, a reaction which is diffusion limited when 
catalysed by superoxide dismutase (see Equation 2). Steady state concentrations 
from physiological processes are around 10-11mol/l150. 
   
        
                    
→                       
 
The resulting hydrogen peroxide, although a weaker oxidant, more easily diffuses 
across phagosomal membranes155. It is found in the cytoplasm at concentrations of 
10-8mol/l156, and up to 15µM in activated polymorphonuclear cells.  
 
Alveolar macrophages may be induced to express by inducible nitric oxide synthase 
(iNOS) by inflammatory signals from epithelial cells157. 
 
Peroxisomes also generate ROS during their oxidation of long chain fatty acids and 
amino acids. Multiple enzymes are involved, predominantly producing H2O2, 
although xanthine oxidase and inducible nitric oxide synthase (iNOS) generate 
superoxide and nitric oxide respectively158. Peroxisomes are well equipped with 
antioxidant systems including catalase and Cu-Zn-superoxide dismutase, 
peroxiredoxin158. Their relative role in macrophage redox balance is not well 
defined. 
Table 1-4 Endogenous sources of free radicals in the lung 
 
In addition to the primary products of these reactions, combinations of ROS can 
generate other, more reactive products. One example is the Fenton reaction. In the 
presence of ferrous iron (Fe2+) or other transition metal, H2O2 can react to form the 
highly destructive hydroxyl radical (see Equation 3). This radical is short lived (half-
life 10-9s)160 
           
                          
→                                     
Another such reaction is for formation of peroxynitrite (ONOO-) from superoxide 
and nitric oxide (see Equation 4). Peroxynitrite anions, and their downstream 
derivatives have cellular effects similar to ROS161, and a half-life of 0.05-1s160. 
   
      →       
ROS and RNS are created in the cell as a result of these fundamentally important 
processes: energy use; metabolism; cellular signalling; defence against pathogens 
and xenobiotics. Antioxidant pathways are of central importance in maintaining 
redox equilibrium and limiting the potential for adverse effects on the host. These 
are summarised below. 
 
Glutathione is the most abundant redox buffer, and is found in particularly high 
concentrations in alveolar macrophages compared to other cell types within the 
lung162. Estimates suggest total concentrations in AM are 6.64µmol/106 cells (4.8mM 
in the cytoplasm)163. This concentration is nine times higher than lung epithelial 
cells. 
The vast majority of glutathione is held in the reduced form (GSH) which is 
regenerated from its oxidised form (GSSG) by the enzyme glutathione reductase, 
using energy from NADPH oxidation. Due to its high intracellular and extracellular 
concentrations, it acts as a buffer against ROS and RNS. Glutathione acts as an 
electron donor in preference to other molecules whose oxidation might have 
adverse functional effects. It is then recycled to its reduced form by the specific GR 
enzyme system. 
As noted in section 1.2.1.1, the oxidation state of glutathione generally equates with 
cellular redox state. The proportion of GSH of total glutathione is estimated at 89% 
in ex vivo rabbit AM163, and over 99% in macrophage cell lines164. This is considerably 
procedure dependent, as ex-vivo data from humans suggests figures of around 50% 
by induced sputum165, whereas data from this project estimate around 96% by 
bronchoalveolar lavage (see section 4.3.3.3). Glutathione is more oxidized in lung 
than other tissue166, perhaps due to high tissue oxygen concentrations. Certainly, 
supra-physiological O2 levels cause oxidative stress in AM in human neonates167 and 
upregulation of antioxidant enzymes in adults168. 
 Glutathione is also excreted by AM, lymphocytes and fibroblasts to form a redox 
buffer in the epithelial lining fluid at 400µM (around 140 fold higher than in plasma) 
of which 96% is in reduced form169, 170. Extracellular glutathione can metabolised by 
γ-glutamyl transferase (GGT) which is present at low levels in epithelial lining fluid 
to increase availability of cysteine to the cells171. Alveolar macrophages rely on GGT 
secreted from type 2 epithelial cells in order to maintain a normal redox balance172, 
173. Using this mechanism, AMs constitute intracellular glutathione from 
extracellular amino acids either via the rate limiting γ-GCS conjugation of cysteine, 
or bypassing this step by utilising γ-glutamylcysteine directly174 (see Figure 1-6, and 
review by Deneke169).  
Figure 1-6 Glutathione transport and synthesis pathways 
 
Pathways derived from description by Deneke169. During times of oxidative stress, glutathione may be 
transported into the cell from extracellular fluid 
During phagocytosis, there is efflux of glutathione from macrophages, although the 
reason for this is unclear175. In reducing environments, feedback inhibition of γ-GCS 
limits GSH production and helps maintain homeostasis176. Conversely, oxidative 
stress in airway epithelial cells induces γ-GCS associated with AP-1 transcription 
response elements. This allows rapid resolution of intracellular GSH after initial 
falls177, 178. Consistent with this, during oxidative stress, both GGT production and 
cysteine uptake are induced, thereby providing extra glutathione for the AM170, 179. 
Experimental data in mouse knockout models confirms the physiological 
importance of these pathways: reduced availability of extracellular GGT causes 
intracellular GSH depletion and oxidative stress172, 173 due to decreased cysteine 
availability180. 
By these mechanisms, some degree of redox homeostasis is achieved. 
 
Multiple other non-enzymatic buffers are present in the epithelial lining fluid 
including surfactant protein181 and urea152. Transferrin prevents hydroxyl ion 
formation as a result of Fenton reactions by sequestration of iron as intracellular 
lactoferrin/ferritin182, 183. Caeruloplasmin is produced throughout the airway, but 
inducible mostly in the larger airways184; its relevance at physiological 
concentrations is debatable185. Ascorbate is present, and at lower concentrations in 
cigarette smokers186, but the degree to which it acts as an antioxidant is variable187. 
As for glutathione, there is potential for transport of ascorbate into the cell during 
times of oxidative stress188. Bilirubin has potential physiological relevance at tissue 
concentrations of 2% oxygen, but is less effective at the higher levels found at the 
lung/air interface189. Albumin and alpha-1-antitrypsin are also present, but at low 
levels compared to that required for antioxidant effect185. Experiments using 
synthetic lung epithelial lining fluid suggest that glutathione and ascorbate 
contribute most to antioxidant effect190. 
  
Superoxide dismutase enzymes are phylogenetically nearly ubiquitous, although 
these are co-factored by different metal ions depending on cellular location and 
species. Copper and zinc SOD (CuZnSOD) are cytosolic proteins common to 
eukaryotes. The manganese co-factored form (MnSOD) is employed by some 
prokaryotes and nearly all mitochondria191. It catalyses the dismutation of 
superoxide (see Equation 2). Alveolar macrophages predominantly express MnSOD 
and the extracellular form (EC-SOD). MnSOD is found at concentrations 5 times 
higher than neutrophils, and 3 times higher than monocytes192. Both forms are up-
regulated by oxidative stress193, although the predominant source of EC-SOD is the 
airway epithelium194.  
 
Two enzyme systems are produced by cells specifically to catalyse the reduction of 
hydrogen peroxide: glutathione peroxidase (GPx, see Equation 6) and catalase (see 
Equation 5.  
GPx activity is optimal at lower concentrations of substrate than catalase (at 5mM 
concentrations of glutathione, Michaelis constant* [Km] =25-60µmol/l for GPx and 
Km=1.1mol/l for catalase195, 196). This suggests different roles for these two enzymes. 
Catalase is found in high concentrations in neutrophils which have high 
endogenous production of H2O2197 in order to provide substrate for 
                                                     
* The Michaelis constant is the concentration of substrate at which the rate of enzyme-
catalyzed-reaction is half of the maximum rate. 
This relates to the model:    
        
→        
    
→      
Where: E = enzyme; S = substrate; P = product; kforward and kcat = rate constants for the 
reactions 
The following assumptions are made: 1) ES is at steady state ie. kforward is fast and kcat is rate 
limiting; 2) the reverse reaction ES E+S is negligible; 3) substrate is in excess compared 
with enzyme 
myeloperoxidase. Alveolar macrophages, by contrast, have much lower levels of 
catalase expression, and higher GPx198. AM have higher intracellular GPx activity 
than other lung cell types, predominantly in mitochondria and to a lesser degree the 
cytoplasm199. The lower Km makes GPx efficient at reducing hydroperoxides even 
when they occur at low concentrations. 
GPx is present in multiple forms resulting from different genes: each has different 
distribution, structure and avidity, but the main four depend on selenium as a 
central co-factor200. Selenium availability limits GPx function in the AM201. Key 
features of the main four GPx types are given in Table 1-5. Of note, in addition to its 
effect on H2O2, GPx is also an important reducer of peroxynitrite202 and the only 
enzyme which is able to reduce harmful lipid peroxides in AMs203. 
GPx-3 is present in the epithelial lining fluid and is excreted by AM and epithelial 
cells in response to oxidative stress177. GPx-3 accounts for over half the alveolar GPx 
activity204. Unlike in the upper airways where lactoperoxidase is the most active 
peroxidase in ELF205, GPx is the most important terminal airway defence against 
H2O2206. 
  
Table 1-5 Glutathione peroxidases – key features 
For a full review see Arthur200, 206, 209. Other GPx forms exist, but are not relevant to this topic. ELF = 
epithelial lining fluid in the lung; TrxR = thioredoxin reductase; Grx = glutaredoxin reductase; Se = 
selenium; GI = gastrointestinal 
The high level of GPx in AM has important implications for cell signalling210, and 
will be described later. 
     
        
→              
           
                      
→                             
 
In a parallel system to GPx, thioredoxins are also potent reducing enzymes. They 
are also selenium dependent. Various isoforms are found depending on cellular 
location; mitochondrial, cytoplasmic and excreted forms exist in mammals. 
Thioredoxin, once oxidised, is itself reduced by thioredoxin reductase 
(peroxiredoxin)211. These proteins have a significant antioxidant effect and roles in 
redox signalling as discussed in section 1.2.4.1. 
 Heme oxygenase-1 (HO-1) is another enzymatic antioxidant expressed in alveolar 
macrophages which may be induced by oxidative stress212. It is up-regulated by the 
antioxidant response element (ARE) in response to particulates and other oxidants, 
leading to catalysis of heme breakdown to elemental iron and bilirubin. Free iron is 
rapidly stored213 as ferritin to prevent Fenton reactions, while bilirubin may act as an 
antioxidant, and HO-1 also alters iron efflux from cells214.  
 
Exogenous oxidants are commonly encountered by the alveolar macrophage, and 
have been extensively investigated ex-vivo and in the context of cell line studies. 
Particulates including PM2.5, wood smoke and concentrated ambient particles (CAP) 
are consistently shown to cause oxidative stress in alveolar macrophages in vitro and 
ex-vivo (see Table 1-2). Response to this oxidative stress, is different in granulocytes, 
monocytes and alveolar macrophages. The degree of inflammation and generation 
of ROS in the macrophage depends on particle type74, is inversely related to particle 
size75, 76, and is compounded by the adsorbed transition metals77. Finer particles are 
more potent in generating ROS, and inducing protective responses (particularly 
HO-1) in macrophages and epithelial cells215. However, as noted previously, coarse 
particles may induce ROS through inflammatory pathways where they are 
associated with adsorbed endotoxin. This is particularly true for concentrated 
ambient particles94, 100, 216. AMs are relatively less sensitive to cytotoxic effects of 
oxidative stress than epithelium, perhaps in part due to differences in the 
metabolism of glutathione precursors, or to the relative concentration of antioxidant 
enzymes164. However, AM are susceptible to upregulation of NADPH oxidase 
subunit p47phox by aryl hydrocarbons which increases oxidative stress78. 
Increasing antioxidant availability may reduce oxidative stress resultant from 
particulate exposure. N-acetylcysteine and catalase supplementation reduces 
ambient particle induced inflammatory signalling in the alveolar macrophage84. 
Increasing extracellular superoxide dismutase has a similar effect: levels of 
glutathione oxidation are lower in cells exposed to products of oil combustion when 
they over-express the enzyme217. 
Redox balance also mediates the response to bacterial peptides. Endotoxins (such as 
LPS), which are associated with respiratory infection218 also potentiate 
inflammation82. Superoxide dismutase supplementation offsets this NF-κB mediated 
inflammatory response219 . 
To investigate more physiological exposures, in vivo studies of humans and animals 
have been performed, and effects on glutathione measured. These are summarised 
in Table 1-6. This table excludes occupational particulate and cigarette smoke 
exposure which have been extensively reviewed. Table 1-6 shows for a broad range 
of inhalable particulates oxidants that glutathione is depleted in the acute exposure 
(hours afterwards), before synthetic enzyme function is up-regulated. After this 
(usually 24 hours), glutathione concentrations in the lung, ELF or AM tend to be 
higher than baseline levels. 
Other studies have examined these stressors for the effects of that oxidative stress 
i.e. changes to antioxidant concentration or activity (see Table 1-7 for a summary). 
There are no direct studies of in vivo exposure to wood smoke. In general, any 
particulate causes an immediate fall in antioxidant enzyme function, and this is 
noted to last after 2 weeks for CAP, DEP and NO2 exposures. Acutely, mRNA for 
antioxidant enzymes is reduced, but no data are available for more chronic 
exposures. 
Table 1-6 Glutathione and acute toxicity 
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* Model details the subject with target compartment in parentheses 
Search terms in PubMed: (particulate OR smoke OR wood[Title]) AND bronchoalveolar lavage AND glutathione   
Table 1-7 Enzymatic antioxidants and acute toxicity 
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* Model names the animal or cell line, and details the compartment measured in parentheses Search terms in PubMed: (particulate OR smoke OR wood[Title]) AND bronchoalveolar 
lavage AND (superoxide dismutase OR glutathione peroxidase OR catalase). Abbreviations: CAT = catalase; GCL = glutamate cysteine ligase; GPx = glutathione peroxidase; GR = 
glutathione reductase; GSTµ = glutathione-S-transferase mu isoform; SOD = superoxide dismutase 
 Acute particulate exposure cause macrophages to generate ROS and inflammatory 
mediators including TNFα and IL-6, IL-8, MCP-1238 which have potential to cause 
tissue oedema and architectural changes in the lung. Acute toxicity to the alveolar 
macrophage leads to apoptosis and can diminish the population of these cells 
leading to impaired immunity (see Table 1-2). Oxidative stress caused by these 
particulates also causes DNA adduct formation110 with potential for cellular harm. 
In the AM of healthy people, such adverse effects of exogenous oxidative stress are 
prevented by a number of mechanisms: 
1) Inherent hypo-responsiveness. Multiple stimuli are required for ROS to 
cause an inflammatory response. For example. in the alveolar macrophage, 
activation of NADPH oxidase and ROS generated by ROFA particles are not 
sufficient to induce NF-κB or inflammatory cytokines100, 239. However, 
mechanistic studies show that higher level source of ROS (H2O2) can 
stimulate NF-κB signalling240 and TNFα production241. Downstream of this, 
alveolar macrophages have weaker TNFα responses than monocytes which 
relates to lower p38 MAP kinase activation by oxidants210 
2) Decoupling of NADPH oxidase activity and ROS signalling. For example, 
hydrogen peroxide produced from the respiratory burst does not cause ERK 
protein kinase signalling even though H2O2 at the same concentration when 
produced from alternative (zymosan) activation can propagate inflammatory 
signalling242. 
3) Specificity of response to phagocytosed particles. Unopsonised particle 
ingestion in AM is mediated by scavenger receptors and is associated with 
reduced oxidative burst by comparison to Fc dependent phagocytosis of 
opsonised particles, presumably to limit the generation of ROS caused by 
inert material243, 244. 
4) Sequestration of iron during inflammatory response. Iron loading of 
lysosomes due to environmental exposure can exacerbate oxidative stress. In 
these circumstances, TNFα enhances lysosomal iron storage by upregulation 
of heavy chain ferritin, and reduces free cellular iron245. 
5) Antioxidant upregulation. Compensatory increases in antioxidants occur in 
vivo as a result of chronic cigarette smoke exposure246. Presumably this also 
occurs in other particulate exposure247 although data are few. Human 
responses to in vivo wood smoke include upregulation of glutathione in the 
epithelial lining fluid228. Nrf2 has a central role in up-regulating antioxidant 
responses to DEP115 and cigarette smoke248.  
Nrf2 can also dampen chronic inflammation in macrophages by its negative 
effect on NF-κB249. The transcription factor AP-1 is also implicated, 
particularly for GPx upregulation206 
 
HO-1 (an enzyme regulated by Nrf2) is up-regulated in smokers, and 
provides protection against inhaled oxidants212. GPx prevents AM death by 
inhibiting apoptosis through the caspase 3 pathway and by maintaining Bcl-
2 levels250. Additionally, GPx reduces NF-κB activity by reducing 
phosphorylation of its inhibitor (IκB)250, 251. It is likely that this explains the 
beneficial dampening effect of pulmonary inflammation in response to 
cigarette smoke252. Ex vivo, antioxidant treatment with glutathione donors 
attenuates the inflammatory cytokine response of AM to wood dust253. 
Similarly, AM from mice overexpressing EC-SOD or from knockout NADPH 
oxidase strains have dampened inflammatory response to inhaled smoke254. 
Where particulates have induced inflammation by another pathway (such as 
arachidonic acid metabolic pathways76, calcium signalling255, 256, transition 
metal or endotoxin257), antioxidants reduce the magnitude of response258. 
Lastly, circumstantial data suggest that antioxidant GPx and SOD have an 
inhibitory effect on NADPH oxidase activity: in animal neonate models, 
levels of GPx and SOD are high and associated with reduced AM respiratory 
burst capacity259. The corollary is that while antioxidant upregulation is 
necessary to protect the host, it may indirectly have negative effects e.g. on 
bactericidal activity or inflammatory response in early infection. 
 From previous sections, maintaining redox balance in the alveolar macrophage by 
antioxidant regulation might be understood to be a necessary defence against 
endogenous and exogenous oxidative stressors. While this is no doubt true, recent 
observations have suggested a finer role for ROS: signalling of cellular behaviour. 
This section reviews mechanisms by which the redox state of the cell might alter its 
function, and mediate inflammatory and other signals. 
 
Glutathione may be seen to be a passive buffer against alterations in the cellular 
redox state, but it also plays a role in adapting cell behaviour to cope with future 
oxidative stress. Its oxidation state can determine cellular behaviour: cellular 
proliferation is favoured by GSH while GSSG promotes cellular differentiation and 
apoptosis148, 260. This is redox signalling, and the same processes may mediate 
inflammatory response. A key mechanism for this is the conjugation of glutathione 
with intracellular proteins261. 
With increasing concentration or production of ROS/RNS a number of changes to 
intracellular proteins can occur149, notably reversible conjugation with glutathione 
(S-glutathiolation) – see Figure 1-7. This has two potential functions; firstly, 
protecting proteins against irreversible structural changes in times of increased ROS 
production: S-glutathiolation occurs early in the respiratory burst (up to 20 minutes) 
262. Secondly, post-translational conjugation with glutathione effects a temporary 
change in protein function, including those involved in signalling. These are not 
fully elucidated, but known to include: reduced activation of caspase-3; reduced 
polymerization of actin; reduced binding of transcription factors NF-κB and AP-1 
(by altering binding of the p50263 and cJun264 subunits respectively). However, some 
protein functions are increased: increased chaperone activity of heat shock protein 
hsp70265; increased sarcoplasmic or endoplasmic-reticulum Ca2+-ATPase (SARCA) 
activity266. Recently, it has been reported that epithelial antibacterial peptide beta-
defensin 1 is only active in its reduced state, and that redox balance therefore has a 
direct effect on the capacity of innate immune responses267. 
The redox balance in the lung certainly determines the cytokine response of alveolar 
macrophages. An increase in total intracellular glutathione reduces NF-κB 
activation268, and hydrogen peroxide activates IKK269 (an upstream regulator NF-
κB). However, oxidative glutathionylation of the IKKβ subunit results in reduction 
of NF-κB activity38 presumably to prevent irreversible inhibition. After such insults, 
glutaredoxin is critical in restoring an adequate inflammatory response in alveolar 
macrophages270, 271. These processes have been recently reviewed272 273. Similar 
pathways are modulated downstream by redox dependant NF-κB binding to 
DNA274, 275. AP-1 transcription factor complex activity276 and the mitogen-activated 
protein kinase (MAPK) and ERK1 cascades may also be affected. However, alveolar 
macrophages are deficient in AP-1 binding activity compared with monocytes277. 
Thioredoxins also reduce oxidised proteins, though in a less specific manner. They 
also decrease DNA binding of NF-κB, but increase that of AP-1278. Specifically both 
cJun-terminal kinases and the p38MAPK have a common upstream mediator, 
apoptosis-signal regulating kinase-1, which is released from its thioredoxin inhibitor 
by the action of ROS, thereby causing activation of the pathway150, 279. In AMs, via 
this pathway, respiratory burst may cause activation of inflammatory JNK-1/c-Jun 
pathway280. The relationship between thioredoxins and the glutathione system have 
been recently reviewed281. 
 
Figure 1-7 Interactions of proteins and the glutathione / glutaredoxin / thioredoxin systems 
 
  
Nrf2 is another important regulator. It is a basic leucine zipper protein which 
recognises the antioxidant response element (ARE). Its binding to DNA up-
regulates transcription of ARE associated genes, especially cytoprotective proteins 
and antioxidant enzymes. It is implicated in many disease processes including 
COPD. Nrf2 has a cytoplasmic half-life or around 20 minutes; it is usually bound to 
the Keap1 dimer which allows ubiquitination by ubiquitin E3 ligase and rapid 
proteasomal degradation285. Keap1 contains cysteine residues which when oxidised 
reduce the E3 ligase activity, and hence increase Nrf2 levels and nuclear 
translocation286. Phosphorylation of Nrf2 by the protein kinase C signalling 
pathway, and possibly others, also lends it stability287. 
Nrf2 binds to promoter elements of target genes leading to their transcription. Such 
targets include: Nrf2 itself288; glutathione; enzymes for GSH production (GCLM, 
GCLC)289; GSH recycling enzymes (GR)260; the regulator of GSH influx 
(cysteine/glutamate exchange transporter)290; enzymes using GSH as cofactor for 
reducing other oxidants and electrophiles (GPx288, 291, GST288); other enzymatic 
antioxidants (SOD, catalase, HO-1); components of the parallel thioredoxin system 
(peroxiredoxin, thioredoxin, thioredoxin reductase).292, 293  
Knockout studies have demonstrated the absence of Nrf-2 results in pneumotoxicity 
of hyperbaric oxygen294, emphysema295 and increased oxidation of glutathione in 
response to LPS296. Where oxidative stress leads to moderate glutathione depletion, 
Nrf2 effects allows macrophages to avoid apoptosis260, 297. Nrf2 upregulation 
improves bacterial phagocytosis, in association with increased expression of 
scavenger receptors298. 
Within cells, crosstalk between Nrf2 and NF-κB pathways exists to moderate 
inflammation; in the absence of Nrf2, NF-κB activation is enhanced during 
lipopolysaccharide challenge, and is associated with increased mortality in septic 
shock296. It seems likely that Nrf2 plays a role in limiting NF-κB activation in 
response to such inflammatory stimuli. Conversely, some of the effects of Nrf2 may 
be mediated by the AP-1 / NF-κB pathways, including transcription of glutathione 
related GCL299, and initial stimulation of Nrf2 by oxidants in the lung is followed by 
a restorative response involving MAP and JNK kinases300. Such Nrf2 responses may 
therefore by short lived. Paracrine effects are also important in modulating the 
cytokine response to oxidative stress301. 
Pro-inflammatory signalling is dampened by antioxidants. Pre-treatment of mice 
with glutathione or its components (such as N-acetylcysteine) reduces in vivo TNFα 
production to lipopolysaccharide302, 303. Similarly, ex-vivo human AMs have an 
enhanced inflammatory cytokine profile when glutathione availability is reduced, 
which is normalised with NAC supplementation304. Moreover, oxidants may also 
antagonise the suppression of pro-inflammatory cytokines pathways by TGF-β by 
inducing p38MAPK activation305. 
Lipids are most potently affected by peroxidation which may, usually after 
initiation by hydroxyl ions, a reaction which can be propagated down a chain of 
adjacent lipid molecules. Oxidation of phospholipids within lipid rafts is 
common306, and seen systemically in humans in chronic exposure to smoke from 
domestic fuel or cigarettes307. Lipid peroxidation in AM reduces sensing of the 
external environment through TLR-2, TLR-4308. Once inflammation is established, 
however, oxidation of phosphatidylserine in other cells’ membranes facilitates their 
efferocytosis by macrophages309. 
Changes to DNA are well documented after alveolar macrophage exposure to 
extrinsic particles310, potentially resulting in altered signalling, cell death and 
mutagenesis. These are widely thought to be pathological phenomena, and multiple 
mechanisms for repair of such damage exist, although these themselves may also be 
impaired by PM311.  
 
The following section examines the overlap between redox signalling, and innate 
immunity in the context of bacterial infection. Finally, therapeutic implications and 
limitations are discussed. 
 
In early pneumococcal infection, NF-κB signalling is important in generating 
sufficient cytokine response312. Alveolar macrophages subjected to oxidative stress 
(those from smokers, with high levels of glutathione) have less nuclear NF-κB 
binding313, and may be less sensitive to bacterial signals. Where acute upregulation 
of antioxidants is expected, due to environmental tobacco smoke, some pathogens 
(e.g. Mycoplasma pneumoniae) interfere with this mechanism which may partly 
explain their association with chest infections in smokers314. Chronic derangement of 
the redox balance of rat AM may reduce antibacterial capacity, which can be 
normalised by supplementation of glutathione pre-cursors315. In chronic oxidative 
stress, such as human COPD, AM responses to pneumonia are less inflammatory 
than non-COPD controls316, and associated with reduced phagocytosis. The situation 
is complicated, however: using AM from COPD patients, increasing antioxidant 
signalling through the Nrf2 pathway pharmacologically (using  sulphorafane) leads 
to improved bacterial clearance by macrophages317, perhaps by upregulation of 
pattern recognition receptors. It seems that both inflammatory and anti-
inflammatory pathways can be blunted by oxidative stress. 
Epithelial responses are also altered. For example, bacterial binding to respiratory 
epithelium is increased by particulate matter generated oxidative stress318, and this 
may increase the chances of invasive disease. 
 
Macrophage responses to overwhelming infection are characterised by ROS 
generation for bacterial killing and neutrophil recruitment which further exacerbate 
oxidative stress. Myeloperoxidase (a potent producer of ROS) from neutrophils 
exacerbates inflammatory recruitment. Cytokine release is also increased, perhaps 
due to a bystander effect on other cell types319. Changes in local environmental 
oxygen tension (hypoxia) can exacerbate inflammatory responses320. 
As a result, acute pneumonia in children is associated with whole body depletion of 
antioxidants measured in the serum (retinol, ascorbate, α-tocopherol, GSH), and 
decreasing levels of enzymatic antioxidants (GPx, SOD), and markers of molecular 
oxidative damage (MDA)321-323. Similar patterns of GSH and antioxidant depletion 
are noted in TB324, 325. Ventilator associated pneumonia is associated with lower GPx 
activity in BAL and increased lipid peroxidation, which is mirrored in the 
circulation326. 
Usually, antioxidant (Nrf2) pathways limit ROS production in phagocytes in 
response to bacterial peptides such as LPS327 (see Figure 1-3); defective antioxidant 
upregulation is associated with lower survival from sepsis296. Indeed, ROS may be 
less important than previously thought in bacterial killing: gp91phox knockout mice 
improve killing responses, maintain higher pulmonary neutrophil numbers with 
lower apoptosis rates and stronger pro-inflammatory signalling62. 
Despite considerable evidence of antioxidant depletion in uncomplicated 
pneumonia, supplementation trials in humans are lacking. In mouse influenza 
pneumonia, inhaled catalase improves mortality and histopathological 
appearance328. Efferocytosis seems to require some oxidation of the target cell 
phosphatidylserine329 by endogenous NADPH330. Exogenous oxidants, however, 
cause a defect in efferocytosis331 and antioxidant treatment with NAC improves such 
cell clearance332. Quality evidence of antioxidant therapy in pneumonia is lacking, 
either at during the acute inflammatory stage or during resolution. Further clinical 
trials would therefore have a sound theoretical basis. 
 
Evidence of efficacy of clinical interventions through antioxidant supplementation is 
not strong. Although the use of zinc in children does prevent pneumonia333, there is 
minimal robust evidence of effect of other supplements (for example Vitamin A 
outside of its use in measles)334, 335. Vitamin D supplementation does not work where 
deficiency is common336. In adults, less is known, but Vitamin E does not prevent 
community acquired pneumonia337, and may have unintended risks, particularly of 
tuberculosis338. 
 
Where local control mechanisms fail, oxidative stress and inflammatory responses 
in the lung may lead to excessive tissue injury, as in Acute Respiratory Distress 
Syndrome (ARDS). Uncontrolled NF-κB activation leads to overproduction of 
cytokines. AM release mediators due to pulmonary stimuli (hypoxia and particulate 
exposure) which have systemic inflammatory effects, including MCP-1339, 340 
Oxidised phospholipids activating the TLR-4 pathway increase these inflammatory 
cytokines. This is associated with increased pulmonary oxidative stress in humans 
with ARDS341, and increased mortality in models of influenza infection and other 
acute lung infection342. 
Treating such patients with acute lung injury with antioxidants is an attractive 
option in order to reduce inflammatory response. However, trials with N-
acetylcysteine have tended no show no mortality reduction, except in specific GST 
genotypes343, but may shorten the duration of disease. Prevention of pneumonia 
with antioxidants in patients at high risk, has been trialled with varying results. 
Additional ascorbate and α-tocopherol did not reduce pneumonia incidence in 
critically unwell trauma patients, but did reduce that of subsequent ARDS344. 
Amongst burns patients, supplementation of high dose trace metals (Cu, Se, Zn) 
does reduce nosocomial pneumonia345. A lack of effect in many supplementation 
trials might represent late treatment in the evolution of disease. However, the lack 
of prevention effect suggests that straightforward antioxidant supplementation 
might not be an effective strategy. 
 
 Redox state in the lung, and more specifically in the alveolar macrophage is of major 
importance to proper homeostasis. Due to the high levels of endogenous oxidative 
processes in the macrophage, and exogenous oxidants in inhaled air, considerable 
resources are expended in maintaining antioxidant defences. These are responsive 
to changes in the redox state, and can be up-regulated as required. 
Changes in the redox state, either acutely due to oxidative stress, or chronically as a 
result of up-regulated antioxidants, might have important effects on redox 
signalling. This collection of processes uses, at its core, glutathione and other redox 
sensitive thiols to sense changes in the environment, and to effect a response by 
alterations to cellular signals. By these pathways, which include NF-κB, AP-1 and 
Nrf2 transcription factors, and protein kinase cascades, inflammation and redox 
balance are tightly knitted. 
Redox balance has the capacity to alter host immune responses, and is integral to 
the effective containment and disposal of infective and non-infective substances in 
the lung. Where high levels of particulates are encountered chronically, up-
regulated antioxidant systems are likely to change the finely controlled balance 
between inflammatory and restorative responses. It is possible that the host 
response to oxidative stress, whilst immediately helpful to the host, is ultimately 
damaging to the innate immune responses. 
This project focusses on redox balance and AM dysfunction in the context of the 
most widespread and overlooked form of particulate exposure in humans: 
household air pollution from the combustion of biomass fuels. Epidemiological 
evidence strongly associates such use with morbidity from chronic respiratory 
disease, and mortality from pneumonia. Work presented here aims to clarify the 
extent to which redox balance impacts on innate immunity in the Malawian 
population: people to whom high particulate exposure in their own homes is a 
normal part of life. 
 
We have addressed three overarching hypotheses within this project. 
1. Particulate exposure is associated with altered redox balance in the lung in 
both intracellular and extracellular compartments 
2. Redox balance in the alveolar macrophage alters innate immune function 
3. Particulate exposure is detrimental to alveolar macrophage function 
 
  
This chapter includes all methodologies used in the project which generated the 
finalised data reported in subsequent results chapters. A number of methods were 
initially tested for fitness, and were unworkable in the context of this project. These 
are included in section 3, together with details of optimisation experiments for those 
methods which have been used. 
 
Ethical approval for the studies were granted as follows:  
Table 2-1 Ethics committee approval for the project in the UK and in Malawi 
Study Ethics body Approval 
number 
Date granted 
Antioxidant defence in the 
lung (UK) 
Cheshire Research Ethics 
Committee (NHS) 
09/H1017/82 14/07/2009 
The role of redox balance in 
pulmonary innate immune 
responses (Malawi) 
Liverpool School of Tropical 
Medicine, UK 
09.69 14/01/2010 
amended 
19/05/2011 
The role of redox balance in 
pulmonary innate immune 
responses (Malawi) 
Malawi College of Medicine 
Research Ethics Committee 
(COMREC) 
P.03/10/916 17/06/2010 
The role of redox balance in 
pulmonary innate immune 
responses – phase 2 (Malawi) 
Malawi College of Medicine 
Research Ethics Committee 
(COMREC) 
P.03/11/1063 06/05/2011 
 
  
Adult volunteers for bronchoalveolar lavage were recruited according to the ethics 
protocols listed above. This included advertising in the local university and 
hospital. Consent was performed in two stages: firstly, a preliminary meeting with a 
member of the study team in order to disseminate information both written and 
oral, and to provide opportunity for early exclusion of those individuals not 
meeting inclusion criteria; secondly, written informed consent in the presence of a 
different member of the study team with full medical examination in order to 
determine fitness for the study procedures. 
All volunteers were healthy adults aged 18 to 50, who had no significant pre-
existing chronic health problems. Exclusion criteria were pregnancy, recent (within 
six months) pulmonary infection, previous tuberculosis. Two cohorts were 
recruited: non-smokers who had not smoked any tobacco or marijuana in the last six 
months; smokers who admitted a regular smoking habits of 10 cigarettes per day or 
more. 
 
Volunteers were recruited by word-of-mouth, and relied on a formal community 
structures whereby village leaders (Chairmen) were asked to disseminate 
invitations to volunteer for the study. Thereafter all information and consent was 
taken in the hospital setting (Queen Elizabeth Central Hospital Blantyre). Consent 
procedures were identical to those used in the UK except that the local language 
(Chichewa) was used for both dissemination of information and consent. 
 
 Exclusion criteria were designed to minimise variability within the volunteers due 
to pathological processes and aging, and for reasons of safety relating to 
bronchoscopy. Exclusion criteria were: 
• Pregnancy or lactation 
• HIV infection (due to the potentially overwhelming confounding effect 
on results) 
• Based on clinical history and examination findings, the presence of an 
underlying health problem which would potentially increase the risk 
associated with bronchoscopy, specifically:  
o Chronic lung disease, including COPD, recurrent chest infections,  
o Chronic heart disease, including heart failure and valvular heart 
disease 
o Previous maxillofacial surgery 
o Previous reactions to medications used during the procedure 
(benzodiazepines) 
• Chest radiograph showing evidence of chronic or active lung or heart 
disease 
• Use of prescribed medications excluding oral contraceptives (due to the 
potential for difficulty in interpreting results 
• Use of antibiotics in the preceding 4 weeks 
• FEV1 <75% predicted (on screening breathing tests) 
• Potential for communication difficulties during bronchoscopy (due to 
language, hearing or understanding) 
• Inability to give informed consent 
 
 Blood was drawn from the antecubital fossa using a Vacutainer system (BD 
Medical, UK). Skin was prepared with 75% isopropyl alcohol, and clean technique 
and universal precautions were used. Specific tubes were collected according to the 
sample required: serum into clot activator (SST tubes, BD); selenium, copper and 
zinc into trace elements tubes (BD); plasma and anti-coagulated blood into 
potassium (K2) EDTA tubes (BD). Samples for lipid peroxide measurement were 
stored on ice until used to prevent degradation. For preparation of peripherally 
derived mononuclear cells, blood was taken into a 50mL syringe, and immediately 
mixed with potassium EDTA to a final concentration of 1.8mg/mL of blood before 
being stored on ice for transport to the laboratory. 
 
Urine was collected from volunteers on the day of bronchoscopy into a universal 
container, and kept on ice until laboratory preparation. Cellular debris was removed 
by centrifugation at 500g for 5minutes before storage in aliquots at -80oC. Urinary 
concentrations were subject to standardisation according to the formula given by 
Heavner346. This assumes that for a spot-test, the ratio of urinary analyte to total 
solute concentration remains constant even where urinary flow fluctuates. This 
formula is validated where paired serum and urinary creatinine values are not 
available, and where more specific details of the urinary excretion kinetics are 
unknown (Equation 7) 
Equation 7:                               (
       
                  
) 
Urinary specific gravity was measured using a manual refractometer with 
automatic temperature compensation (Zhangzhou Sino Science & Technology Co., 
Ltd, China. Cat#RHC-200ATC) calibrated to a blank of distilled water. 
 Primary human alveolar macrophages behave differently than other human cellular 
models (see section 4.3.1), and discrepancies with animal studies are common. This 
project aimed to study innate immunity in context of “natural” exposure in human 
populations, and this justifies the use of human alveolar macrophages. Previous 
research studies have found bronchoalveolar lavage (BAL) to be well tolerated and 
safe; the protocol detailed below is a development of those used by these projects347-
350  
Standard operating procedures for bronchoscopy were the same in both UK and 
Malawi sites, and consistent with guidelines issued from the British Thoracic 
Society351. Preparatory measurements of blood pressure, heart rate, pulse oximetry 
and respiratory rate were taken. The mucosal surface of the nasopharynx was 
anaesthetised with topical lignocaine gel (CliniMed Limited, UK), and with 
lignocaine spray to the oropharynx (Xylocain 10%, AstraZeneca, UK). Sedation of 
the volunteer was rarely performed, and only used in the UK. In these cases, 
intravenous midazolam was administered according to response with the aim of 
reaching a relaxed but coherent state in the volunteer. Further topical anaesthesia at 
the level of vocal cords was achieved with 4% lignocaine, and 2% lignocaine was 
used in the larger airways. The maximum dose used was 8.2 mg per kilogram. 
Bronchoalveolar lavage was performed by advancing the bronchoscope to a sub-
segmental bronchus of the right middle lobe in order to achieve a seal. Warmed 
sterile normal saline was instilled in four aliquots to a total volume of 200mL. 
Lavage fluid was withdrawn by gentle suction after each aliquot, and stored on 
melting ice until laboratory preparation. 
Supplemental oxygen was not routinely used, but was given in cases where pulse 
oximetry indicated saturations of less than 92% during the procedure. All 
volunteers were reviewed before discharge for immediate complications, and 
returned within 72 hours for further review and clinical examination. 
 
 
Total glutathione was measured using the assay developed by Anderson352 and 
Tietze353 which is based on the reaction of glutathione with 5,5’-dithiobis-(2-
nitrobenzoic acid) (DTNB). Reduced glutathione (GSH) is oxidised by DTNB to give 
oxidised glutathione (GSSG) with formation of 5-thio-2-nitrobenzoic acid: 
Equation 8:           →         
GSSH is reduced to GSH by the specific enzyme GSSG reductase, which is 
dependent on nicotinamide adenine dinucleotide phosphate (NADPH): 
Equation 9:               
              
→                         
From Equation 8, the rate of TNB formation is proportional to the sum of GSH and 
GSSG present, given constant temperature. It can be followed by measuring 
absorbance at 412nm, and used to determine total glutathione. In order to measure 
oxidised glutathione, 2-vinylpyridine is used to sequester GSH, and the assay 
repeated to measure GSSG only, and calculated as Equation 10. 
Equation 10: [                                
It should be noted that each molecule of GSSG is equivalent to two of GSH. 
Throughout this work, glutathione concentrations are reported in GSH equivalents. 
  5% (w/v) 5-sulphosalicylic acid (5-SSA. Sigma, UK. Cat#247006) in 
deionised water 
 Glutathione reductase from yeast (600U/mL: Roche Diagnostics Ltd, 
UK. Cat#10105678001) 
 Glutathione - oxidised form (GSSG) (Mw = 612.6, Sigma, UK) 
 Glutathione - reduced form (GSH) (Mw = 307.3, Sigma, UK. 
Cat#G6529) 
 Stock buffer: 143mM Disodium hydrogen phosphate Na2HPO4 (Mw = 
141.96), 6.3mM tetrasodium EDTA dihydrate (Mw = 416.20), pH 7.5 
 Reaction buffer: 0.3mM NADPH (Mw = 744.4, Sigma-Aldrich, UK. 
Cat#N1630) in stock buffer, made daily and stored on ice 
 DTNB solution: 6mM 5,5’-dithiobis-(2-nitrobenzoic acid. Mw = 396.35. 
Sigma, UK. Cat#D8130) in stock buffer 
 Triethanolamine 50% w/v (TEA. Sigma, UK. Cat#90278) 
 2-vinylpyridine (2VP. Sigma, UK. Cat#132292) 
 
When using cells from bronchoalveolar lavage, 30mL of whole BAL fluid was spun 
at 4oC at 500g for 5 minutes. The supernatant was saved, and the pellet 
(approximately 106 cells) was dissolved in 500µL cold 5% 5-SSA. For assays of 
plated macrophages, 2x106 cells in 6 well plates were scraped into 250µL cold 5% 5-
SSA using a cell scraper. These steps were performed as cold and as quickly as 
possible to prevent oxidation of GSH prior to the addition of 5-SSA. The resulting 
suspension of lysed cells was pelleted by centrifugation (10000rpm for 5 minutes, 
4oC). The supernatant was assayed for glutathione, and the precipitate was frozen at 
-30oC pending total protein analysis by the Lowry method. Standards were made 
fresh by serial dilution of a 50:50 mixture of oxidised and reduced glutathione in 5% 
5-SSA to give a range of 10.4µM to 0.325µM. Blanks contained 5% 5-SSA only. 
For total glutathione, sample supernatants were diluted 10x in 5% 5-SSA. Samples 
for oxidised glutathione were derivitivized in triplicate, each by the addition of 2µL 
2-VP to 100µL sample, with vigorous vortexing. The pH of each derivitivized 
sample was brought to between 6 and 7 by addition of 50% triethanolamine in 
water, and samples were left at room temperature for 1 hour to allow full 
degradation of the 2-VP before analysis. Standards for the oxidised glutathione 
assay were obtained using the same process, giving a range of 5.2µM to 0.325µM. 
Standards and samples (20µL each) were pipetted into 96 well plates in triplicate. 
Immediately before starting the kinetic assay, the reaction mixture (8.4mL daily 
buffer, 1.2mL DTNB, 1.2mL H2O) was mixed with 120µL glutathione reductase. 
Immediately, 200µL of this solution was added to each well using a multichannel 
pipette, and the absorbance of each well at 412nm was recorded using a plate reader 
(Fluostar Omega, BMG Labtech, UK), reading every 20 seconds. The reaction 
undergoes linear kinetics until the DTNB oxidation is saturated or NADPH 
availability becomes limiting. Standard curves were derived from the linear portion 
(usually until 8 minutes), and used to calculate sample concentrations (see section 
3.2). 
  
  
Cytospin produce a relatively uniform scattered monolayer of cells from a 
suspension. Centripetal force acts to evenly disperse cells from a fine aperture 
plastic funnel outwards onto a microscope slide. These preparations were used to 
obtain a cellular differential count and in order to quantify cytoplasmic carbon area 
by image analysis (using Fields B stain, Sigma, UK). For differential counts, 
following fixation in methanol, slides were sequentially subjected to: May-
Grunwald-Giemsa stain for 10 minutes; rinse buffer pH 6.8 briefly; Giemsa stain for 
15 minutes; acetone briefly to dehydrate the sample. 
 
A volume of 70µL was used in each funnel, at cell concentrations of 3.3x105/mL and 
6.7x105/mL. These were spun at 450rpm for 5 minutes in a Shandon Cytospin 
(Thermo Scientific, UK). Slides were air-dried. Fixation in methanol was used for 
staining purposes. 
 
 
Concentrations of selenium and other trace metals can be accurately quantified by 
Inductively Coupled Plasma Mass Spectrometry (ICP-MS), as previously 
published354. Within a plasma of argon formed in a radio frequency magnetic field, 
samples or interest are partially ionised, thus allowing detection of components of 
the sample, particularly metal ions. These are detected by mass spectroscopy  
Samples used for calibration are blanks, 1.9µmol/L and 3.8µmol/L. Quality 
assurance was done using a stable lyophilised human based serum (Seronorm, 
Biostat, Norway). Indium is added to the sample as an internal standard355. 
For selenium, six isotopes stably exist (74, 76, 77, 78, 80, 82)355. Two of these are 
measured: 77Se and 82Se. Due to limitations of the ICP-MS the most abundant 
isotopes are not easily quantified (76S and 80S due to the presence of argon dimers 
formed from 40Ar, and 38Ar). However, these are considerably reduced in this assay 
by the use of butan-1-ol as diluent. Results assume that the ratio of isotopes is 
relatively constant; although abundance in soils varies considerably, the absolute 
proportion of each isotope varies by less than 3%356. 
 
 Diluent: 1% nitric acid, 0.2% butan-1-ol, 0.2% propan-2-ol, 10 ppb 
indium (VWR) 
 Seronorm (Bio-Stat Diagnostics, Norway) 
 Selenium atomic absorption standard solution 1000µg/mL (Sigma-
Aldrich) 
 
All samples were prepared, analysed and reported by the Biochemistry department 
of the Royal Liverpool University Hospital as part of the routine analysis for NHS 
patients. After dilution 1:9 of the sample in diluent, 100µL was injected into the 
plasma and assayed using indium as an internal standard.  
  
  
Descriptions of macrophage phenotype have undergone considerable change in 
recent years. At least in mouse models, a spectrum of activation is accepted with 
variations in the degree of expression of certain receptors, and the phenotype of the 
macrophage357, 358. These have been divided into M1 and M2 designations to denote 
inflammatory and anti-inflammatory type macrophages respectively. Further 
subdivision of M2 types has been suggested (see Table 2-2) although plasticity of 
phenotype is well recognised, and in vitro macrophages may be switched between 
these phenotypes depending on external stimuli359. Transcriptional profiling has 
defined these macrophage populations more specifically. Genes may be defined by 
type: “M1” type if they are up-regulated in response to INFγ or LPS; M2 if up-
regulated by Th2 cytokines IL-4 or IL-13 (designated alternately activated), IL-10 
(deactivated), or another anti-inflammatory stimulus such as TGF-β or 
glucocorticoids360.  
Table 2-2 Surface markers of human macrophage activation 
α γ
α
β
α
β
Phenotypic classification is not complete: in some cases surface markers have not been specifically reported or are 
of variable expression; these are designated “O” above 
In order to characterise human alveolar macrophages, we used a panel of surface 
markers, with mouse antibodies as detailed in Table 2-3. 
 
Table 2-3 Antibody cocktail use for alveolar macrophage phenotyping 
 
Ex vivo macrophages were washed twice in PBS with braked centrifugation at 500g 
for 5 minutes. Antibodies were added as above in a total volume of 100µL made up 
with PBS. After 20 minutes incubation at RT, three further washes were performed 
to remove unbound antibodies. Flow cytometry was performed using appropriate 
excitation and filter combinations. Colour compensation was also acquired using 
single-labelled samples. Analysis was performed in FlowJo software v7.64 (Tree 
Star, Inc. USA). 
 
Particulate exposure in the lower airways may be quantified by light microscopy of 
alveolar macrophages347. Digital image analysis of cytospin preparations are stored 
and analysed using freely available ImageSXM software v1.92 (Dr Steve Barrett, 
University of Liverpool, UK. Available from: http://www.liv.ac.uk/~sdb/ImageSXM/ 
Slides fixed in methanol were stained with Fields B (Sigma, UK) in order to identify 
cytoplasm. An overview of the digital image processing and analysis is shown in 
Figure 2-2. Nuclear stain is not applied, as previous evaluation showed that this 
tends to make image analysis less accurate361. Accurate results rely on careful 
standardisation of both the staining and analysis protocols. Staining is standardised 
to 10 seconds exposure to stain with rapid draining; images were taken with the 
condenser focus fully raised, and the diaphragm fully open in order to reduce the 
dark appearances of cell outlines; at least 50 images were taken for each individual. 
Within the slide, images were taken according to a predetermined path in order to 
minimise operator bias (see Figure 2-1). 
Figure 2-1 Path taken when recording digital images for analysis. 
 
The circle in this diagram represents the outer border of the cell “spot” generated from cytospins. 
Each image was visually assessed for accuracy by comparing the original slide to 
the computer generated map of cytoplasmic carbon. Images were excluded from the 
analysis only if slide artefact has introduced over-identification of particulate.  
  
Figure 2-2 Overview of the digital image analysis performed by ImageSXM 
  
 Two forms of particulate were used in challenge experiments. Ultrafine carbon 
black (Printex 90, Degussa, Germany) was used where relatively inert particles were 
required. These have relatively little adsorbed metal ions, and a consistent diameter 
of 90 nm. In vitro challenge experiments used a fine suspension of this powder 
created by sonication in culture medium to the required density. 
In vivo smoke exposure was modelled using particulates obtained from a controlled 
combustion of wood commonly used in Malawi for cooking. Mopani wood from 
Blantyre was burnt at University of Aberdeen (Dr S Semple) and the method used 
resulted in collection of respirable size particles. The resulting smoke was drawn 
over a polycarbonate isopore filter with 2µm pore size (Millipore, MA USA), using 
an Apex pump (Casella CEL, Bedford, UK) attached to a Higgins-Dewell cyclone 
(respirable dust) at a flow rate of 2.2L/min. The filters were kept dry and cold (4oC) 
until particulate extraction into methanol. Briefly, filters were weighed before 
submerging in HPLC grade methanol (Sigma, cat #34898). The particulate 
suspension was produced by serially sonicating in a water bath (Thermo Scientific, 
UK), each time for 2 minutes repeated five times. The filter was removed, air dried, 
and re-weighed in order to determine the mass particulates removed. Appropriate 
aliquots of the methanol suspension approximating 250µg of particulate were then 
made in glass vials and dried over nitrogen gas. In order to distribute the nitrogen 
to multiple vials and minimise exposure time, it was dispensed through a plate 
washer (Immuno Wash 12, Nunc, UK) as shown in Figure 2-3). 
Figure 2-3 Preparation of smoke extract 
 
Left: Plate washer used to dispense dry nitrogen gas for drying methanol suspensions. 
Right: Resulting dehydrated particulate sample ready for resuspension in culture medium. 
Dried particulate samples were stored at -80oC until required. Resuspension was 
performed by adding culture medium to the vial to the correct concentration, and 
sonicating in a water bath until a fine suspension was seen. 
 
 
Streptococcus pneumoniae was used as the bacterial model of infection due to 
epidemiological evidence that it is the most common cause of pneumonia in sub-
Saharan Africa362. Clinical isolates of type 2 D39 serotype have been previously 
isolated (WT). Additionally, we used a mutated form from which amino acids 55 to 
437 of the pneumolysin product have been removed by an in-frame deletion363. This 
type is referred to as ΔPly in the original work, and here. 
Supernatants of the bacterial culture were used in stimulation experiments to test 
the potential effect of bacterial proteins on the alveolar macrophage during 
pneumococcal infection. The relative impact of pneumolysin could also be assessed 
by comparison of the D39 wild-type with ΔPly strain. 
 Clinical isolates of D39 type Streptococcus pneumoniae were grown on blood agar 
overnight. The correlation of bacterial density to optical density was previously 
determined by removing small aliquots every hour, plating out according to Miles-
Misra protocol (see 2.13, carried out by Dr E Sepako, MLW, Malawi) and 
quantifying colony forming units. Three colonies were transferred to Todd Hewitt 
broth, and grown to an estimated density of 1x108/mL (OD=0.4 at 620nm). 
Growth was terminated by centrifugation (3000g, 30 minutes), after which the 
supernatant was passed sequentially through 0.45µm and 0.2µm filters under 
suction (Nalgene 20mm filter unit, 250mL capacity, UK). Filtered supernatant was 
concentrated approximately 10x by centrifugal ultrafiltration across a 
polyethersulfone membrane (Vivaspin 20, Vivaproducts, UK). Protein concentration 
of the concentrate was determined by the Bradford method (see 2.15) in order that 
known concentration could be added to in vitro challenge experiments. 
Using this method, bacterial suspensions were grown to mid-log phase before 
freezing aliquots at -80oC with 10% glycerol for future use. 
 
Quantification of the bacterial concentration is used here for two purposes: 
1. To enable correlation of optical density of media containing viable bacteria 
with concentration of those bacteria 
2. To check post-hoc that bacteria numbers in some assays are consistent over 
time 
The Miles and Misra technique364 counts colony forming units (CFU) by surface 
counting on blood agar plates. In order to estimate counts over a wide range of 
concentrations, sequential dilutions of the suspension to be assayed are made in 
phosphate buffered saline. Typically six log10 dilutions are made. Each resulting 
suspension is dropped onto a different demarcated area of a blood agar plate. A 
total of 30µL in 3 separate spots are used and left to air dry before overnight 
incubation at 37oC in an environment of 5% CO2. Concentrations of bacteria are 
determined from the area with the most individually identifiable colonies. The CFU 
is given by Equation 11. 
                         
  
    
                
 
 
A number of methods were used for determining protein concentration. This was 
due to the relative limitations of each method according to sample type, and 
convenience of measurement. 
The Lowry method365 was used specifically for analysis of highly alkaline sample 
required analysis: glutathione levels reported throughout this project are corrected 
to Lowry determined protein concentrations. Under alkaline conditions, an excess of 
divalent copper chelates peptide bonds, forming univalent copper ions in 
proportion to the concentration of peptide bonds (the Biuret reaction). This 
subsequently is used to reduce Folin-Ciocalteu reagent (a mixture of 
phosphomolybdate and phosphotungstate) which itself undergoes a colour change 
in the reduced state, thereby increasing the sensitivity of detection by ten times. 
Concentrations of reduced Folin-Ciocalteu reagent were measured by absorption at 
750nm in a microplate. Bovine serum albumin (BSA) was used as a standard. Where 
samples fell outside the standard range, dilutions were performed, with appropriate 
corrections.  
  Bovine serum albumin standard 1mg/mL (Sigma, UK. Cat #P0914) 
 2% sodium carbonate (Na2CO3, Mw = 106) in deionised water 
 2% sodium-potassium tartrate (KNaC4H4O6·4H2O, Mw = 282.1) in 
deionised water 
 40mM copper sulphate solution (CuSO4.5H2O, Mw = 249.68). Stored in 
the dark 
 Folin-Ciocalteu reagent (Sigma-Aldrich, UK. Cat #47641) 
 
Samples were digested in 1M sodium hydroxide for 3 hours at 37oC. Standards were 
prepared fresh in the same diluent. In a microplate 20µL of standards and samples 
were pipetted in triplicate. 200µL of freshly prepared Biuret solution (1:1:100 
mixture of copper sulphate, sodium tartrate, sodium carbonate) was added to each 
well using a multichannel pipette. The microplate was agitated and incubated in the 
dark. Exactly ten minutes after the introduction of Biuret solution, 20µL of 50% 
Folin-Ciocalteu reagent in water was added. After further two hour incubation in 
the dark366, absorption was read from each well at 750 nm. 
 
The reaction of Coomassie brilliant blue G250 with proteins in solution causes a 
protein-dye complex to form. This results in a change of absorption in the solution 
from a peak of around 465 nm to 595 nm. Briefly, commercially obtained Bradford 
solution was used (Sigma, UK. Cat # B6916) according to the manufacturer’s 
instructions against standards of BSA from 50µM to 1mg/mL (Sigma, UK. Cat 
#P0914). Samples and standards were run in triplicate, and absorption at 595 nm 
read by a plate reader (BMG Omega, BMG Labtech, UK). 
  
Quantification of cytokines and chemokines in the experimental supernatants of in 
vitro challenge measurements was performed by multiplex bead cytokine array 
analysis using the Luminex platform. Custom kits were provided by R&D systems, 
UK. 
In principle this is a sandwich ELISA technique couples with flow cytometric 
detection through which quantitative measurements of multiple target proteins can 
be made (see Figure 2-4). Sets of microbeads are variously identifiable by their size 
and degree of labelling with a fluorophore. Each set is also covalently bound to an 
antibody against a specific protein of interest (here, a cytokine). The “sandwich” 
formed by the bead, the target protein, and the reporter antibody conjugate (biotin-
streptavidin-PE) can be detected by flow cytometry. As each bead set is unique, the 
concentration of each target protein can be measured indirectly by the intensity of 
PE wavelength fluorescence after comparison to a set of standards of known 
concentration. 
Figure 2-4 Detection of protein by multiplex bead array 
 
Bead analytes are recognised according to intensity of primary flurophore label and bead size. The signal 
from PE flurophore is read by a second laser. Concentrations are determined accoridng to a standard 
curve generated using purified, standardised cytokines 
 
A panel of cytokines were tested using a kit from R&D systems according to the 
manufacturer’s instructions. Analytes were chosen in order to reflect the profile of 
inflammatory and anti-inflammatory cytokines, and specifically those thought to be 
regulated by the redox environment of the cell. Results were reported uncorrected 
for multiple comparisons; such corrections in this case are too conservative given 
that behaviour of individual cytokines are highly likely to be related367. 
For a full justification of the choice of analytes, and further details see 5.3.1. 
 The principle of HPLC is that the hydrophobic and molecular weight properties of 
molecules may be used to separate components of a mixture in solution. Samples 
are dissolved in a solvent and injected under high pressure into a sealed porous 
column. The time taken to pass through this column depends on the polar 
characteristics of the substances being analysed and those of the solvent, the 
molecular weight and the properties of the column. By measuring absorbance or 
fluorescence properties of the eluted fluid at specific time points, the molecular 
composition of the sample may be quantified368. 
Lipid peroxides are formed within polyunsaturated fatty acid residues as a result of 
reactive oxygen species, particularly the hydroxyl ion. This is commonly formed by 
the Fenton reaction of molecular iron with hydrogen peroxide and may be initiated 
in the presence of haem groups369. The resultant result of the loss of hydrogen atom 
from CH2 groups destabilises the molecule which rearranges to a conjugated 
diene370. Propagation of lipid peroxidation may occur along the fatty acid chain by 
the reaction of oxygen with the diene forming a peroxyl radical142. Ultimately, the 
lipid hydroperoxides may generate secondary products which can lead to further 
cellular damage. Malondialdehyde (MDA) is one such substance which may be 
determined by the thiobarbituric acid reacting substances (TBARS) assay. 
Some criticism of this method is made in that there are other sources of 
malondialdehyde from within cells including the production of prostaglandins. 
However the vast majority of cellular MDA relates to oxidative damage to lipids: as 
a measure of the effect of reactive oxygen species it is well validated371. A second 
criticism levelled at this assay is that it is non-specific, and other adducts of 
thiobarbituric acid may be formed during the assay reaction. However, by using 
reverse phase high pressure liquid chromatography (HPLC), those formed with 
MDA may be separated and individually quantified372. 
In this method, an HPLC column composed of octodecyl carbon chain (C18) is used 
with a pore diameter of 5nm. The solvent is 20% acetonitrile, run at 1mL/minute. 
MDA:TBARS adducts pass through the column in around 4.8 minutes. Older 
methods have used absorption measurement at 533nm as an endpoint. However 
fluorescence detection after HPLC has increased the sensitivity and specificity of the 
assay372. Here an excitation wavelength of 515 nm was used while monitoring 
fluorometrically emission at 553nm. 
 
 HPLC column (Sphereclone 5µm ODS 1 250x4.6mm, Phenomenex, 
Macclesfield, UK) 
 Autosampler (Gynkotech Gina 50, Macclesfield, UK) 
 Fluorescence detector (Gilson model 121 fluorometer, Gilson, Middleton, 
USA) 
 2M sodium acetate pH 3.5: made by titration of 2M glacial acetic acid (Mw = 
60.05, Sigma, UK. Cat #320099) with 2M sodium acetate trihydrate 
(NaC2H3O2.3H2O, Mw = 136.08, Sigma, UK. Cat #71188)  
 2% w/v 2-thiobarbituric acid: 40mg (C4H4N2O2S, Mw = 144.15. Sigma, UK. 
Cat #T5500) in 2M acetate buffer 
 5% w/v butylated hydroxytoluene (BHT, [(CH3)3C]2C6H2(CH3)OH, Mw = 
220.35. Sigma, UK. Cat #W218405) in ethanol 
 4.4M 1,1,3,3,-tetraethoxypropane (TEP, density 0.919 g/mL at 25°C, Mw = 
220.31. Sigma, UK. Cat # T9889) 
 20% acetonitrile (CH3CN, density 0.786 g/mL at 25°C, Mw = 41.05. Sigma, 
UK. Cat# 34967) in water 
 Butan-1-ol (CH3(CH2)3OH, density 0.81g/mL at 25°C, Mw = 74.12. Sigma, UK. 
Cat # 34867) 
 
Pilot experiments informed the dilution range of clinical samples. Using 2M acetate 
buffer (pH 3.5), urine was diluted 1 part in 9 parts buffer; serum was diluted 1 part 
in 10 parts buffer; cell suspension from bronchoalveolar lavage was diluted 1 part in 
9 parts buffer 
In order to form TBA adducts, 20µL 2% TBA and 3µL 5% BHT were added to 200µL 
of each sample and standard. This reaction was performed at 95oC for 1hour, after 
which samples were kept on ice. To each mixture 100µL butanol was added for 
extraction. After vigorous vortexing, samples and standards were centrifuged at 
20000g for 5 minutes, and the resulting top butanol layer transferred carefully into 
glass HPLC vials without contamination with the aqueous layer. 
HPLC detection was performed in a mobile phase of 20% v/v acetonitrile in water. 
Sample volumes of 20µL were introduced to the HPLC column running at 
1mL/min. Detection by fluorescence (excitation=530nm emission=553nm) 
demonstrated peaks at between 4.5 to 5 minutes; signal area and peak height of all 
samples and standards were recorded from the detector. Sample concentrations are 
calculated from the resulting standard curve. 
 
 
Internalisation of particles by macrophages may occur by a number of pathways 
depending on the particle size and characteristics, and the receptor engaged (see 
section 1.1.4.1). Other stimuli may direct a less inflammatory process of phagosome 
destruction373. For example, apoptotic cells have alternative and poorly delineated 
pathways for recognition and removal which are distinct from those used for 
microbial and other non-self particulate matter374. 
Russell and colleagues have developed assays of this intraphagosomal bacterial 
killing capacity375. These assays measure the maximal capacity of macrophages to 
produce oxidative burst and proteolytic activity within the phagolysosome. The 
method involves challenge of adherent macrophages with silica beads which are 
coated with the reporter molecule which acts as a substrate for either the oxidative 
burst pathway (Oxyburst fluorochrome), or the proteolytic pathway (DQ Green BSA 
conjugate). The increase in fluorescence of the reporter substances is a quantitative 
measure of phagosomal activity which may be detected using flow cytometric or 
plate-based fluorometric readers. 
Figure 2-5 Diagram of Oxyburst / DQ Proteolysis beads. 
 
Carboxylated silica beads are conjugated to immunoglobulin, reporter fluorochrome and calibrator 
fluorochrome. The ratio of calibration and reporter fluorochrome is constant and allows the use of 
fluoresence ratios as a metric of the degree to which the reporter fluorochome chnages. 
In order to enhance uptake into the macrophage and to direct beads to the 
phagosome, the silica beads are coated in immunoglobulin (IgG). Co-labelling with 
a second fluorophore which is unchanged by phagosomal reactions allowed 
calibration of the system, and the use of ratios to define activity. Reporter 
fluorochromes are excited at 488nm, whereas calibration fluorophore may be chosen 
to excite best at 405nm or 633nm. 
Conjugation is accomplished using carbodiimides which allow cross-linking of 
carboxyl groups376 on the silica beads to primary amines within the BSA. 
 
 Carboxymethylated silica beads of 3µm diameter (Kisker Biotech, 
Germany) 
 Dimethylsulfoxide (DMSO) (Sigma, UK. Cat#D2650) 
 OxyBurst Green succinimidyl ester (H2DCFDA-SE, Invitrogen, UK. 
Cat#D2935) dissolved to 25mg/mL in DMSO 
 DQ-BSA Green conjugate (3x1mg) (Invitrogen, UK. Cat#D12050) 
 Alexa 405 succinimidyl ester (Invitrogen, UK. Cat#A30000) dissolved 
to 5mg/mL in DMSO 
 Human IgG 10mg/mL (Sigma, UK. Cat#I4506) 
 N,N’-dicyclohexylcarbodiimide (Sigma, UK. Cat#36650) 
 Bovine serum albumin (BSA) defatted and low endotoxin 10 mg/mL 
(Sigma, UK. Cat#A8806) 
 Sodium borate 0.1M buffer at pH 8.0 
 Sodium azide (Sigma, UK. Cat#S8032) 
 
250µL of silica beads were washed twice in phosphate buffered saline using a 10 
second quick spin at 5000 rpm to precipitate out the beads after each wash. Beads 
were re-suspended in 1 mL phosphate-buffered saline, and added to 20 mg of N,N’-
dicyclohexylcarbodiimide. The mixture was incubated for 20 minutes at room 
temperature on a rotational mixer. Three further washes in phosphate-buffered 
saline were performed to remove excess carbodiimide. From this point, all 
manipulations of the beads were performed quickly in lowlight conditions, and 
incubations performed on a rotational mixer at room temperature while protected 
from light. 
In order to conjugate to DQ substrate, the bead pellet was re-suspended in 1mL 
coupling buffer, 10µL IgG and 3mg of DQ-BSA. Incubation for 12 hours is allowed 
for this conjugation to take place. 
For conjugation to Oxyburst substrate the method differs: to the bead pellet, a 
mixture of 900µL coupling buffer, 100µL of defatted BSA and 10µL of IgG was 
added. After an incubation of 12 hours followed by three washes in coupling buffer, 
the beads were incubated in 5µL Oxyburst-SE and 95 mL of DMSO for 60 minutes. 
The beads were rinsed once in coupling buffer and the Oxyburst labelling step 
repeated once. 
From this point, both DQ and Oxyburst label beads were treated similarly in order 
to couple to the calibration fluorochrome. After two washes in coupling buffer, the 
beads were re-suspended in 1mL coupling buffer with 5µL Alexa 405 and incubated 
for 60 minutes at room temperature. To further washes in coupling buffer and one 
wash in PBS were performed to remove excess unconjugated calibration 
fluorochrome. The prepared beads were stored in 500µL PBS with sodium azide 
0.02% at 4oC in the dark. 
 
For mechanism of labelling and detection, see 2.18. Macrophages ex-vivo were 
plated at 1x106 per well in a 24 well plate and allowed to adhere for at least two 
hours. Cells were washed once with RPMI1640 with 5% FCS. For each well to be 
tested, 1.5µL of pre-prepared detection beads (see 2.18) were washed three times in 
RPMI1640 with 5% FCS before being added to the plate to a total well volume of 
500µL. At 10 minutes, excess beads were washed off in PBS, and the medium 
replaced. For cell removal, the wells were filled with cold citric saline solution 
(0.015M sodium citrate, 0.135M potassium chloride) to effect detachment of the cells. 
After five minutes incubation, cell suspensions were removed, centrifuged at 450g 
for 5 minutes and suspended in PBS with 1% formaldehyde for flow cytometry 
analysis. 
For each volunteer, a number of controls were used (see Table 2-4 and section 3.8). 
Table 2-4 Oxyburst and proteolysis bead assay – controls and samples 
 
Flow cytometry was performed using a Beckman Coulter Cyan system. Detection of 
the reporter fluorochromes used 488nm excitation, 520nm emission, and calibrator 
fluorochromes were detected through 405nm excitation, and 420nm emission. Strict 
analytical procedures were followed in order that bias was minimised. Steps are 
illustrated by flow cytometry output summarised below, and illustrated in Figure 
2-6. 
1. Bead and cell samples were captured using the same detector voltages. A 
“cell gate” was set on macrophages to exclude unbound beads using 
forward scatter (FSC) and side scatter (SSC) parameters 
2. The “cell gate” was adjusted if necessary using the FITC channel 
fluorescence of unlabelled cells to identify macrophage autofluorescence and 
to minimise the inclusion of cell debris 
3. A bifurcating gate was set within the cell gate at the 98th centile of 405/420nm 
channel of unlabelled cells. This was applied to all bead-challenged cells and 
enabled consistency in identifying macrophages with and without associated 
beads 
Activity indices of Oxyburst and proteolysis detecting beads were calculated 
according to Equation 12, Equation 13 and Equation 14. 
Equation 12: 
               
                                     
                                       
 
 
Equation 13: 
               
                    
                      
 
 
Equation 14:                
              
              
 
Figure 2-6 Gating strategy for analysis of phagosomal bead assay 
  
Nrf2 is a protein with a short cytoplasmic half-life due to its continual degradation 
by the proteasome377. Under the action of electrophilic attack or oxidative stress 
however, this destructive pathway is slowed resulting in increased cytoplasmic 
concentrations of unbound Nrf2293. Concomitant translocation to the nucleus 
occurs378 where Nrf2 has a role as transcription factor for genes associated with the 
antioxidant response element (ARE). Downstream effects of this transcription factor 
include translation of a number of cytoprotective proteins including those for 
glutathione and thioredoxin homeostasis, antioxidant enzymes (GPx, GR, TrxR), 
NADPH regenerating enzymes379. 
Western blotting allows specific detection of this Nrf2 and other proteins or peptide 
fragments in solution. Prior fractionation of cellular components may be performed 
in order to specifically measure cytoplasmic or nuclear Nrf2. In this project, whole 
cell concentrations of Nrf2 are reported unless otherwise stated. This assumes that 
cytoplasmic concentrations are proportional to those in the nucleus, and therefore to 
the expected increase in ARE transcription activity380. 
The process involves denaturation of proteins, followed by their electrophoretic 
separation on an SDS-PAGE gel according to their relative properties of size and 
electrical charge. This is followed by transfer of these separated proteins onto a 
membrane in order that they may be probed by specific (primary) antibodies. 
Detection systems vary, but in this case a secondary antibody conjugated to 
horseradish peroxidase (HRP) was used to detect the antibody-antibody-antigen 
conjugate. This uses light produced by the HRP catalysed oxidation of luminol by 
hydrogen peroxide: the light emitted is detected by photographic film or by charge-
coupled device.  
 
 NuPAGE sample buffer (Life Technologies, UK. Cat#NP0007) 
 NuPAGE sample reducing agent (Life Technologies, UK. Cat#NP0009) 
 NuPAGE 4-12% Bis-Tris gel 1.5mm 15 well (Life Technologies, UK. 
Cat#NP0336) 
 3-(N-morpholino)propanesulfonic acid buffer (MOPS buffer, 20x) 
 209.2g MOPS (Sigma, UK. Cat#M1254); 121.2g Tris base (Sigma, UK. 
Cat#T1503); 20g SDS (Sigma, UK. Cat#L4390); 6g EDTA (Sigma, UK. 
Cat#E9884) in water 
 Transfer buffer (10x) 
 150.2g glycine (Sigma, UK. Cat#G8898); 30.3g Tris base (Sigma, UK. 
Cat#T1503) in 1:2:7 ration of 10x transfer buffer: methanol: water 
 Bio-Rad Kaleidoscope molecular weight markers (Bio-Rad, UK. 
Cat#161-0375)  
 Nitrocellulose membrane 0.45µm – GE Hybond HCl (GE, UK. 
Cat#RPN303D) 
 Bio-Rad blotting grade blocker (Bio-Rad, UK. Cat#170-6404) 
 TBS buffer (20x) 
 175.2g sodium chloride (Sigma, UK. Cat#S9888); 4.48g potassium 
chloride (Sigma, UK. Cat#P9541); 60.6g Tris base (Sigma, UK. 
Cat#T1503)at pH 7  
 TBS-Tween buffer (TBST) 
 TBS buffer as above with 1% Tween 20 (Sigma, UK. Cat#P7949) 
 Detection system – Western Lightning Plus ECL (Perkin Elmer, MA, 
USA. Cat# NEL104001EA) 
 Hyperfilm ECL X-ray film (GE Amersham, UK. Cat#ST03-B004) 
 Rabbit anti-human Nrf2 antibody (Abcam, US. Cat#ab62352) 
 Mouse anti-beta actin antibody AC-15 (Abcam, US. Cat#ab6276) 
 Anti-rabbit secondary antibody (Sigma, UK. Cat#A9169) 
 Anti-mouse secondary antibody (Sigma, UK. Cat#A9044) 
 
Cells were lysed in RIPA buffer with 0.5% protease inhibitor and frozen at -80oC 
until analysis. Typically, 200µL of buffer was used per 106 cells. Samples were 
volume corrected to give standardised protein concentrations for each lane. This 
was determined by Bradford protein assay (see 2.15) with correction to an estimated 
20µg in 10µL of buffer (1x sample buffer, 1x reducing buffer). Each sample was 
denatured by incubation at 80oC for 6 minutes before loading onto precast 
electrophoresis gels. Molecular weight markers (4µL) were run concurrently. SDS-
PAGE gels were immersed in MOPS buffer, and subjected to 90V for 10 minutes 
followed by 170V for 60 minutes in order to give adequate protein separation. 
Transfer to the nitrocellulose membrane was performed in cold MOPS buffer at 
230mA for 65 minutes. The gel was separated between 66kDa (Nrf2) and 42kDa 
(beta actin) in order to stain with separate primary antibodies, before overnight 
blocking in 2% milk powder at 4oC to minimise non-specific binding. After three 
washes in TBS-Tween buffer (TBST), gels were incubated at room temperature with 
primary antibody in TBST with 2% milk powder. Three hour incubation was used 
with anti-human Nrf2 (1:400 dilution), and 30minute incubation with anti-beta actin 
(1:10000). After six washes in TBST on a rocking platform, each of 10 minutes, 
secondary antibodies were introduced in TBST with 2% milk powder. Secondary 
antibodies (1:10000 anti-rabbit for Nrf2 and 1:10000 anti-mouse for beta actin) were 
incubated for a further 1 hour at room temperature before six final 10minute washes 
were performed. The gels exposed to the ECL detection mixture as per 
manufacturer’s guidelines. Gels were aligned within an X-ray cassette and exposed 
to X-ray film under dark room conditions. Relative quantification of Nrf2 signal was 
standardised to beta actin signal. 
 
 
During cell culture, monocytes undergo a phenotypic and morphological change 
towards macrophage type behaviour and appearance. Peripheral blood 
mononuclear cells may therefore be used to produce monocyte derived 
macrophages, which are a model for alveolar macrophages. 
Whole blood centrifugation leads to a Buffy coat layer which contains most 
leucocytes and platelets. To enhance extraction of mononuclear cells, density 
centrifugation may be refined using a Ficoll-hypaque interface which has a density 
of 1.077 g/mL381 which does not allow monocytes or lymphocytes to penetrate, and 
enhances coagulation of erythrocytes, and sedimentation of neutrophils. 
Mononuclear cells appear as a cloudy layer at the Ficoll interface; approximately 
20% of these are monocytes382. After removal the cells are introduced to cell culture 
plates allowing enrichment of monocytes concentrations by adherence and relative 
loss of lymphocytes383. 
 
 Neubauer Haemocytometer (Sigma, UK. Cat#Z359629) 
 Lymphoprep (Ficoll-Hypaque) (Axis-Shield, UK) 
 RPMI1640 culture medium (Sigma, UK. Cat R 8758) 
 Fetal calf serum (Sigma, UK. Cat#F7524) 
 EDTA 0.5M (Mw = 336.21.Sigma, UK. Cat# E7889) 
 Anti-coagulated blood (4.5mM final concentration of EDTA) was carefully pipetted 
into a 50mL centrifuge tube. This was slowly overlaid with half volume of 
lymphoprep in order to generate a clean blood-Lymphoprep interface. This was 
then centrifuged at 800g for 20 minutes at room temperature. The mononuclear cell 
layer was removed with Pasteur pipette, and the cells washed twice in large 
volumes PBS with pelleting first at 450g then 250g. The final cell pellet was re-
suspended in RPMI1640 for counting and haemocytometer. Mononuclear cells were 
pipetted into 24 well plates (Greiner BioOne, UK)at 2x106 per well for overnight 
adherence. The next day, culture media was entirely replaced, and subsequently 
changed every three days. 
 
Glutathione peroxidase (GPx) activity was measured by spectrophotometry using a 
method described by Paglia and Valentine (1967). The catalysed reaction uses 
cumene hydroperoxide to oxidise glutathione as per Equation 15 
           
   
→                
Sodium azide is used to reduce the competitive catalase activity of other substances. 
GSH is kept at constant concentration during the assay by using an excess of 
glutathione reductase to recycle the GSSG (Equation 16). 
              
  
→             
As NADPH is oxidised, its absorbance at 340nm decreases; monitoring this change 
photometrically after addition of cumene hydroperoxide to a sample allows 
calculation of enzyme activity.  
Glutathione peroxidase activity was determined by this method using a kit (Ransel, 
Randox UK, Cat#RS504) using a Randox RX Imola auto-analyser, by Randox 
laboratories, UK. One unit of GPx activity catalyses the oxidation of 1μmol of 
reduced glutathione per minute at pH 7.0 at 25°C (see Equation 17). 
          ⁄    
                       
    
           
         
  
 ∆A340 =the rate of change of absorbance at 340nm 
2 = correction for 2µmol GSH per 1µmol NADPH 
6.22 = millimolar extinction coefficient of NADPH at 340nm 
0.05 = volume of enzyme used (mL) 
volreaction = volume of reaction (mL) 
volenzyme= volume of enzyme used (mL) 
 
 
Clinical information was collected and recorded for three purposes: 
 To allow appropriate interpretation of research findings 
 To allow healthcare professionals seeing the subject after the 
bronchoscopy to know what has been done e.g. if the patient suffers 
complications 
 To allow tracing of the patient if abnormal findings are detected at 
bronchoscopy or in later laboratory observation 
True anonymisation was therefore neither desirable nor possible in maintaining the 
safety of participants. Research data was therefore pseudo-anonymised by the 
unique study number.  
Laboratory measurements were requested and reported using the unique study 
number. Demographic and questionnaire data was collected on a paper Clinical 
Report Form (CRF), and double entered into an SQL database maintained by the 
Data Department of Malawi-Liverpool-Wellcome (MLW) Clinical Research 
Laboratories. Front end access to this was provided by a REDCap384 (Vanderbilt 
University, US) system hosted locally. Pseudo-anonymised paper CRFs were kept in 
a locked room, and in a separate location tracing information contained details of 
participants’ names, addresses and contact details cross referenced to study number. 
Only the research nurse and the principle investigator had access to this tracing 
information. 
On closure of the study, the database was directly exported to Stata v12 (StataCorp, 
US) for data analysis. Haematology and biochemistry results from the MLW 
laboratory were incorporated at this stage by first exporting to CSV format, and 
merging records according to unique study identifier. Where direct electronic 
transfer was not possible, data were entered and verified on two separate occasions. 
 
Statistical methods and choice of significance tests are described in the methods 
sections associated with each results chapter. 
  
All methods used in this project appear in previously published research, as cited. 
However, some optimisation was required for cell type. For assays where there was 
significant change to published protocols, precision estimates have been given, 
quoting coefficient of variation (CV) values as shown in Equation 18. 
Equation 18    
 
 
 
                  
    
 
 
 
The recycling assay for glutathione (see 2.6) is sensitive and known to work on a 
variety of sources. In order to optimise the protocol for human alveolar 
macrophages and number of experiments were run, and are described below. 
 
Initial assay optimisation used an adherent HK-2 cell line seeded in Dulbecco’s 
Modified Eagle’s Medium (DMEM. Sigma, UK. Cat: # D5796) at 2x104/well and 
grown to 90% confluence in 6 well plates. After pre-exposure to N-acetylcysteine for 
1 hour in DMEM, 600µL 1% 5-sulfasalicylic acid was added to each well. 
Glutathione was assayed as described in the methods using DTNB was used at a 
concentration of 1.1mM in line with previous protocols. 
Figure 3-1 Standard curve of glutathione concentration vs rate of change in absorbance 
 
The absorbance was measured here at 412nm for the first two minutes after addition of glutathione 
reductase. Two fitting equations are drawn: linear (red), and 2nd polynomial (blue). 
Figure 3-1 shows the standard curve generated. Although the lower five standards 
are approximately linear, there is considerable deviation at higher concentrations, 
suggesting that the enzyme catalysed kinetics are becoming limited by a reactant 
other than glutathione. This is seen to happen if the reaction is monitored for longer 
periods (see Figure 3-2). However, if this occurs earlier (in the time period over 
which kinetic measurements are taken), it is a violation of the method’s principle 
that all reactants should be present in excess, and therefore makes the assay 
unreliable. Such limitations may be due to a relative shortage of DTNB, glutathione 
reductase or NADPH. Increasing the DTNB concentration to 6mM improved the 
linearity (see Figure 3-3) and the reaction proceeded more slowly associated with 
minor improvements in accuracy and precision (see Table 3-1). Despite these 
advantages, the blank reaction appeared to proceed faster than the lowest three 
standards, as evidenced by the blank corrected absorbance change in Figure 3-3. 
Figure 3-2 Glutathione assay reaction becoming saturated when observed for long periods 
 
In this example, after 900 seconds, it is likely DTNB has become maximally oxidised. Similar patterns 
occur where NADPH availability becomes limited 
Figure 3-3 Standard curve of glutathione concentration – improved linearity 
 
Absorbance was measured here at 412nm for the first eight minutes after addition of glutathione 
reductase. Blank corrected absorbance values are used. A linear fitting equation is added 
  
Table 3-1 Accuracy and precision of glutathione assay – comparison of the assay 
performed with DTNB at 1.1mM and 6mM 
  
 
 
 
 
 
  
Left table: Accuracy determined according to known concentrations of total glutathione (mean of n=2) 
Right table: Precision as determined by variability of calculated concentrations from samples 
representative of range (0.625 – 10.4µM). n=4 
When the absorbance over time was examined, the reaction kinetics showed a 
concave upwards appearance or “lag” phase (see Figure 3-4). By pre-warming the 
reaction mixture, this artefact improved, and the blank reaction rate fell below that 
of all of the standards (see Figure 3-5). 
Figure 3-4 Reaction kinetics of glutathione standards followed over time 
 
Points represent the absorbance at 412nm as measured every 15 seconds 
Figure 3-5 Reaction kinetics of glutathione standards over time after pre-warming of 
reaction mixture 
 
Points represent absorbance at 412nm as measured every 15 seconds. Blank reaction is shown in red. 
Some other possibilities which improve sensitivity were considered but discounted 
where they significantly added complexity or time to the assay method. Such 
examples, from Brehe385 are: removing the ammonium sulphate preservative from 
glutathione reductase to increase activity; the addition of bovine serum albumin to 
increase GR stability (Brehe); buffering the reaction in imidazole to increase 
NADPH stability. Other acids may be used instead of 5-SSA, for example 
hydrochloric acid386. For consistency with previously stored samples, this change 
was not adopted. 
 
Relatively low numbers of cells are expected from bronchoalveolar lavage; BAL 
volumes used in the assay, and their cell concentration was optimised for precision 
and practicability. Decisions regarding methods were made early in the project and 
based on a small number of samples; those decisions relating to CVs and accuracy 
tended to be conservative i.e. to be biased towards improving reproducibility at the 
expense of increased sample use. 
Changes in the concentration of DTNB improved the precision of estimates in the 
lower reference range (see Table 3-2). Further work determined the number of cells 
required, using PBMC as a model. 
Making the assumption that oxidised glutathione represents 1 to 5% of the total, 
total concentrations should therefore exceed 32.5µM in order that measured GSSG 
should exceed the lower limit of detection (0.325µM). PBMC were seeded in 24 well 
tissue culture plates (Greiner BioOne, UK) at a density of 1.5x106 per well and used 
on day 10 to 14 of adherent culture. Multiple experiments were carried out varying 
both the cell number and volume of 5-SSA. Due to the variable proportion of 
monocytes in PBMC preparations (usually 10-20%) and inconsistent adherence to 
culture plates, absolute cell numbers were difficult to determine. However, four 
wells of PBMC in 200μl 5% 5-sulfasalicylic acid gave total GSH concentrations of 
between 42.3 and 94.6µM in the assay i.e. adequate concentrations for measuring 
GSSG even at the lower estimate of relative concentration. Estimation of required 
cell numbers was done as follows: 
           
                                                              
                        
This informed the standardised protocol for ex vivo glutathione measurement. From 
previous data, approximately 8 million alveolar macrophages are isolated following 
bronchoalveolar lavage in a volume of 120mL. From this estimation, 15mL of whole 
BAL would contain 1x106 cells, and was therefore incorporated into the protocol. 
After ten BAL procedures, cell numbers were consistently lower (8.6x105 estimated 
in the glutathione sample), although the proportion of GSSG was higher (5.2%). In 
one sample the GSSG was below the limit of detection. Future glutathione 
measurements on BAL were performed on 30mL to reduce the likelihood of this 
recurring. 
PBMC were seeded in 24 well plates at a density of 1.5x106 per well and used on day 
12 of adherent culture. Parallel estimation of total glutathione and the oxidised form 
was done as described in section 2.6 using 4 wells of PBMC for each condition in a 
total of 200µL 5% 5-SSA. Oxidised glutathione was measured from only one 
derivitivisation, run in duplicate (see Table 3-2). 
Table 3-2 Precision of the oxidised glutathione assay. 
Precision as determined by variability of calculated standards and samples, CV for samples represents the 
variability within multiple measurements of the same sample (before optimisation using PBMCs [n=2 for 
each sample] and after optimisation using ex vivo alveolar macrophages [n=6 for each sample]). Values in 
parentheses for samples are the range of CV values obtained from these 10 samples. 
On the basis of imprecision (optimally less than 15%), particularly at lower 
concentrations, samples were subsequently derivitivized in triplicates, and each 
derivitivized sample run in duplicates within the plate. The standard range for 
GSSG was increased to include a higher top standard. Retrospective data from the 
first 10 volunteers are given in this table for comparison; these are likely to reflect 
precision of the final results. Here, CVs indicate the within sample variation of the 
derivitivisation and measurement process i.e. the precision of the 6 measurements 
for each sample. 
 
Glutathione and other assays used in this project require normalisation against 
protein content. This is partly because bronchoalveolar lavage gives a variable 
sample in terms of cell number. It is also known that macrophage size varies with 
particulate exposure (cigarette smoke)387. Moreover, macrophage turnover is likely 
to change the average size as (smaller) monocyte influx is in part responsible for 
replenishing AM populations388. Cell number is therefore not an ideal method 
where a denominator is required for assay results e.g. glutathione is better expressed 
as µmol per milligram of cellular protein compared with µmol per 106 cells. 
The Lowry method (see 2.14) was chosen for its relative advantages in alkaline 
solution. Early tests showed significant non-linearity of the higher part of the 
standard curve (see Figure 3-6). It has been noted that some non-linearity is to be 
expected, therefore the standard range was truncated 0-400µg/mL to improve 
performance. Samples were therefore diluted as required. This had other benefits in 
terms of reducing the problem of precipitation within the Lowry reagent, 
presumably by decreasing the concentration of potassium ions389.  
Figure 3-6 Linearity of the Lowry assay 
 
The absorbance at 750nm for each standard concentration of BSA is shown. Linear model fitting is shown 
by the red lines; one for the entire range (0-1600µg/mL) and the other for 0-400µg/mL). An exponential 
fit is also shown (dotted, black line) 
Colour development has been noted to continue until approximately 2 hours after 
addition of the Folin–Ciocalteu reagent, and that accuracy tends to improve over 
this time366. This was repeated using high and low standards, with colour 
development assessed as light absorbance at 660nm and 750nm (see Figure 3-7). 
These wavelengths represent the lower and upper boundaries usually tested for 
determining concentrations by the Lowry method. This experiment does not 
compare enough values to give adequate estimates of precision. However, minimal 
change in absorbance occurred after 2 hours, and in line with previously published 
recommendations, this time point was used in any further assays. 
Coefficient of variation (CV) of all the standards and 20 unknown samples was 
calculated based on concentrations derived from absorbance measurements at 
120minutes (see Equation 18). There was no difference in CV of results from 660nm 
absorbance measurement (10.34%) vs. that from 750nm (10.43%) p=0.96 by t-test. 
Therefore 750nm was chosen as the wavelength to measure, as at this wavelength 
there are fewer likely interfering substances.  
Figure 3-7 Colour development of the Lowry assay 
 
Absorbance of light at 660nm and 750nm by a developing Lowry assay. Each point represents duplicate 
standards of bovine serum albumin. Data for higher (400µg/mL) and lower (50µg/mL) standards are 
shown. 
 
In order to compare the intraphagosomal function of ex-vivo human alveolar 
macrophages with other measurements (such as particulate density or redox 
balance), smaller scale assays of the former method were required. Previously, 6 
well plates were used, and cells were removed mechanically by scraping. In order to 
use fewer cells (in either 96 or 24 well plate format), and alternative mechanism was 
required. The requirements for a new method were that it would be: 
 fast (less than 10 minutes in order that the time-dependent functional 
assays remained meaningful); 
 non-oxidant (to prevent oxidation of reporter fluorochromes before 
analysis) 
 associated with low rates of cell lysis (to prevent systematic errors in 
interpretation of phagocytosis);  
 usable in combination with other flow cytometry based assays for 
surface marker phenotyping  
A number of methods were trialled, as detailed below. These used both PBMC and 
HAM models according to their availability at the time of experiment. 
 
Trypsin-EDTA is commonly used during the passage of adherent immortalised cell 
lines. As a serine protease, the trypsin cleaves extracellular proteins, some of which 
are responsible for cell attachment. EDTA chelates calcium and magnesium ions 
which otherwise inhibit enzymatic proteolysis. 
PBMC at day 11 of adherent culture (see 2.21) were washed twice in Ca2+ and Mg2+ 
free PBS before being incubated at 37oC with 1x trypsin (Sigma, UK. Cat#T4549) in 
RPMI-1640 medium according to the manufacturer’s protocol. Macroscopic 
appearance was judged every 5-10 minutes. Using this technique, 10 minutes of 
incubation time was required for all cells to be removed even with vigorous 
pipetting: this method was therefore abandoned. 
 
Peripherally derived mononuclear cells at day 12 of maturation, initially plated at 
1.5x106 total PBMC per well, were gently washed twice with 1mL PBS. Lignocaine-
EDTA buffer (1mL/well of lignocaine hydrochloride 15mM, EDTA 10mM in PBS) 
was added with incubation at 37°C. Observation by light microscopy showed 
approximately one third of cells had become detached at 5 minutes but the majority 
remained irregular and adherent. Even with exposure times to detachment buffer of 
up to half hour, the remaining cells could not be detached without vigorous 
pipetting. Previous literature suggested that a late stage of tissue culture, the cells 
cannot be effectively removed without significant degree of destruction390. This 
approach was therefore not used. 
 Citric saline was chosen for testing as an alternative to trypsin which can cause 
oxidative stress in cells391. As with previous trials, plated cells were washed twice 
with PBS before exposure to 500µL/well of sterilised removal buffer (here: 5g 
potassium chloride; 2.2g sodium citrate in 500mL water). Alveolar macrophages 
were used in this evaluation as they were available. After 5 minutes at 37oC, minor 
pipetting removed all cells from the plate. Microscopically, minimal fragmentation 
was noted. This method was used hereafter for detachment of HAM.  
 
 
A real time marker of oxidative stress would be highly valued, and one candidate is 
the degree to which cellular lipids have undergone peroxidation (for a single point 
in time measure, see 2.17). This would allow tracking of rates of peroxidation, and 
the potential for spatial analysis by confocal microscopy. 
We tested the viability of using the oxidation sensitive lipid probe C11-
BODIPY(581/591). While in principle useful due to its spectral properties, stability, 
good signal-to-noise ratio and lipophilic tendency even once oxidised392, it has not 
been fully tested in macrophages. C11-BODIPY when loaded into the cells becomes 
incorporated to lipid membranes. It has two emission peaks of 520 nm and 590 nm; 
on becoming oxidised, emission at 590 lessons while at 520 increases. 
 
In a cell free system, C11-BODIPY (Invitrogen, UK. Cat#D3861) was reconstituted in 
ethanol, and introduced to 96 well plates at concentration range 0 to 200 µmol. 
Cumene hydroperoxide (C9H12O2. Sigma, UK. Cat #C0524) was used at 
concentration of 10mM in order to induce oxidation. Fluorescence emission was 
measured using a fluorescence plate reader (BMG Omega, excitation 484 nm, 
emission 520 and 590 nm band-pass filters). 
Concentrations of transition metal ions in the presence of hydrogen peroxide 
promote Fenton reactions (see section), and are expected to increase the rate of lipid 
peroxidation. This was tested using copper (40nM) as the sulphate ion in the 
presence of C11-BODIPY 581/591 with hydrogen peroxide as the oxidising agent. 
Equal volumes of solution were tested for detectable evidence of oxidised C11-
BODIPY in 96 well plates at baseline, 60 minutes and 120 minutes (see Figure 3-8). 
Figure 3-8 Effect of oxidising C11-BODIPY 581/591 in an acellular environment 
 
Ordinate reports the ratio of fluoroscence emissions (exλ488nm emλ520nm to exλ544nm emλ590nm) as 
an average of two wells. Conditions are the presence of copper ions (40nM) and hydrogen peroxide 
(200µM) 
In the presence of an oxidising agent alone, C11-BODIPY 581/591 does not exhibit 
any changes indicating oxidation. Only after the addition of transition metal ions in 
this cell free system does the emλ520 increase relative to emλ590, in line with 
previous observations393. 
 PBMC were used at day 14 of adherent cell culture in 96 well tissue culture plate 
(Greiner Bio-One, UK) from an initial seeding density of 1x105/well. These cells were 
loaded with 5µM C11-BODIPY 581/591 in RPMI-1640 medium without FBS for 30 
minutes at 37oC. Serum was omitted in order to prevent absorption of the 
fluorochrome onto soluble protein. Wells were washed three times, and then 
incubated with combinations of control (phenol red free RPMI-1640 media only), 
copper sulphate and hydrogen peroxide. Fluorescence was measured using 
equivalent settings to the cell-free trial; results are shown in Figure 3-9. 
Loading at this dose appeared to be successful: while fluorescence at exλ485nm 
emλ520nm stayed constant, that at exλ544nm emλ590nm increased approximately 
six fold in the control wells. A systematic effect of the presence of copper ions could 
be seen throughout as a reduction in the exλ485nm emλ520nm channel , 
presumably due to direct absorption. It was expected that hydrogen peroxide would 
initiate oxidation resulting in an increased ratio of these fluorescence measurement. 
However, no immediate effect was seen, and both absolute and relative fluorescence 
intensities were unchanged when followed for 3 hours (data not shown). A further 
identical experiment using the more lipid soluble cumene hydroperoxide (Sigma, 
UK. Cat#247502) at 200µM gave similar results. 
Figure 3-9 The fluorescence of C11-BODIPY 581/591 in a cellular system 
 
PBMC loaded with 5µM BODIPY immediately after addition of hydrogen peroxide (200µM) and copper 
sulphate (40nM). Bars represent the relative fluorescence from a) exλ485nm emλ520nm and b) 
exλ544nm emλ590nm and c) the calculated ratio of a:b. Four replicates per condition are shown: error 
bars represent SD. 
 
As both H2O2 and cumene hydroperoxide are substrates for glutathione peroxidase, 
and this enzyme is present in macrophages, the experimental design was extended 
to study the effects of endogenously produced oxidants. As previously (section 
3.5.1.2), PBMC at 14 days were loaded with C11-BODIPY 581/591. Cells were 
incubated in the plate reader with: vehicle only (DMSO 0.4%, Sigma, UK. Cat# 
D2650); cumene hydroperoxide 200µM as a direct oxidant; apocynin 300µM (4′-
Hydroxy-3′-methoxyacetophenone. Sigma, UK. Cat#55539) as a direct stimulant of 
NADPH oxidase (see Figure 3-16); fMLP (formyl-methionyl-leucyl-phenylalanine. 
Sigma, UK. Cat# F3506) as a stimulant of oxidative burst. Figure 3-10 shows these 
results. Good loading of the fluorophore is confirmed by the increase in exλ544nm 
emλ590nm fluorescence in vehicle treated compared with unloaded cells. Again, 
throughout the conditions, minimal change is seen in either fluorescence channel 
suggesting that lipid peroxidation is not occurring at a detectable level or that the 
C11-BODIPY 581/591 is a relatively insensitive reporter. Further examination of this 
compound was not undertaken; elsewhere in this work, lipid peroxidation has been 
measured by the thiobarbituric acid reducing substances (TBARS) assay coupled to 
HPLC fluorescence detection (see section 2.17). 
Figure 3-10 Oxidation of C11-BODIPY 581/591 in a cellular system with endogenous oxidant 
production. 
 
PBMC loaded with 5µM BODIPY (except the “unloaded” control). Bars represent the relative 
fluorescence from exλ485nm emλ520nm (green, upwards hatch) and exλ544nm emλ590nm (red, 
downwards hatch) shown immediately after addition of the stimulus, and at 60 minutes. DMSO was 
used as a negative control, as it is the vehicle for other conditions. CumOOH = cumene hydroperoxide. 
Apocynin used at 300µM. fMLP (formyl-methionyl-leucyl-phenylalanine) used at 10mciroM. Four 
replicates per condition are shown: error bars represent SD. 
 
A number of experiments were planned to investigate the relationship between 
levels of oxidative stress in macrophages, and their ability to produce reactive 
oxygen species by NADPH oxidase (oxidative burst activity). This was postulated as 
a mechanism which would explain the epidemiological association between high 
levels of particulate exposure in the home (from the burning of biomass fuels) and 
the incidence of pneumonia. 
In order trial methods for ROS detection, we used monocytes and macrophages in 
adherent cell culture, and confined investigation to fluorescent reporter molecules. 
A number of such compounds exist, each with distinct profiles (see Table 3-3). 
Carboxydichlorofluorescein diacetate (carboxy-H2DCFDA, Invitrogen. Cat#C400) 
was chosen for evaluation due to its relative advantages: relatively cell permanent; 
broad sensitivity; low toxicity; previous successful use of this class of indicator in 
alveolar macrophages394, 395. 
Table 3-3 Characteristics of commonly used fluorescence probes for detection of reactive 
oxygen and nitrogen species in phagocytes395 
 
 Optimal cell loading concentrations for carboxy-DCF were determined. Briefly, 
monocyte derived macrophages at day 5 of adherent cell culture were washed in 
PBS, then incubated in RPMI-1640 medium without phenol red, with carboxy-DCF 
(0-100µM) for 30 minutes at 37oC. Initial incubation time was consistent with similar 
work reported for alveolar macrophages in the literature399. Excess media and probe 
were removed by three further washes, and fluorescence measured using a plate 
reader. Additional hydrogen peroxide was injected to each well to final 
concentrations of 0-100µM. Figure 3-11 shows the relative fluorescence of the well 
contents at 60 minutes after addition of H2O2: good loading was noted in terms of 
signal: background ratio i.e. comparing the fluorescence of the control (control well 
to that of the treatment well with 100µM H2O2); the best ratio was noted at maximal 
dose of reporter fluorophore. However, concerns over toxicity to cells, or the altered 
behaviour or phenotype in the presence of carboxy-H2DCFDA led to the lower 
doses being used in further experiments. 
Figure 3-11 Optimising loading of PBMCs with carboxy-H2DCFDA 
 
After 30 minutes of incubation with the reporter compound, cells were washed and incubated with 
culture medium with varying concentrations of hydrogen peroxide. Relative fluorescence at 520nm was 
measured from all wells at 60 minutes. Each condition is a mean of duplicate wells with blank correction 
(to wells containing media only). 
Inset: Table of signal:background ratio for each concentration of carboxy-H2DCFDA (fluorescence[H2O2 
100µM] / fluorescence[H2O2 0mM]) 
 
The development of fluorescence was followed according to the method in section 0. 
Figure 3-12 shows this over the hour following addition of hydrogen peroxide. It 
would be expected that the oxidant effect of H2O2 be short lived due to intracellular 
cellular glutathione peroxidase and catalase. However, increased in fluorescence 
seemed to be exponential at all doses of carboxy-H2DCFDA. This indicated auto-
oxidation, or an initiation of oxidative burst by the monocyte/macrophage cells, or 
photo-oxidation as a result of repeated interrogation within the plate reader. 
Figure 3-12 Increasing oxidation of carboxy-H2DCFDA over time 
 
After 30 minutes of incubation with varying concentrations of the the reporter compound, cells were 
washed and incubated with culture medium with 100µM hydrogen peroxide. Relative fluorescence at 
520nm was measured from all wells over 60 minutes. Each condition is a mean of duplicate wells, with 
blank correction (to wells containing medium only). 
 
Using a constant concentration of carboxy-H2DCFDA for cell loading, and the same 
protocol as section 0, the relative signal from different concentrations of hydrogen 
peroxide was followed in order to establish the dose to be used as a positive control.  
Figure 3-13 Optimising the dose of hydrogen peroxide as a positive control 
 
After 30 minutes of incubation with 100µM of the reporter compound, cells were washed and incubated 
with culture medium with varying concentrations of hydrogen peroxide. Relative fluorescence at 520nm 
was measured from all wells over 60 minutes. Each condition is a mean of duplicate wells, with blank 
correction (to wells containing medium only). 
Figure 3-13 shows clearly that 100µM hydrogen peroxide gave the highest 
fluorescence signal. However 25 and 50µM solutions did not differ significantly; in 
both the 100µM H2O2 resulted in between 3 and 4 times higher fluorescence after 15 
minutes when corrected for the baseline of untreated cells. We have subsequently 
used 100µM of H2O2 as positive control. 
 
Within in vitro experiments, extrinsically manipulating the antioxidant content of 
cells is useful. Decreasing glutathione concentration is dealt with in Section 0. In 
order to investigate the potential for increasing antioxidant buffering, N-
acetylcysteine (Sigma, UK. Cat#A9165) was used. PBMC from NHS Buffy coats 
seeded at 4x104/well in 96 well plates, at day 8 of adherent cell culture were 
incubated for 18 hours with varying concentrations of N-acetylcysteine (0-50mM). 
Cells were then washed three times, incubated with 25µM carboxy-H2DCFDA for 60 
minutes and washed again. Hydrogen peroxide (final concentration 100µM) was 
added and the fluorescence at 520nm recorded using a plate reader (BMG Omega) 
over 60 minutes. Another condition was treated similarly to the control (no NAC 
loading), but had 50mM NAC within the media at the time of adding H2O2. 
As shown in Figure 3-14, N-acetylcysteine reduced oxidation of the reporter at 5mM 
and 50mM, and was not demonstrably dose dependent in this experiment. As 
expected, using NAC in the media at the time of H2O2 introduction entirely buffered 
the oxidant effect. 
Figure 3-14 The effect of N-acetylcysteine on carboxy-H2DCFDA fluorescence in monocyte 
derived macrophages after addition of H2O2 
 
Prior loading of cells with NAC (5 or 50mM) or media only (control) for 18 hours as indicated. Cells 
were loaded with 25µM carboxy-H2DCFDA, washed and hydrogen peroxide added to all wells (final 
concentration 100µM). NAC media represents wells which were not loaded with NAC, but had this 
added concurrently with H2O2. Fluorescence values are not blank corrected. Error bars represent SD of 
duplicate wells (n=2). 
 
The formation of oxidative species may be affected by the presence of transition 
metals, as discussed elsewhere. Most commonly, in terms of exposure of alveolar 
macrophages, this will be ferrous iron. Under these circumstances, hydroxyl ions 
might be expected to generate earlier or stronger oxidation responses, and might 
form the basis for augmenting the positive control signal. 
This was investigated using monocyte derived macrophages in day 5 of adherent 
cell culture in black walled 96 well tissue culture plates (Greiner Bio-One, UK). 
These cells were loaded with carboxy-H2DCFDA as in 0, washed 3 times in PBS, and 
fluorescence at 520nm monitored over 1 hour after the addition of H2O2 (final 
concentration 100µM), with varying concentrations of ferrous sulphate (0-2000µM). 
Figure 3-15 shows two representations of the same data. The top panel indicates that 
the highest concentration of ferrous iron results in an early and significant increases 
in fluorescence of the reporter although this effect tailed off after 10 minutes, and 
overall oxidation was less than control at the end of 1 hour. This concentration is 
likely to be supra-physiological under most circumstances. However, the error bars 
(SD around the mean for the triplicate wells) are extremely wide. When further 
examined, it seemed that the ultimate fluorescence for each well depended largely 
on the starting conditions; early small differences within each replicate were 
compounded over time leading to the large final variation. This is seen more 
obviously in the bottom panel, where values are calculated as fold increase over the 
starting fluorescence of each well. Here, error bars are much narrower. 
This illustrates a difficulty of using this assay; relative and absolute changes may be 
interpreted differently. Early signals becoming amplified suggest that auto-
oxidation is a significant problem here; this problem is shared by many of the DCF 
based reporter compounds. Initial differences may be related to variations in cell 
numbers; in adherent cell culture there is inevitable loss of cells during changes of 
media. 
If interpretable at all, these data suggest that small amounts of ferrous iron make no 
difference to carboxy-H2DCFDA oxidation, although high concentrations may have 
an early effect.  
Figure 3-15 The additional effect of ferrous iron on oxidation of carboxy-H2DCFDA in 
monocyte derived macrophages 
 
 
Top panel: Absolute blank corrected increase in fluorescence. Intermediate concentrations of ferrous 
sulphate (20 and 200µM) are excluded for clarity 
Bottom panel: Blank corrected increase in fluorescence proportional to the starting fluorescence of each 
condition 
Lines represent the mean of triplicate wells for each condition. Error bars show SD. 
 
 Physiological controls for the intracellular oxidation assay would be improved by a 
more physiological positive control. In monocytes and macrophages, stimulation of 
the NADPH oxidase mechanism would provide this. A number of compounds are 
known to cause assembly and activation of NADPH oxidase. Three were 
investigated: phorbol myristate acetate (PMA. Sigma, UK. Cat#P1585); apocynin 
(acetovanillone. Sigma, UK. Cat#A10809 ); N-Formyl-Met-Leu-Phe (fMLP. Sigma, 
UK . Cat# F3506). PMA is an non-specific activator of protein kinase C, with wide 
ranging effects including phagosome-lysosome fusion. fMLP is a peptide known to 
induce chemotaxis and activate macrophages. Apocynin is a vanillin, and acts as a 
selective inhibitor of NADPH oxidase derived from plant sources. 
PBMCs were loaded with 25µM carboxy-H2DCFDAas detailed in section 0. This 
experiment was performed using PBMCs in suspension i.e. before adherence in 
order to test the hypothesis that cell number variation due to cell culture caused the 
wide margins of error around the mean seen in section 3.6.1.5, and to select which 
positive controls were most promising. After loading, cells were washed three times 
in PBS and loaded into 96 well plates at 8x104 cells/well, and fluorescence of the 
reporter fluorophore measured over 60 minutes. 
Figure 3-16 shows an insignificant rise in oxidant production of cells exposed to 
vehicle (DMSO) compared to control. fMLP at 1µM appears to give rise to oxidant 
response, but less than the heretofore used hydrogen peroxide positive control. 
PMA was superior to H2O2. Standard deviations around the mean values were 
considerably tighter than experiment 3.6.1.5. 
Figure 3-16 Oxidation of carboxy-H2DCFDA in PBMCs: evaluation of cellular positive 
controls 
 
PBMCs in suspension were loaded with 25µM carboxy-H2DCFDA, washed and incubated with various 
stimuli. Fluorescence was tracked over one hour. Lines represent the mean of triplicate wells. Error bars 
are SD. Final concentrations of stimuli are: control (media only); vehicle (DMSO, 0.2%); fMLP 10µM; 
PMA 2µM; Apocynin 300µM. 
Apocynin was, surprisingly for a documented inhibitor of NADPH oxidase subunit 
assembly404, associated with significant fluorescence increases. These data are 
consist with published literature which suggests that phagocytes and non-
phagocytes respond differently to apocynin; although in both fibroblasts and 
macrophages there is initial stimulation of reactive oxygen species, in fibroblasts 
this continues. In macrophages, perhaps due to the presence of peroxidases, 
apocynin is postulated to be converted into an inhibitor of NADPH oxidase405, 406. 
Due to the issues of auto-oxidation described above, any early increase in ROS 
production might feed forward to a strong positive fluorescence signal despite later 
changes in apocynin behaviour in the cell. 
These findings were replicated in alveolar macrophages in adherent cell culture 
(day 3 after isolation from BAL); results are shown in Figure 3-17. In this cell type, 
fMLP and DMSO caused small but non-significant increases in oxidation. PMA and 
apocynin approximated the effect of H2O2. These data are consistent with findings 
that PMA is not as robust a positive control in alveolar macrophages compared with 
its use in monocytes and neutrophils396. Future use of positive controls used both 
PMA and apocynin. 
Figure 3-17 Oxidation of carboxy-H2DCFDA in AMs: evaluation of cellular positive controls 
 
AMs in adherent cell culture were loaded with 25µM carboxy-H2DCFDA, washed and incubated with 
various stimuli. Fluorescence was tracked over one hour. Lines represent the mean of triplicate wells. 
Error bars are SD. Final concentrations of stimuli are: control (media only); vehicle (DMSO, 0.2%); 
fMLP 10µM; PMA 2µM; Apocynin 300µM. 
 
In addition to a robust positive control, inclusion of a condition which decreased 
cellular antioxidant capacity would be useful. The effect of buthionine sulfoximine 
(BSO) is reported in section 0. Here, an inhibitor of glutathione peroxidase, 
mercaptosuccinate (Sigma, UK. Cat#M6182) underwent preliminary testing in a 
similar dose range to other experiments involving alveolar macrophages407. Alveolar 
macrophages on day 2 of adherent cell culture after isolation were pre-incubated 
with mercaptosuccinate 0-1500µM in culture medium for 1 hour. After a single 
wash, media were replaced with 25µM carboxy-H2DCFDA for a further hour. Each 
well was washed three times replaced with RPMI-1640 without phenol red, and 
positive controls added (PMA 2µM, H2O2 100µM, Apocynin 300µM final 
concentrations). Fluorescence was recorded at 60 minutes; results are shown in 
Figure 3-18. Contrary to the expected result (that mercaptosuccinate would increase 
oxidation effect), there appeared to be a dose dependent decrease in fluorescence of 
the reporter, especially notable with apocynin as the stimulant. Explanations for this 
might include: deterioration in cell function i.e. toxicity of the mercaptosuccinate; 
rapid increase (over 2 hours) in the intracellular concentrations of other antioxidant 
as a result of mercaptosuccinate e.g. glutathione synthesis. Despite its introduction 
to a buffered solution, mercaptosuccinate altered the pH of cell medium as observed 
by the yellowing of phenol red. This suggests the former explanation is more likely. 
In view of the likely toxicity, mercaptosuccinate was not used in further 
experiments. 
Figure 3-18 The effect of a glutathione peroxidase antagonist on intracellular oxidation of 
carboxy-H2DCFDA in alveolar macrophages. 
 
Cells at 5x104/well were preincubated with varying doses of mercaptosuccinate (0-1600µM) for 1 hour, 
followed by washing and loading for 1 hour with carboxy-H2DCFDA 25µM. After 3 further washes, 
positive controls were added, and fluorescence at 520nm measured over 1 hour. Bars represent mean 
values of triplicate wells, with error bars indicating SDs. 
 
 Using DCFH, previous work has described that when comparing different 
phagocytes, polymorphonuclear cells had the greatest capacity to produce oxidants, 
with monocytes less capable, and alveolar macrophages the least oxidant producing 
cell type of the three197. However, although this data probably accurately describes 
propensity to oxidative stress (within the cytoplasm), this does not necessarily 
correlate with local concentration of superoxide and hydrogen peroxide within the 
phagosome i.e. that response which is antibacterial. As a result of preliminary 
investigation detailed here, cytoplasmic reporter methods were dropped in favour 
of a more targeted method using reporter beads taken into the phagosomal 
compartment (see 3.8), which have the following benefits: 
 Specifically report the intraphagosomal rather than cytoplasmic 
conditions and therefore reflect more accurately antibacterial capacity 
 Are not susceptible to variation relating to cell loading and 
cytoplasmic retention of the fluorescent reporter 
 
 We sought a method for causing glutathione depletion in monocytes and 
macrophages which could be used as a probe for the effect of oxidative stress.  
Buthionine sulfoximine is a specific inhibitor of γ-glutamylcysteine synthetase  and 
has been shown to alter macrophage behaviour and function by causing 
intracellular glutathione depletion, and a relatively more oxidising environment. 
Specifically, BSO can reduce activation and iNOS activity408, although in other 
studies enhances inflammatory cytokine production in human alveolar 
macrophages304. Doses used in preliminary experiments were taken from previous 
macrophage studies409. 
Initial studies were undertaken to optimise the dose, and to confirm a reasonable 
time frame for BSO treatment of ex-vivo alveolar macrophages. Specific concerns 
were: 
1. To identify the degree of glutathione change after BSO treatment (see 
3.7.1) 
2. To check that this did not lead to significant short term cell toxicity 
which might affect experimental results due to loss of adherence of 
cells in culture 
 
The effect of BSO on intracellular glutathione concentration was assessed in ex vivo 
human alveolar macrophages. On the day of isolation, these were plated at 
3x106/well, and rested overnight in RPMI-1640 medium with 10% FCS. The next 
day, and for 24 hours, the macrophages were incubated with medium with and 
without additional BSO (0.2mM and 0.5mM). At this point, the adherent cells were 
washed twice in PBS. 500µL of 5% 5-sulfasalicylic acid was added, and the 
suspension used according to the glutathione assay method detailed in section 2.6. 
Concentrations of both reduced and oxidised forms were calculated from the 
recycling assay (see Figure 3-19 and Figure 3-20). Maximal reduction in glutathione 
appeared to require 0.5mM (55% reduction from baseline after 24 hours, although 
0.2mM produced a 51% reduction. HAMs from one individual appeared unaffected 
by BSO. Although numbers in this preliminary study were few, both doses of BSO 
were concluded to have a significant reduction in total glutathione. 
Levels of oxidised glutathione were, generally, concomitantly reduced. This is seen 
in Figure 3-20, where although total glutathione availability was reduced on average 
to 30.4% of original values, the proportion of oxidised glutathione showed no 
consistent pattern, and in all four volunteers remained under 5%. Based on the 
mechanism of action of BSO i.e. reducing the intracellular synthesis of glutathione, 
these patterns might be expected, provided the mechanisms for recycling oxidised 
glutathione to reduced glutathione were intact. The data supports this in that total 
glutathione was reduced, but oxidised glutathione was unchanged as a proportion 
of the total. 
Figure 3-19 Effect of buthionine sulfoximine on intracellular total concentration of 
glutathione in ex vivo alveolar macrophages. 
 
HAMs exposed to BSO in culture medium for 24 hours. Glutathione concentration is not normalised to 
protein due to the comparable cell numbers in each condition (3x106 macrophages per condition). 
Figure 3-20 Effect of buthionine sulfoximine on the proportion of intracellular glutathione in 
oxidised form in ex vivo alveolar macrophages. 
 
HAMs exposed to BSO in culture medium for 24 hours. 
 
 Toxicity to cells was assessed by the degree to which intracellular lactate 
dehydrogenase was lost into culture medium. One widely used method uses as a 
primary reaction the reduction of NAD by LDH (see Equation 20) 
            
                     
→                                   
Subsequent catalytic reduction of a yellow tetrazolium salt by NADH results is a 
blue formazan product (see Equation 21) 
                         
          
→                      
Absorbance maximum of formazan is 492nm – over a fixed time, the increase in 
absorption at this wavelength is proportional to the initial LDH concentration, and 
by implication the number of cells with disrupted plasma membranes410. 
Alveolar macrophages were incubated on the day if isolation in RPMI-1640 medium 
with 10% FBS at 106/well, and with varying concentrations of BSO in triplicates. 
After 24 hours, culture supernatants were removed and frozen for later testing. 
Alveolar macrophages which had been cultured in RPMI-1640 medium with 10% 
FBS only were lysed in water with 1% Triton-X. The resulting lysate was vortexed 
vigorously, spun at 10000g for 5 minutes in a microcentrifuge (Hereus, UK) and the 
supernatant used as a positive control. Relative LDH concentrations were measured 
by a kit according to the manufacturer’s instructions (Sigma, UK. Cat#TOX7). There 
was no increased release of LDH in either BSO 0.2mM or BSO 0.5mM compared 
with control (p=0.70 and p=0.50 respectively by paired t-test). There was increasing 
variation in LDH response as BSO dose increases which might represent the 
uncertainty around the estimate of treatment effect, or suggest a dose response. As a 
result of these data, and the similar efficacies of both doses of BSO in reducing 
glutathione concentration, the dose of 0.2mM was chosen for future experiments. 
Figure 3-21 Toxicity of butathionine sulfoximine to alveolar macrophages. 
 
LDH content of culture supernatant after 24 hour exposure of alveolar macrophages to BSO (n=6). p 
values represent paired t-test results. 
 
Methods for assessing intraphagosomal function have been developed by Prof 
Russell’s group375. As described, of 2',7'-dichlorodihydrofluorescein diacetate 
succinimidyl ester (H2DFCDA-SE), is used as a reporter for oxidation. 
A number of issues were addressed in order to improve the appropriateness of the 
published method to the small numbers of alveolar macrophages: 
Table 3-4 Method development issues with the use of intraphagosomal reporter beads 
 
Alveolar macrophages when examined by transmission light microscopy, or by 
digital image analysis (see section 2.10) show heterogeneity in terms of particulate 
content; this is both between and within volunteer samples. Any method which uses 
light absorption or emission to probe the character or function of these cells might 
necessarily be affected by the presence and concentration of these particulates. 
The relative effect of various particles on light absorption was tested by generating 
serial dilutions in RPMI medium without phenol red. Particles were vortexed and 
sonicated prior to each dilution, and before introduction to 96 well plates for 
absorbance measurement in a plate reader (BMG Omega). Absorption at 485nm was 
recorded, and is shown in Figure 3-22. Wood smoke was used as the most relevant 
particulate to the Malawi in vivo exposures. Specific particulates were: fine carbon 
black (as Huber 990, Haeffner & Co Ltd, Chepstow, UK, donated by Dr R Duffin, 
University of Edinburgh), mean diameter 260.3nm, surface area 7.9m3/g; ultrafine 
carbon black (as Printex 90, donated by Degussa GmBH, Germany) as a 
standardised microparticle, mean diameter 14.3nm, surface area 253.9m3/g; wood 
smoke as described in section 2.11. 
As expected with high surface area to volume ratio, the absorption was higher per 
unit weight for ultrafine carbon black compared with other particulates. 411. Wood 
smoke was more similar to fine carbon black (less than one quarter of wood smoke 
particles have a diameter of <100nm even under smouldering conditions412; fine 
carbon black is a better approximation of wood particulates by this measure). The 
linear relationship between concentration and absorption for all three groups was 
expected, and this provided evidence that particulate suspension generation 
according to the devised method produced a relatively homogenous particle 
distribution with minimal clumping. 
However, significant light absorption by the particles has the potential to cause 
error or bias in methods which use fluorescence reporting systems. Further work 
was therefore done to assess the likelihood of this interference, and is detailed 
below. 
Figure 3-22 Absorbance at 485nm of particulate suspensions. 
 
fCB = fine carbon black; ufCB = ultrafine carbon black. Solid black lines represent linear regression line. 
 
In terms of light absorption, within the scope of this project, the most likely assay to 
be affected would be the tests of intraphagosomal function. In order to assess this, 
wood smoke particulates in at a concentration of 50µg/mL in aqueous suspension 
were introduced to clear 96 well plates. Absorption of light at 10nm intervals 
between 350 and 650nm were recorded using a plate reader (BMG Omega). These 
data are represented in Figure 3-23, overlaid on information on the absorbance and 
emission spectra of the relevant fluorochromes. 
Wood smoke might interfere with fluorescence signals by absorbing 
electromagnetic spectrum radiation between the excitation source and fluorophore, 
or between the fluorophore and detector. Due to these multiple interactions, 
deduction of actual effect is complex. However, the intraphagosomal activity assays 
use as a metric the ratio of fluorescence of AF405 to DCF, and an estimate of effect 
may be made thus: 
 
 The excitation wavelengths within the flow cytometer are 405nm and 
488nm 
 The absorbance of wood smoke at these wavelengths is taken from the 
experiment as 0.2915 and 0.2340 respectively 
 The detection filter bandwidths are 450/50 and 530/40 
 The mean absorbance of wood smoke in these bands (425-475nm and 
510-550nm) is calculated from the experiment as 0.2596 and 0.2418 
respectively 
 The change in ratio of DCF to AF405 fluorescence as a direct result of 
wood smoke is likely to lie between 0.2596/0.2418 = 1.07 times and 
0.2915/0.2340 = 1.25 times. 
The effect of wood smoke is likely to be to increase the relative fluorescence of DCF 
compared with AF405. The estimate of effect given here is highly cautious: this 
acellular model exceeds considerably, by visual appearances, the most densely 
loaded macrophages. It is concluded that the effects of differential electromagnetic 
spectrum absorption are unlikely to have material effects on the results or 
interpretation of further experiments. 
Figure 3-23 Absorption spectrum of wood smoke particulates relative to Alexa Fluor 405 
(AF405) and dichlorofluoroscein (DCF) 
 
Solid black line indicates the absorbance of woodsmoke particles. Dotted lines represent the absorption 
spectra of AF405 and DCF. Shaded areas represent emission spectra of AF405 and DCF. Data for AF405 
and DCF taken from BD website413. Absorption values are only relevant to woodsmoke. 
 
One of the difficulties of positive controls when using these beads is that the 
fluorophore is esterified to improve cellular retention of the fluorescent product. 
This structure makes the fluorophore initially relatively insensitive to oxidation 
which has benefits in terms of the shelf life of reagent and improving artefact due to 
prolonged storage. In macrophages, after internalisation, the action of intracellular 
esterases exposes the oxidation site of the fluorophore, allowing the oxidation 
dependent increase in fluorescence to take place. 
In order to maximally oxidise the Oxyburst fluorophore, either chemical or 
enzymatic removal of the two acetate groups should be followed by continuous 
exposure to hydrogen peroxide or another oxidant for a period of time. The latter 
might be maintained at a constant concentration by the action of glucose oxidase414. 
However, as a daily method for testing oxidation sensitivity this is not pragmatic, 
and bolus addition of hydrogen peroxide was chosen as the oxidant delivery 
method as in previously published methods375. Preliminary tests of bead oxidation 
following both chemical and biological methods for de-esterification were 
performed with the intention of trying to improve the existing practice for checking 
bead activity i.e. adding 1% hydrogen peroxide directly to untreated H2DCFDA-SE 
coated beads. Both chemical and biological means were examined as alternatives 
using hydroxylamine treatment and exposure to leucocyte lysate respectively. 
 
Hydrolysis with hydroxylamine was done by incubation of bead suspension in 
0.15M hydroxylamine hydrochloride (NH2OH.HCl Sigma, UK. Cat#55459) in 
aqueous solution at pH 8.5 for 1 hour at room temperature415. Each condition was 
performed in duplicate in a 96 well plate with 1µL of beads per well. A single bolus 
of hydrogen peroxide (250mM final concentration) was added to each well in either 
water or citric saline. The latter was to test the hypothesis that it would protect 
beads from further oxidation after cells were removed from culture plates (see 
3.4.3). At all times, reagents were protected from light. Fluorescence of the beads 
was measured using a plate reader (BMG Omega) with excitation wavelength of 
488nm and emission of 520nm (see Figure 3-24). 
Untreated beads, were relatively resistant to oxidation: fluorescence increased to 
1.48x baseline after treatment with hydrogen peroxide: Both sets of de-esterified 
beads were, at baseline, more fluorescent that untreated beads (2.14x in water and 
2.59x in citrate buffer). In pure aqueous solution, H2O2 caused de-esterified beads’ 
fluorescence to increase to 5.63x baseline compared with 2.61x where citrate was 
present. This experiment demonstrated that: 1) following de-esterification, beads 
became more sensitive to oxidation; 3) the presence of citrate protected beads in 
suspension from oxidation. 
Figure 3-24 Fluorescence of H2DCFDA-SE coated beads in a cell free system - the effect of 
oxidation on untreated and chemically de-esterified beads 
 
De-esterified beads were incubated with 0.15M hydroxylamine. Bars show an average fluorescence of 3 
wells normalised to control (esterified, without H2O2). Oxidation was performed with a bolus of 250mM 
hydrogen peroxide. 
 
PBMCs were derived from 20mL fresh whole blood by density centrifugation (see 
2.21). This cell suspension was lysed in 2mL PBS by vigorous repeated passage 
through a 22G needle in the presence of 0.1% Tween 20 (Sigma, UK. Cat#P2287). The 
supernatant was removed following centrifugation at 10000rpm for 5 minutes. 
Thereafter 5µL of beads were added to 100µL supernatant for 30minutes at 37oC. 
The pH of the suspension was 6.6. Control beads were similarly treated except by 
substitution of PBS for cell lysate supernatant. Beads were washed twice in PBS 
before 1% hydrogen peroxide (final concentration) was added. Fluorescence of both 
reporter and calibrator were measured by flow cytometry using a Cyan ADP 
machine (see Figure 3-25). Similarly experiments were performed using beads 
exposed to hydrogen peroxide but without prior incubation with cell lysate 
supernatant. 
Figure 3-25 Flow cytometry plot of reporter beads before and after de-esterification and 
oxidation 
 
Left panel: Latex beads coated with both H2DCFDA-SE (reporter fluorophore) and Alexa 405 (calibrator 
fluorophore) were incubated either in PBS (control, displayed blue) or PBMC extract (a source of 
intracellular esterases, displayed red). Rightward shift represents increased oxidation of H2DCFDA-SE 
Right panel: Beads similarly treated with control or hydrogen peroxide, but without de-esterification. NB: 
Dissimilar acquisition settings do not allow direct comparison of left and right panels. 
Where de-esterification had been attempted with cell lysate supernatant, the 
fluorescence of the calibrator compound changed as a result of hydrogen peroxide 
treatment (reduction of 5.8%, p<0.0001 by t-test) presumably due to degradation of 
Alexa 405. However the magnitude of this change is very small compared with that 
induced in the reporter (increase of 2.4 fold over control, p<0.0001 by t-test). Thus 
the use of calibrator fluorescence as a denominator in the activity index calculations 
is justified (see 2.19). Where de-esterification was not attempted, the beads behaved 
similarly with respect to reporter (3.1 fold increase, p<0.0001) but changes in 
calibrator fluorescence were not significant (1% fall, p=31 by t-test). It was 
concluded firstly that exposure to cell lysates rather than oxidation per se degraded 
the calibrator. Secondly, although oxidant response of the reporter is blunted 
without de-esterification (see Figure 3-24), direct addition of hydrogen peroxide 
produced a slightly superior effect when beads had not been exposed to cell lysates. 
There may be a number of possible explanations. Firstly, monocytes have limited 
esterase activity compared with macrophages398, although still sufficient for 
significant hydrolysis416. Secondly, that this protocol released insufficient non-
specific esterases, or that esterase inhibitors in addition to esterases were released; 
these hypotheses have not been tested. 
Positive controls for bead activity in further experiments therefore used hydrogen 
peroxide treatment alone. 
 
Although de-esterification was relatively unsuccessful using cell lysates, it was 
expected that within phagosomes it would be maximal. The effect of hydrogen 
peroxide on beads thus exposed was tested in order to determine if the positive 
control might be improved. 
Ex vivo alveolar macrophages were used on the day of bronchoscopy. Reporter 
beads with H2DCFDA-SE were used according to the method given in section 2.19. 
Synthesis of the flow cytometry data from one individual is given in Figure 3-26. 
Compared with either cells or beads alone, a rightward shift in the reporter 
fluorescence histogram is noted in the 60 minute exposed beads and further in 60 
minute exposed beads subsequently treated with 1% hydrogen peroxide. This graph 
suggests that: intraphagosomal oxidation is taking place, because there is a 
rightward shift in the fluorescence of cells containing beads compared to unexposed 
cells and beads alone; the beads response to oxidation is not saturated in this 
individual because further oxidation is possible with H2O2; there is a heterogeneous 
oxidant response within the macrophage population, because the peaks are broad 
and irregular compared with controls. Compared with beads alone, there was a 3.31 
fold increase in mean reporter fluorescence of cells with beads, and 7.11 fold 
increase in cells with beads treated with hydrogen peroxide. On this basis, future 
positive controls contained (where cell numbers allowed) cells exposed to beads 
followed by H2O2. As shown in section 0 however, there is reason to suspect that the 
degree of additional chemical oxidation by H2O2 may be strongly altered by the 
presence of cellular antioxidant, which shows considerable interpersonal variation. 
Its use as a control is therefore limited, although it does provide reassurance that 
beads remain responsive to oxidation after some time in storage. 
Figure 3-26 Fluorescence of reporter beads in alveolar macrophages. 
 
Data from flow cytometry are represented in four overlaid histogram plots of H2DCFDA band 
fluorescence. 
A Cells alone, gated on macrophages according to FSC and SSC properties 
B Beads alone, no gating 
C Beads incubated with cells for 60 minutes using macrophage gate in A and child gating on 
calibrationhigh population 
D Beads incubated with cells for 60 minutes, with subsequent addition of 1% H2O2, gated as C 
 
Data from this section (3.9) was experimentally derived and analysed by Dr 
Fullerton. It is presented here to provide background information to the in vitro 
work done in this study. 
Wood smoke extract is used throughout this study for ex vivo challenge of HAM 
and MDM. In order to inform on the appropriate concentration to be used, 
particulate loading experiments were performed using MDMs (see Figure 3-27). 
Monocyte derived macrophages were derived from Buffy coat blood (UK Blood 
Transfusion Service). This was diluted 1:1 in normal saline, layered onto 
Lymphoprep® gradient separation (Axis-Shield UK) and centrifuged according to 
the manufacturer’s directions. Cells were seeded in a 24-well plate in RPMI 1640 
supplemented with 10% FBS and 2mM L-glutamine. Cells were cultured on 
borosilicate glass coverslips at 37ºC in 5% CO2 for 10 days. Media was changed after 
24 hours and every 3 days to remove non-adherent cells leaving MDMs adherent to 
the coverslips in each well. Wood smoke particles (see section 2.11) were added in 
fresh media after 10 days of adherent cell culture at doses of 5, 10, 50 and 100μg/mL. 
After 5 hours, the coverslips were washed twice in PBS, fixed, permeabilised and 
stained. Staining and subsequent analysis of particulate density was performed as 
described in section 2.10. 
There was a dose dependent uptake of particulate matter after challenge with wood 
smoke extract, from 1.5% with 5μg/mL to 16.2% with 100μg/mL. Unpublished data 
from our group demonstrate a similarity of response between MDM and HAM in 
terms of particulate density after in vitro challenge. 
There is a dose dependent relationship in MDMs between the concentration of 
wood smoke particles added to culture medium, and the resulting cellular 
particulate density. Fifty micrograms per mL was chosen as the dose to be used 
subsequently, based on the observation that this produced particulate densities 
similar to those seen in the highest exposed Malawian HAMs (around 10%) and for 
consistency with previous work in our group. 
Figure 3-27 Dose dependent effect of wood smoke concentration on particulate density in 
monocyte derived macrophages 
 
Monocyte derived macrophages at day 10 challenged for five hours with varying concentrations of wood 
smoke extract (n=5). 
 
Ex vivo alveolar macrophages were used to investigate the effect of particulates and 
inflammatory stimuli on redox balance as measured by relative oxidised glutathione 
levels. Wood smoke extract used throughout this project derives from the same 
batch of filters, processed at the same time using the same equipment. In order to 
test the hypothesis that this particulate suspension could cause oxidative stress, ex 
vivo alveolar macrophages were exposed at 50μg/mL. Cells were harvested, 
processed and plated into 6 well plates at 3x106/well. After 18 hours of adherent 
culture, cells were washed in warm culture medium (RPMI-1640) and then 
incubated at 37oC with medium only, or 50μg/mL re-suspended wood smoke 
particles (see section 2.11 for preparation). After 20 minutes, cells were scraped into 
ice cold 5% sulfasalicylic acid and assayed for oxidised and reduced glutathione, 
and total protein as previously described in section 2.6. Change in oxidised 
glutathione was tested using paired t-tests. 
Figure 3-28 Effect of wood smoke and inflammatory stimuli on intracellular oxidised 
glutathione concentrations in ex vivo alveolar macrophages 
 
Statistics: Paired t-test used for comparisons. n=7 for LPS and pneumococcal analyses. n=17 for wood 
smoke analysis. Abbreviations: LPS lipopolysaccharide; WT and Ply neg culture supernatant from 
Streptococcus pneumoniae sertoptype D39 wildtype and pneumolysin deficient respectively. 
As seen from Figure 3-28, at 20 minutes the proportion of oxidised glutathione had 
increased from a baseline mean of 2.40% to 3.56% (p=0.0046). There was no change 
in those cells exposed to LPS (mean 2.57% to 3.01%, p=0.37). Exposure to 
supernatants of both wild type Streptococcus pneumoniae and that of the pneumolysin 
deficient strain did not affect the proportion of oxidised glutathione. 
This established in vitro evidence that relevant particulate exposure (i.e. respirable 
wood smoke particles) can produce redox responses in human alveolar 
macrophages, and that this is likely to be independent of the effect of bacterial 
endotoxin (as seen from the inconsistent response to LPS). 
  
 
The redox state of a cell has broad implications for its behaviour and function, as 
described in section 1.2. It has been well described in disease states (cigarette 
smoking417, asthma418, pulmonary vascular disease419, cystic fibrosis420, ventilator 
associated pneumonia326, Farmer’s lung421 and HIV422), and in a number of specific 
exposures (ozone423, glass dust exposure424). No such study has been undertaken 
within a population of healthy people at risk of redox alterations due to high levels 
of environmental particulates. 
This section examines such individuals, in the context of exposure to household air 
pollution from the combustion of biomass fuels. Comparison is made with 
unexposed individuals, and with cigarette smokers who are known to exhibit both 
oxidative stress and compensatory upregulation of antioxidant systems. The study 
has been performed in the UK and in Malawi. 
 
In vitro studies of particulate exposure lead to the expectation that individuals 
exposed to wood smoke and other products of biomass fuel combustion are likely to 
demonstrate relatively high levels of alveolar oxidative stress76, 82, 84, 134, 425, 426. In 
healthy individuals, the effect of in vivo wood smoke exposure has been studied in 
controlled environments. Barregard et al subjected individuals in a chamber to four 
sessions of wood smoke exposure at a PM2.5 concentration of 240-280µ/m3. After 
hour long exposures, lipid peroxidation and exhaled nitric oxide levels were raised 
compared with air exposed controls91. Bronchoscopic studies are few, but 
demonstrated that after 3 hours, 224µg/m3 wood smoke causes increase in epithelial 
lining fluid glutathione, suggestive of mobilisation of antioxidant as a protective 
mechanism against local oxidative stress. 
A study of atopic individuals thought to be more prone to airway oxidative stress 
have shown no increase in exhaled nitric oxide or short term pulmonary function 
after 3 hours of 400µg/m3 wood smoke427. Another 3 hour 354microg/m3 exposure 
study failed to demonstrate evidence of oxidative stress or inflammatory response 
in peripheral leucocytes428. Responses to other particulates including concentrated 
ambient particles and diesel exhaust particulates are detailed in Table 1-2. At lower 
particulate concentrations, these exposures demonstrate airway antioxidant 
upregulation429, 430, and glutathione mobilisation to the airway120 with measurable 
airway inflammation120 and systemic inflammatory responses431. 
These controlled exposure studies in humans have carefully defined acute exposure 
to particulates. However, practical limitations of the wood smoke experiments limit 
the generalizability to chronic “natural” exposures seen from human populations 
using biomass fuel in the home: 
  
1. Indoor air particulate concentrations have mean PM10 concentrations 
300µg/m3 to 3000µg/m3, and peaks reaching 30000µg/m39. Such high 
exposures are difficult to model in the laboratory and might cause concern 
regarding harm to the research volunteers  
2. Chronic exposures behave differently to acute ones, particularly with respect 
to redox balance. Acute exposures and disease processes tend to reduce 
alveolar concentrations of glutathione and enzymatic antioxidants GPx and 
catalase (such as pneumonia326 and acute cigarette smoke exposure417). 
Generally, chronic exposures potentiate upregulation mechanisms, resulting 
in higher levels than unexposed individuals (chronic cigarette smoke 
exposure417), although reach a point in disease progression after which a 
decline occurs (asthma194, COPD432). 
3. The distinction between intracellular and extracellular redox balance in ex 
vivo studies cannot always be defined, for example where exhaled breath 
concentrations are measured. Bronchoscopic studies have often used whole 
BAL as an indicator or airway redox balance. This mixture of extracellular 
fluid (predominantly formed by epithelial cells) and intracellular fluid 
(predominantly macrophages) gives an overview, but is insufficient to 
explain the effect of redox balance on innate immunity. Extracellular 
glutathione has been extensively studied in humans185, but intracellular 
glutathione studies have been mostly limited to animal and cell line models, 
and to cigarette smokers. 
 
Ex vivo study of human exposure, although difficult, is therefore required to 
complement the current literature.  
 In examining the issues of redox balance with respect to cellular compartment, cell 
type and acute vs chronic exposure, tissue culture models of alveolar macrophages 
have some advantages in improving homogeneity, reducing complexity and 
avoiding the research need for bronchoscopy and bronchoalveolar lavage. One such 
model is monocyte derived macrophages (MDM) which are peripheral blood 
mononuclear cells in prolonged (7-14 days) of adherent culture. It is expected that in 
maturing from peripheral monocytes to adherent MDMs, cells move towards a 
macrophage phenotype, and this can be enhanced by the presence of GM-CSF in the 
culture medium. While AM are known to proliferate within the lung, contributing 
to the slow turnover kinetics433, repopulation by monocytes has a role in 
replenishing numbers434. Alveolar macrophages are noted to have high antioxidant 
buffering capacity, and relative insensitivity to oxidants compared with 
monocytes210. Tissue culture models of macrophages often use PBMCs after 
extended adherent culture; the degree of similarity to primary tissue macrophages is 
investigated here. 
 
 
 This chapter presents results relating to the following hypotheses: 
1. Monocyte derived macrophages represent an adequate model of alveolar 
macrophages with respect to redox balance 
2. Chronic alveolar redox balance may be described by a universal stress 
response i.e. high levels of oxidative stress is associated with a co-ordinated 
response leading to: 
a. Up-regulated intracellular and extracellular glutathione levels 
b. High proportions of total glutathione existing in oxidised form 
c. Up-regulated intracellular antioxidant enzyme activity (specifically 
glutathione peroxidase and superoxide dismutase) 
d. High levels of cellular lipid peroxidation 
3. Enzymatic stress responses (glutathione peroxidase) are confined to the lung 
4. Individuals living in Malawi have higher levels of oxidative stress than those 
in the UK due to higher levels of particulate exposure from domestic 
biomass fuel use 
Within hypothesis 2, determinants of the degree of glutathione derangement and 
enzymatic upregulation are investigated. 
 
 
Healthy adults were recruited to this study in two sites; Liverpool, UK and Blantyre, 
Malawi. Potential volunteers were screened by medical interview and examination, 
spirometry and HIV testing as described in section 0. 
Volunteers from Malawi underwent specific questioning relating to their 
socioeconomic status as this is likely to impact on their exposure to smoke from 
biomass fuel combustion435, discussed in sections 1.1.4.2 and Table 4-2. Markers of 
socioeconomic status were chosen for compatibility with previous research projects 
in Malawi, including items from the principle components analysis used by the 
Malawian Ministry of Health for resource allocation436. 
In order to improve the external validity of comparisons between UK and Malawi 
cohorts, in addition to healthy non-smokers, comparison was also made with UK 
cigarette smokers. This gives “positive control” individuals who are known to have 
alterations in their redox balance437. These individuals were screened identically to 
non-smokers, and were recruited if they smoked more than 10 cigarettes per day. 
 
Spirometry was performed according to American Thoracic Society guidelines438 
using an ndd EasyOne World spirometer (ndd, Switzerland). Data for FEV1 and 
FVC are presented as percentage of predicted rather than raw values. The use of z-
scores, which have some advantages over percentage predicted values439, has not 
been adopted here for two reasons: 1) there will be no longitudinal comparisons; 2) 
the lack of a local reference range for Malawians considerably lessens the 
advantages of z-scores. The same predicted ranges were used for all cohorts, but the 
ERS/ECCS normal reference range used takes into account age, sex and height with 
a correction factor of 0.88 for FEV1 and FVC in black individuals. 
 
Laboratory assays were carried out as described in section 2. For specific details, 
please see the following sections: glutathione (2.6); glutathione peroxidase (2.22); 
superoxide dismutase (2.22); protein concentration (2.14 and 2.15); plasma selenium 
(2.8); cellular particulate burden (2.10); lipid peroxidation (2.17). 
GPx and SOD and haemoglobin were measured by Randox laboratories, UK. 
Plasma selenium was measured in the Royal Liverpool University Hospital, UK. All 
other assays were performed by the author. 
Initially, oxidised glutathione was measured in the extracellular compartment of 
BAL. However, absolute levels were consistently below the limit of detection of the 
assay (results not shown). 
 
Peripheral blood mononuclear cells (PBMCs) were isolated from citrate anti-
coagulated blood by density centrifugation as detailed in section 2.21, and cultured 
in 6 well plates at 6x106 per well. At days 0 (2 hours), 1, 3, 5 and 7 after the initial 
adherence step, the contents of one well were scraped into 250µL phosphate 
buffered saline, and frozen at -80oC pending analysis. Cell culture medium from 
remaining wells was removed and replaced with fresh medium (RPMI 1640 + 10% 
FCS). 
 
Bronchoscopy was performed as described in section 2.5. Extracellular samples 
analyses for glutathione are reported as uncorrected results. For consistency with 
previous published literature, intracellular glutathione is here corrected to total 
protein of the sample as determined by the Lowry method.  
 
As bronchoalveolar lavage returns variable quantities of fluid, various devices are 
used to correct raw results. These include protein (for cellular samples) and urea 
(for extracellular samples). Extracellular samples were reported as raw results only, 
despite some authors using the urea method. This correction technique assumes that 
after instillation of the fluid, urea in the bronchoalveolar lining fluid is diluted, and 
that the extent of that dilution is proportional to the BAL to serum urea ratio. 
However, due to concentration gradient after fluid instillation, urea crosses the 
capillary membrane into the alveolar space thereby violating the underlying 
assumption of a fixed ratio440. 
 
All analyses were performed using Stata v12 (StatCorp, USA). 
MDM maturation glutathione and antioxidant enzyme levels are shown as 
connected dot plots for each individual donor. For comparison, a box blot is given to 
indicate levels found within human alveolar macrophages (from the Malawi 
cohort). Changes in levels over time in maturing MDMs are compared with 
Kruskal-Wallis one way analysis of variance. The usefulness of monocytes and 
MDMs as a model for redox balance in HAM is assessed by comparison of day 0 
and day 7 MDMs with HAM using Mann-Whitney U test at α=0.05 significance 
level. 
For comparisons of the human cohorts, t-tests and one way analysis of variance 
(ANOVA) is used to compare baseline characteristics where described by normally 
distributed continuous data. Where data do not follow normal distributions, Mann-
Whitney U and Kruskal Wallis tests are employed. Categorical data are compared 
using Fisher’s exact test. 
One non-normally distributed variable (particulate loading) was normalised by log 
transformation for the purposes of all analyses in order that parametric tests could 
be used. In all other cases, such transformation did not improve the normality of 
distribution, and variables were therefore analysed using non-parametric tests. 
Univariate analyses of predictors of glutathione, GPx and SOD were performed 
using linear regression against continuous variables and ordinal categorical 
variables. No correction for multiple analyses was made. A significance level of 
p<0.1 was used to identify candidate associated variables. A model was then fitted 
using these variables, and refined by backward elimination, where variables were 
removed singularly based on Wald statistics using a cut-point of p=0.05. 
Correlation of antioxidant enzyme activities in blood and urine were compared with 
linear regression with analysis of covariance (ANCOVA) testing for differences 
between groups. Cohorts from the UK and Malawi were compared with respect to 
glutathione peroxidase and lipid peroxides by t-test. 
 
 
Representative images of the maturing cells are shown in Figure 4-1 showing the 
increase in size and irregularity of PBMCs over time indicating a transition towards 
the morphological appearances of macrophages.  
Figure 4-1 Representative polarised light microscopy images of PBMC maturation in 
adherent culture 
   
Day 1 Day 3 Day 7 
Images are taken at x40 magnification in all cases. 
Cellular glutathione levels are shown in Figure 4-2. Median concentrations, when 
corrected for total protein, were 10.71nmol/mg (range 2.7 to 23.1) in the adherent 
monocytes day 0 compared with 20.09nmol/mg (IQR 11.58 to 27.19) in HAM, 
although this difference did not reach statistical significance (p=0.051). Significant 
variation was observed in PBMC glutathione content as previously reported: a 
study of healthy volunteers found concentrations of 16.1nmol/mg  ±SD 5.2)441. This 
may represent differing cell viabilities during culture, or variations in the 
proportion of monocytes within collected PBMCs. Over the first 24 hours, 
glutathione levels dropped in every sample, although five out of six showed 
subsequent increase from day 1 to day 7. However, among these six samples, there 
was no statistically significant change over time (p=0.25). By day 7, MDM had 
reached cellular glutathione levels in the range see in HAM (p=0.91) with median 
levels of 18.6nmol/mg (IQR 11.98 – 25.38) in MDM vs. 20.09nmol/mg (IQR 11.58 to 
27.19) in HAMs. 
Figure 4-2 Glutathione concentrations of PBMCs in adherent culture over time 
 
Glutathione is corrected to total protein for MDM (n=6). Levels for human alveolar macrophagesfrom 
Malawian volunteers (HAMs) are given for comparison (n=42). Box plot represents: centiles 2.5, 25, 50, 
75, 97.5. * Mann-Whitney U test comparing monocyte/MDM with HAM. ** Kruskal-Wallis one way 
analysis of variance for difference within the groups 
Data for antioxidant enzyme levels are shown in Figure 4-3. Glutathione peroxidase 
tends to decrease during cell culture, and changes significantly over time (p=0.0075). 
At baseline, median GPx activity was 77.1U/mg protein (IQR 51.9 to 123.4). At day 7, 
median activity had fallen to 29.3U/mg (IQR 19.7 to 37.9), and was significantly 
lower than HAM at both time points (p=0.001 and p=0.0002 respectively). Indeed, 
prolonged tissue culture seems to exacerbate the differences. 
For superoxide dismutase, median activity at baseline was 1.41U/mg (IQR 0.60 to 
2.02), and 1.3U/mg (IQR 1.87 to 2.70) by day 7. Overall there was no difference 
during maturation (p=0.72). Baseline levels were significantly lower than HAM 
(p=0.0068), although at day 7, this difference was non-significant (p=0.17). 
Figure 4-3 Glutathione peroxidase and superoxide dismutase levels of PBMCs in adherent 
culture over time 
  
 
GPx and SOD activities are reported as Units/mL corrected to total protein (n=6). Levels for human 
alveolar macrophages (HAMs) are given for comparison (n=42). * Mann-Whitney U test comparing 
monocyte/MDM with HAM. ** Kruskal-Wallis one way analysis of variance for difference within the 
groups 
 
 
In order to support comparison between groups, it is necessary to demonstrate 
baseline similarities. Table 4-1 gives a summary of key demographic findings of the 
three cohorts from which ex vivo data on redox balance and alveolar macrophage 
behaviour are drawn: UK non-smokers, UK smokers and Malawian non-smokers. 
Of those comparisons within Table 4-1, no differences were seen by sex or body 
mass index (BMI). Malawian volunteers were on average older (mean age 30.6 years 
compared with 24.2 in the UK volunteers as a whole). As expected, Malawians were 
significantly shorter at 1.62m (p<0.0001 across all groups). No differences were 
found between UK non-smokers and Malawian non-smokers in terms of exposure 
to second hand cigarette smoke in the home (p=027), previous smoking history 
(p=0.29 for “ever smoker” and p=0.13 for pack years smoked). 
Summary statistics of socioeconomic status of the Malawian volunteers are given in 
Table 4-2. These are presented to inform on the generalizability of results to the 
wider Malawian and sub-Saharan African population. Where national statistics 
were available from the National Statistical Office survey442 for urban populations, 
the recruited volunteers were similar to these in terms of household goods and size 
and type of water supply. Recruited individuals were better educated than urban 
averages (56.8% completed primary education compared with 26%), but had less 
access to transport (car availability 1.6% vs. 8.0%, and bicycle 14.0% vs. 34.5%). 
Use of biomass fuel in for cooking and lighting amongst the Malawian cohort is 
described in Table 4-3. Most individuals cooked inside the home (77, 60.6%), and 
119 (93%) used open wood fire or charcoal as the main fuel. Even for lighting, a 
minority used electricity (31, 24.4%). The remaining volunteers reported use of 
paraffin or candle lighting (35.4% and 37% respectively). Overall, the use of biomass 
fuel in the home for heating or lighting was nearly universal; only 9 individuals 
(7%) used electricity for both purposes. 
Table 4-1 Demographic summary for Malawian volunteers 
Summary statistics given as mean (SD) unless otherwise indicated. Continuous data tested for 
significant disparity using ANOVA test. Categorical data were tested using Fisher’s exact test. “n/a” 
denotes a comparison which was not tested due to pre-selected groups where bias was intentionally 
introduced i.e. in the selected smokers, “ever smoker” must by definition be universal. * indicates only 
UK non-smokers and Malawian non-smokers were compared. 
 
Table 4-2 Socioeconomic summary for Malawian volunteers 
Study data and national statistics are given as percentages (n=128). National statistics labelled “Overall” 
are representative of the wider Malawi population, including rural areas.  
Table 4-3 Use of biomass fuel amongst Malawian volunteers 
n=127. Study data and national statistics are given as percentages (n=128). National statistics labelled 
“Overall” are representative of the wider Malawi population, including rural areas. 
 
Spirometry was performed on all volunteers. Overall, 87.7% of traces were 
acceptable: 2 (14.3%) were excluded each from the UK non-smoker and smoker 
groups; 16 (12.7%) were omitted from the Malawi group. Figure 4-4 summarises the 
results across each group with respect to FEV1, FVC and FEV1/FVC ratio. There were 
no statistical differences between non-smoking cohorts in the UK and Malawi. UK 
smokers had higher mean FEV1 as percentage of predicted value than their non-
smoking UK counterparts (116.2% vs. 99.1%, p=0.0086). FVC was also 
disproportionately increased in smokers (123.1% predicted vs. 99.2%, p=0.0005) 
leading to a lower FEV1/FVC (80.5% vs. 86.0%, p=0.046). 
Figure 4-4 Spirometric indices from volunteers in UK and Malawi 
 
Only volunteers producing adequate traces are included here (n=13 for UK non-smokers, n=12 for UK 
smokers, n=110 for Malawi non-smokers). Comparisons are made between UK non-smokers and UK 
smokers, and between UK non-smokers and Malawi non-smokers using t-tests. 
As a result of spirometry, ten individuals were stopped from further participation in 
the research project as their FEV1 did not meet the minimum requirement for 
bronchoscopy (this level of 75% predicted was established before recruitment 
commenced, and designed to increase safety of the bronchoscopy). 
 
Table 4-4 summarises the results of all blood tests and bronchoscopies from the 
study volunteers. Volunteers across all three groups were similar in terms of 
haemoglobin and mean red cell volume and platelets. As expected, total white cell 
counts were lower in the Malawi group (p<0.0001). 
Trace element levels are pertinent to this analysis as a number of antioxidant 
enzymes contain copper, zinc and selenium at their active site (see section 1.2.3). Of 
these, the latter two show no significant differences across groups (Table 4-4). The 
copper levels are lower in the non-smoking UK cohort (mean 13.72µmol/L [SD 1.80] 
, p=0.020). No differences were noted in BAL fluid returned, or the proportion of 
macrophages in the fluid. Variability of BAL cell differential counts is small across 
the three cohorts: the median macrophage content as a proportion of total cells in 
the returned fluid is 96.2%, with IQR of 93.7% to 98%. 
Macrophage particulate content was lower in the UK non-smokers compared with 
Malawians (0.13% vs. 0.81%, p=0.0035). Variability in the latter group was much 
greater with interquartile range 0.20 to 0.95 compared with 0.0 to 0.30 
Table 4-4 Details of blood tests and bronchoscopies in the three cohorts 
Summary statistics given as mean (SD) unless indicated with *, where median and IQR are used due to 
skewed distribution. Continuous data tested for significant disparity using ANOVA test, except for those 
marked with * = skewed distribution and Kruskal-Wallis test used. Summary statistics are reported to one 
more significant figure than the source data.Multiple statistical comparisons have been performed; these 
are given to inform on potential covariates and confounding and are therefore presented 
uncorrected443.Data for macrophage viability were not fully recorded for the UK smokers cohort, and are 
therefore omitted from this table. BAL return is after instillation of 200mL of normal saline. 
 
 The following section compares all three cohorts with respect to glutathione in 
intracellular and extracellular compartments of bronchoalveolar lavage fluid. The 
Malawi cohort is examined for evidence of in vivo determinants of glutathione 
status. 
 
Figure 4-5 shows glutathione levels in the cellular component of bronchoalveolar 
lavage fluid from three cohorts i.e. the cells remaining after centrifugation of BAL. 
These are 96% alveolar macrophages (Table 4-4). 
Uncorrected glutathione levels are similar across all groups. There are, however, 
lower median corrected glutathione levels in the UK smokers compared with non-
smokers (13.1nmol/µg protein vs. 27.7, p=0.037), but no statistical differences were 
found comparing non-smokers from the UK and Malawi (13.1nmol/µg protein vs. 
20.1, p=0.055).  
Figure 4-5 Total glutathione concentration in cellular component of BAL – raw and 
corrected results 
 
Panel A: glutathione levels in ex vivo BAL cells when corrected for total protein 
Panel B: glutathione levels without protein correction 
Lines represent median values. Comparisons were made using Mann-Whitney U tests as distributions 
were not normal. 
 
Results for the three cohorts are shown in Figure 4-6. 
Compared with the UK non-smoking group, concentrations of extracellular 
glutathione are higher in the UK smokers (p=0.0033), and amongst the Malawian 
non-smokers (p=0.0046). Median values are 1.18µM (IQR 0 to 1.27), 3.84µM (IQR 
2.66 to 4.59) and 2.05µM (IQR 1.25 to 3.22) respectively.  
Figure 4-6 Extracellular total glutathione in bronchoalveolar lavage fuid 
 
Horizontal lines indicate median values with IQR. Groups compared using Mann-Whitney U test. Four 
data points in the UK non-smoking group lie below the lower limit of detection. 
 
As discussed in section 1.2.1.1, the ratio of oxidised to total glutathione is a measure 
of the redox balance. Cellular redox balance in bronchoalveolar lavage is 
summarised in Figure 4-7. 
UK non –smokers have a median cellular ratio of 4.74% compared with 10.70% in 
UK smokers and 2.98% in Malawian non-smokers. Means (SD) are considerably 
different, especially in Malawian non-smokers 4.41% (2.83), 11.80% (6.34), 4.26% 
(3.28) respectively, demonstrating a non-normal distribution. Median values for UK 
non-smokers differ from UK smokers (p=0.0055), but do not significantly differ from 
Malawian non-smokers (p=0.49). 
Examination of Figure 4-7, however, reveals a considerably positively skewed 
distribution amongst Malawian non-smokers (skewness 1.61, p<0.0001 by Shapiro-
Wilk test). Figure 4-8 shows that the UK non-smoker and Malawian non-smoker 
populations appear differently distributed with respect to oxidised glutathione 
proportion in the cellular compartment. Cumulative proportion histograms are 
preferred to “ordinary” histograms due to their more precise depiction of the small 
UK dataset. For orientation, a probability histogram of the Malawi group is also 
shown in Figure 4-8. While the UK group approximates a normal distribution, 
observations within the Malawian cohort appear bimodally distributed. 
Due to the relatively small numbers of observations from which to draw 
conclusions, mathematical models were created using a number of potential 
scenarios which might describe the data. This modelling was done by Prof Diggle at 
Lancaster University, UK using R444. The script for this analysis has been annotated 
by JR, and appears in full in section 7.1.1. 
We evaluated the following hypotheses: 
Null hypothesis 1: Oxidised glutathione in the Malawian non-smokers is 
described no better by a bimodal (i.e. two normally distributed sub-
populations) model than a single normal distribution 
Null hypothesis 2: Under the assumption that the UK is a homogenous 
(normally distributed) group and Malawi a mix of two different 
(normally distributed) subgroups, one of the Malawian subgroups 
the same as the Liverpool group 
 
For each hypothesis, a null model and alternative model were created and fitted to 
the original data. Maximum likelihood estimation was to generate the most likely 
parameters for each model. The log-likelihood for each model was recorded, which 
is a measure of goodness of fit. Models were then compared to each using the log-
likelihood ratio i.e. how much more likely the first model is to describe the data 
compared to the second model. From log-likelihood ratios, p values are determined 
as a measure of statistical significance445. 
Null hypothesis 1 was rejected: log likelihood ratio was 11.64 in favour of the 
bimodal model, translating to p<0.0001. Maximum likelihood estimation suggested 
two subpopulations of mean 2.75% and 8.55% with standard deviations of 1.05 and 
3.33 respectively. The smaller subgroup (with higher levels of oxidised glutathione) 
was estimated to account for 26.8% of the overall population. The fit of the model is 
shown visually in Figure 4-9. 
Null hypothesis 2 was similarly rejected (p=0.003). Neither the “low” nor the “high” 
peaks amongst the Malawi data corresponded to the UK single peak.  
Figure 4-7 Proportion of cellular BAL glutathione in oxidised form  
 
Horizontal lines are medians. Comparisons use Mann-Whitney U test as data are not normally 
distributed. 
 
Figure 4-8 Histograms of cellular BAL glutathione in oxidised form 
 
 
 
 
Figure 4-9 Fitted model of the “two normally distributed subgroups” compared with 
observed results – cumulative proportional histogram 
 
Model fitted from maximum likelihood estimation of the statistical model given in 7.1.1. 
 
We undertook an investigation of the predictive factors for oxidised to total 
glutathione ratios. This would identity variables which determined or associated 
with high levels of oxidative stress in the alveolar macrophage. 
Variables included in the analysis were: 1) those relating to the primary hypothesis 
(that particulate exposure causes oxidative stress); 2) antioxidant enzymes which 
share a common physiological purpose and are therefore likely to be confounders); 
3) basic physiological parameters; 4) indicators of cell type and viability within the 
lavage fluid. This univariate analysis is shown in Table 4-5. 
Oxidised glutathione ratio was significantly negatively associated with total 
glutathione, glutathione peroxidase activity and lighting with an open paraffin lamp 
(p<0.1). No other predictors were found. In multivariate analysis, all of these 
remained significantly negatively associated with oxidised glutathione at p<0.05 
(see Table 4-6). 
Table 4-5 Associations of oxidised glutathione within the cellular component of 
bronchoalveolar lavage fluid – univariate analysis 
* where the position of a volunteer on the bronchoscopy list might impact on time to processing the 
sample. Comparator group for cooking fuel was those who used wood: this was chosen in order to give a 
greater precision of the estimate as only a small number of individuals used electricity. Lighting 
comparator group was those using electricity as greater numbers were available for comparison. 
 
Table 4-6 Associations of oxidised glutathione within the cellular component of 
bronchoalveolar lavage fluid – multivariate analysis 
 
 
 
Data on 93 individuals were available for univariate analysis of determinants of 
glutathione peroxidase and superoxide dismutase levels. Table 4-7 shows this 
analysis. No correction for multiple comparisons has been made here. 
Criteria for univariate analysis were as specified in 4.3.3.3. Associated with GPx at a 
significance of <0.1 were: age; cell viability; glutathione concentration; SOD activity; 
serum copper. When introduced to the multivariate model (see Table 4-8), only 
glutathione and SOD activity remained in the model at p<0.05. Of note, particulate 
load in the alveolar macrophage was not associated with GPx activity. 
Superoxide dismutase levels were associated with: age; volume of bronchoalveolar 
lavage returned; glutathione; GPx activity; lighting the house with candles. In the 
multivariate model (Table 4-9), only GPx activity and total glutathione remained 
significant. Particulate load was not associated with SOD activity. 
Table 4-7 Associations of glutathione peroxidase and superoxide dismutase activity in the 
cellular compartment of bronchoalveolar lavage fluid – univariate analysis 
Although cell viability is strongly negatively skewed, linear regression modelling has been used as the 
residuals do follow normal dsitributions. No correction has been made here for multiple comparisons 
 
Table 4-8 Determinants of glutathione peroxidase activity in the cellular compartment of 
bronchoalveolar lavage fluid – multivariate analysis 
 
Table 4-9 Determinants of superoxide dismutase activity in the cellular compartment of 
bronchoalveolar lavage fluid – multivariate analysis 
 
 
Glutathione peroxidase is positively correlated with plasma selenium levels, 
increasing proportionally with selenium to around 1.3µmol/l446. This is due to dose 
dependent incorporation of selenocysteine residues, increased stability of GPx 
mRNA at higher Se concentrations, and probably the requirements of other tissues 
for selenoenzymes447. At higher levels, this relationship is less well pronounced. The 
use of plasma or serum selenium as a biomarker for whole body selenium status is 
well accepted, although no “gold standard” test exists448. 
As a major determinant of red cell and plasma glutathione peroxidase, selenium 
was specifically examined in terms of its relationship to alveolar macrophage GPx. 
Figure 4-10 shows data from 89 Malawi volunteers for whom these parameters were 
available. As a major determinant of red cell and plasma glutathione peroxidase, 
selenium was specifically examined in terms of its relationship to alveolar 
macrophage GPx. There is no evidence of a linear relationship between HAM GPx 
activity and plasma selenium (p=0.90). Similarly, there was no correlation between 
glutathione peroxidase activity in the alveolar macrophage and in whole blood (see 
Figure 4-11). 
Figure 4-10 Relationship between alveolar macrophage glutathione peroxidase activity and 
serum selenium concentration 
 
Alveolar macrophage GPx is corrected to total protein. Solid black line represents linear regression model. 
p-value represents the probablity that the line of linear regression is horizontal. 
Data from the UK and Malawi are shown in Figure 4-12. Both cohorts show a 
statistically significant correlation when fitted to the linear model. Analysis of co-
variance (ANCOVA) testing compared the degree of selenium-GPx relationship. 
Results do not refute the null hypothesis that the groups are significantly different 
in slope (p=0.35) despite a higher correlation coefficient in the UK group (0.29 vs. 
0.074). 
Overall, no differences were seen in whole blood glutathione peroxidase levels 
when comparing UK non-smokers, smokers and Malawi subjects (see Figure 4-13). 
Figure 4-11 Relationship between alveolar macrophage glutathione peroxidase and whole 
blood glutathione peroxidase activity 
 
Whole blood GPx is corrected to haemoglobin concentration. Alveolar macrophage GPx is corrected to 
total protein. Solid black line represents linear regression model. p-value represents the probablity that 
the line of linear regression is horizontal. 
 
Figure 4-12 Relationship between whole blood glutathione peroxidase activity and serum 
selenium concentration in Malawian(top)  and UK (bottom) volunteers 
 
Whole blood glutathione peroxidase is corrected to haemoglobin concentration. Solid black line represents 
linear regression model with 95% confidence intervals indicated by dashed line. p-value represents the 
probablity that the line of linear regression is horizontal. Data are shown for Malawi (top graph) and UK 
(bottom graph). 
 
Figure 4-13 Whole blood glutathione peroxidase activity in UK non-smokers, UK smokers 
and Malawi non-smoking cohorts 
 
Whole blood glutathione peroxidase is corrected to haemoglobin concentration.Horizontal lines represent 
mean and 95% confidence intervals. 
 
As a downstream maker of oxidative stress in the cellular compartment, lipid 
peroxides from BAL derived cells were measured. Results are shown in Figure 4-14, 
normalised to total protein levels. These data are normally distributed, and 
demonstrate a significantly higher mean level of malondialdehyde in the Malawian 
cohort compared with UK volunteers (5.79nmol/mg protein vs. 3.36nmol/mg, 
p=0.026).  
Figure 4-14 Cellular peroxidation in bronchoalveolar lavage from UK and Malawi non-
smokers 
 
Malondialdehyde measured by TBARS reaction with fluorescence detection of the MDA:TBA adduct 
using HPLC.Groups compared using t-test.Total protein measured using the Bradford method. 
 
 
Decreasing glutathione peroxidase activity over time in MDMs runs counter to the 
expected three fold rise given the hypothesis that PBMCs mature towards HAM-like 
cells (termed monocyte derived macrophages). Similarly, although not reaching 
statistical significance, superoxide dismutase levels were lower in MDMs than 
HAM. 
Initial falls in the glutathione concentration after adherent culture might represent a 
fall in cellular viability. As lower glutathione availability predisposes to apoptosis315 
this may be a cause of increased cell death, perhaps due to availability of substrate 
for synthesis in the medium, or initially increased oxidative stress in vitro. However, 
cell concentrations of glutathione fall during apoptosis as an effect of multiple 
processes, and results here more likely reflect this. At the end of seven days of tissue 
culture, glutathione levels were not significantly different from HAM.  
Given these data, examination of antioxidant enzyme levels in MDM models are 
likely to be misleading, and further investigation using the primary HAM is 
strongly supported. Our phenotypic data is supported by cDNA microarray 
analysis which finds significant differences between MDMs and HAMs449. 
Interpretation of existing data which uses MDM models in assays of oxidative stress 
should not be generalised to HAMs. 
Other culture conditions are likely to impact on ex vivo studies for both HAM and 
MDM models. For example, bovine serum albumin varies in selenium content, and 
this may alter GPx availability. For the purposes of this project, BSA from the same 
batch was used, and culture medium from a single manufacturer was used 
throughout. 
 
In this section, the validity of making comparisons between the UK and Malawian 
groups in terms of their baseline characteristics is considered (section 4.4.2.1). There 
follows discussion of the interpretation of results concerning redox balance in the 
lung. 
 
Direct comparisons of the three cohorts in terms of lifestyle are complicated by 
living conditions, educational level and other socioeconomic variables. Ethnicity 
may also be an independent predictor of some endpoints within this study, 
although there are no published data on the effect of ethnicity on these biochemical 
measures of redox balance. 
Malawian volunteers were older than those from the UK. Decreasing availability of 
antioxidant capacity is documented in animal models of aging450, but not well 
documented in human lungs451. While statistically significant here, the small 
absolute difference seems unlikely to contribute to biochemical differences; data 
from human plasma samples shows no significant change in glutathione between 
these two age groups452. 
 
Malawian volunteers seem to represent the wider urban population in terms of 
markers of socioeconomic status, household water, cooking and lighting use and 
number of people in the household. On average, volunteers were better educated 
than the national average, although no urban data comparison was available from 
national statistics. These data help to define the studied population, and to confirm 
that biomass smoke exposure is likely. To support this, 33.6% used wood as the 
main fuel for cooking, and 60.6% cooked indoors. Furthermore electricity was used 
as the main source of lighting only by a quarter; the remaining volunteers tended to 
use paraffin (35.4%) or candles (37%). Together, this burning of biomass fuel in the 
home is known to cause both alveolar macrophage particulate loading347, and 
symptoms and signs of respiratory disease453. 
 
It was hypothesised that the Malawi cohort would have lower FEV1 and FVC than 
the UK group as a result of suboptimal nutrition in early life and exposure to indoor 
air pollution454 amongst other factors. These data do not support this conclusion; 
spirometric values as a proportion of predicted are similar in UK and Malawi 
cohorts. Absolute values for FEV1 and FVC are, as expected, significantly lower in 
the Malawi non-smokers (p<0.0001 for both) due to relative stunting in the 
Malawian cohort. The FEV1/FVC ratios do not differ. 
Generalisation from these data is precluded as they are not randomly selected from 
the wider population, but based on opportunistic sampling. Such sampling bias 
may explain the statistical significantly higher FEV1 and FVC in UK smokers 
compared with their non-smoking counterparts. FEV1 was 116.2% predicted in 
smokers vs. 99.1% in non-smokers. (p=0.0086) and FVC 123.1% predicted vs. 99.2% 
respectively (p=0.0005). Young people taking up smoking may self-select based on 
respiratory symptoms and therefore initially have higher FEV1 than non-smoking 
counterparts (as previously reported)455. Lastly, the number of individuals in each 
UK cohort is small and therefore susceptible to bias resulting from the exclusion of 
“poor quality traces” from analysis. If such individuals among the smoking group 
tended to have poorer lung function, then the mean values for the remaining 
volunteers would be artificially elevated. 
 
Lower white cell counts in Malawians are consistent with previously observed racial 
differences, and which is unlikely to significantly impact the interpretation of the 
study as this is not thought to be clinically significant456. Multiple factors might 
explain the lower urea in the Malawian cohort; machine calibration; differences in 
hydration; lower consumption of red meat or protein; renal disease. The differences 
are unlikely to represent clinical differences as all volunteers underwent health 
screening. 
Trace metal concentrations showed significant variation only in copper between UK 
non-smoker and Malawi cohorts. However, serum copper levels are noted to be 
higher in smokers457, and are generally correlate with dietary intake, sex, 
inflammatory indices such as CRP and caeruloplasmin and serum lipid levels 
(specifically HDL-C)458. As laboratory analyses were identical in all groups, it seems 
likely that any differences result from multiple factors, most likely dietary and 
possibly higher inflammatory responses in the smokers and Malawian groups. 
These issues are not further pursued here. 
 
Cellular glutathione in bronchoalveolar lavage compares reasonably with another 
study of healthy volunteers from Germany459, which reported mean levels of 
12.4nmol/mg protein in non-smokers (in this Malawian cohort, 19.8nmol/mg). 
Similarly in this study, smokers were reported to have lower intracellular levels of 
glutathione than never smokers despite high levels in the epithelial lining fluid, 
which is reflected in our results. This may be due to impairment of the glutamate-
cysteine ligase enzyme which is rate limiting in glutathione synthesis, or an 
inflammatory phenotype which causes reduction in the activity of the Nrf2 
pathway, hence restricting anti-oxidant supply at the point of transcription460. High 
levels of oxidation can also oxidise glutathione, and cause reduction in its 
availability and from data presented in section 3.10, in vitro evidence for this exists 
in alveolar macrophages treated with wood smoke particles. Finally, in the absence 
of an influx of inflammatory cells within the BAL fluid (see Table 4-4), these results 
might represent greater numbers of less mature macrophages. 
The relatively high levels of extracellular glutathione in both smokers and Malawian 
non-smokers are highly suggestive of oxidative stress resulting in higher levels of 
extracellular antioxidant capacity. Such augmentation of glutathione in the 
epithelial lining fluid is well documented in animal models after an initial fall 
following smoke exposure. Human studies confirm the chronically higher levels of 
extracellular glutathione in smokers170, and upregulation in people experimentally 
exposed to wood smoke228. 
In terms of oxidised glutathione ratio mean and median levels between the UK and 
Malawian non-smoker cohorts were not dissimilar. However, due to the observed 
differences in distribution between the two groups, we performed mathematical 
modelling which showed strong evidence against a normal distribution in the 
Malawian non-smokers, and against the hypothesis that the Malawian cohort 
represented a population similar to the UK non-smokers. This evidence suggests 
that compared with the UK cohort, the majority of Malawian non-smokers have 
lower proportions of oxidised glutathione within the cellular component of 
bronchoalveolar lavage fluid. A subpopulation, however, have higher levels than 
those volunteers from the UK. If considered as a measure of susceptibility to 
oxidative stress, higher GSSG to total glutathione levels suggest lower antioxidant 
capacity, and vice versa. This population distribution suggests, among Malawians 
but not those from the UK, a bimodal distribution of exposure to oxidants or a 
bimodal distribution of response to oxidants. 
The exploratory analysis of determinants of oxidised glutathione, as might be 
expected, showed potential antioxidants had a statistically significant negative 
association with oxidised glutathione ratio. These included total glutathione, 
glutathione peroxidase and superoxide dismutase activity. This suggests that 
individuals with higher levels of antioxidant buffering capacity have lower levels of 
oxidised glutathione, or conversely that increased oxidative stress reduces the 
capacity of cells to buffer against it. In a physiologically stable system, considering 
the feedback mechanisms available to up-regulate cellular antioxidants, the former 
scenario is most likely. 
These results are prone to the type 1 error due to the multiple statistical testing. 
However, the plausibility and consistency of association gives confidence in the 
laboratory assays and in the conclusions. As no other predictors were found within 
those factors tested, an association with antioxidant activity does not ultimately 
explain the relative levels of oxidised glutathione. This may only reflect an 
antioxidant feedback mechanism i.e. is likely to mask the effect of underlying 
chronic stressors due to the physiological response. 
A number of explanations are possible, including methodological variation. 
However, as all samples were processed by the same team according to standard 
operating procedures in a single laboratory, this seems unlikely. Other possibilities 
have not been testable within the limitations of this study, including: 
 A genotypic difference which limits availability of antioxidants in a sub-
population e.g. relative inability to up-regulate or produce effective 
glutamate cysteine ligase461, hence lower glutathione availability 
 The influence of a strong environmental insult in a sub-population which 
was unmeasured or unmeasurable e.g. differences in particulate exposure in 
terms of concentration, time course or particle content which are not well 
reflected by the proxy measure of macrophage particulate burden. 
 
Overall, glutathione, GPx and SOD are strong co-variates. This is unsurprising as 
they are all up-regulated by common pathways including Nrf2 in response to 
oxidative stress462. This is the most consistent finding throughout the multivariate 
models. There is further strong evidence for a higher level of oxidative stress in the 
alveolar macrophages of the Malawian cohort. 
Univariate analysis identified that GPx was negatively associated with cell viability, 
which might represent reduction in GPx and other proteins during apoptosis and 
cell death. However, its absence from the multivariate model suggests co-variation 
with another variable as the explanation. 
The association of superoxide dismutase levels with BAL volumes in univariate 
analysis might be explained by with small returns representing fluid from more 
proximally in the bronchial tree, and therefore is not representative of alveolar 
conditions. Indeed, higher BAL returns are significantly, but weakly associated, 
with higher macrophage viabilities (r2 = 0.11, p<0.0001). In this way, dead and 
apoptotic alveolar macrophages are better represented in the more proximal 
washings as they are removed by the mucociliary escalator. However, this 
association is not important in the final multivariate model. 
Positive correlations between selenium levels in serum and blood glutathione 
peroxidase activities are well documented (see section 1.2.3.2). We hypothesised 
that such a relationship would also occur in alveolar macrophage GPx activity. The 
data presented here demonstrate no such relationship, and we could find no 
published data with which to compare our findings. Different types of glutathione 
peroxidase are present depending on location; within alveolar macrophages, GPx1 
(the cytoplasmic form) is likely to predominate, although these cells are known to 
secrete GPx3 (the plasma form)204. Each GPx behaves differently at suboptimal 
selenium status resulting in uneven usage both within and between tissue types463. 
For example, the reduction in GPx4 (the phospholipid, monomeric form) as a result 
of selenium deficiency is less pronounced in the lung than that of GPx1, but levels of 
both in brain are preferentially preserved compared with liver and kidneys208. Total 
levels of GPx in lung are high relative to other organs463, and high concentrations are 
particularly important in alveolar macrophages in order to prevent excessive redox 
signalling210. It is possible that this absence of relationship with plasma selenium is 
an indicator of preferential selenium use by HAMs. Alternatively, as an inducible 
enzyme, such compensatory mechanisms might dwarf a relatively weak 
relationship with selenium concentration. To test these hypotheses would require 
intervention studies in an animal model to demonstrate changes during selenium 
depletion and repletion. 
It was postulated that Malawians would have higher levels of glutathione 
peroxidase in the cellular component of bronchoalveolar lavage due to this 
enzyme’s importance in protecting the alveolar macrophage from oxidative stress204, 
and the hypothesised higher levels of oxidative stress from inhaled particulate 
matter. 
 
Neither fuel types for lighting and cooking nor particulate density were consistently 
found to associate with measures of oxidative stress. There is no evidence that, 
according to the proxy measurements of personal exposure presented here, 
particulate inhalation causes a measurable upregulation in antioxidant capacity, nor 
oxidative stress. Limited evidence from controlled human studies demonstrate signs 
of oxidative stress in the first day after wood smoke exposure91 as measured by 
nitric oxide and malondialdehyde in exhaled breath condensate. In vitro studies 
consistently show the potential for oxidative stress induced by wood smoke 
particles. 
That we did not demonstrate this in our cohort of individuals might have a number 
of explanations. Firstly, in a stable physiological system, compensation mechanisms 
such as Nrf2 related translation of GPx and SOD are likely to mask the primary 
measure of oxidative stress (GSSG:GSH). However, this would also be expected to 
produce a differential upregulation of these antioxidant enzymes relating to 
particulate levels. We found no strong evidence to support this hypothesis, 
although the high levels of extracellular glutathione and lipid peroxidation in the 
Malawi cohort are suggestive of chronic, compensated oxidative stress. These 
cohorts have potentially many other differences than their exposure to airborne 
particulates, and confounding is likely. Despite this, the observation of such broad 
variation between healthy human populations has not previously been described.  
Secondly, although the use of particulate area within macrophages is widely 
accepted, this single measure is unlikely to fully represent the inhaled oxidant load 
from indoor air pollution. This is due to the diverse range of fuels used, and their 
variable combustion products: elemental carbon, trace metals, carbon monoxide, 
nitrous oxide, and multiple complex organic molecules are differentially present 
and depend on the completeness of combustion and the type and state of fuel9. 
Thirdly, it is uncertain to what degree the macrophage particulate measure 
responds to intensity of exposure. We did not perform individual air quality 
monitoring, but a previous study in the same geographical area showed short, high 
intensity particulate exposures in the home361. Oxidative stress resulting from such 
exposures might be expected to reflect changes in particulate exposure i.e. large 
derangements of short duration. It is possible, if macrophage phagocytosis was 
saturated during high exposure periods, that particulate levels in the cells do not 
correlate with physiochemical effect on them. 
Finally, the volunteers recruited to this study had relatively lower levels of 
particulate within the macrophages than in other studies464. This may represent 
methodological differences, or generally lower exposures relating to the recruitment 
and selection criteria used. This is discussed below. 
 
 Opportunistic sampling may be flawed where there it introduced systematic bias i.e. 
the recruits do not represent the population from which they are drawn. However, 
due to the relatively invasive research methods employed (i.e. bronchoscopy), using 
healthy volunteers, such sampling is the only method which does not infringe the 
ethical principle of autonomy. It is likely that the Malawian group represent their 
urban counterparts based on the available socioeconomic data. However, data will 
not be generalizable to rural populations. This limits the generalizability, 
particularly as rural populations differ considerably in type and amount of biomass 
fuels used, and therefore the particulate exposure348. Relative comparisons within 
the recruited population are likely to remain valid in terms of the effect of 
particulate on biochemical behaviour and function. 
Bias may arise as a result of exclusion of individuals from bronchoscopy due to poor 
lung function. Given the inverse relationship of lung function and biomass smoke 
exposure454, these ten individuals are likely to have had higher particulate densities. 
The effect of exclusion is to reduce the relative differences amongst the group, and 
to decrease the chances of finding real associations between particulate exposure 
and other parameters. 
We have demonstrated high levels of oxidative stress in a healthy Malawian 
population which in many aspects of antioxidant balance reflects changes seen in 
cigarette smokers. Despite methodological consistency, epidemiological differences 
between the groups make causative factors difficult to infer. However, the groups 
are well balanced in terms of basic demographics, trace element levels and lung 
function. Macrophage particulate content is considerably different between the UK 
and Malawi cohorts and at least circumstantially implicates environmental 
particulates. 
The novel description of bimodal distribution of intracellular glutathione oxidation 
state requires further work to test the hypothesis that a genetic determinant may 
underlie this. Of a number of candidate polymorphisms, the population frequency 
of GSTM1 null and GSTP1 AA (Ile105Val; AA → AG/GG) genotypes are similar to 
the proportion of “highly oxidised” subgroup from this cohort (around one 
quarter)465, 466. Both genotypic variations are likely to alter propensity to the effects of 
oxidative stress, and the GSTP1 AA genotype appears to have an influence on lung 
function measures after exposure to particulate matter466.  
As has been discussed in section 1.3, oxidative stress and antioxidant buffering has 
the potential to alter cell phenotype and response to infection. Specifically, 
antioxidants in vitro reduce the inflammatory response and promote cell survival. 
Given the considerable variation in oxidative stress between populations, and 
within the Malawi cohort, such results of variation in the redox environment might 
be expected to be measurable ex vivo. 
 
  
 
Epidemiological evidence consistently demonstrates an association between all-
cause mortality and particulate matter (PM) in ambient air467, 468. The dose-response 
relationship extends even to the lowest PM concentrations469. The relative effect of 
PM on death is greater for respiratory than for cardiovascular causes470, 471, and is 
particularly strong in the elderly472 and in those under five years473, 474. In developed 
countries the number of attributed deaths are greater for cardiovascular causes475 
due their relatively high prevalence. Low income countries differ considerably from 
higher income countries: lower respiratory tract infection is the most common cause 
of death80 and smoke from domestic biomass fuel use is the greatest source of PM 
exposure476. Biomass fuel use increases the risk of childhood pneumonia by 1.8 
times477, and attributable risk fractions suggest this translates to 900000 deaths per 
year in children under 5 years478. The most commonly isolated bacterial respiratory 
pathogen is Streptococcus pneumoniae479. 
Mechanisms to explain the relationship between particulate exposure and failure of 
pulmonary immunity against infection have been described extensively in animal 
models. As the primary tissue phagocyte, the alveolar macrophage is widely 
assumed to have a central role in this association. As described in section 1.1.4, the 
AM must maintain a fine balance between appropriate inflammatory responses, for 
example against bacterial infection, and the suppression of excessive inflammation 
caused by inhalation of particulate matter. Both antibacterial and inflammatory 
responses can be altered by redox balance (see section 1.2.3.5), and failure of either 
function is detrimental to the host. 
Competent alveolar macrophages, faced with infection by Streptococcus pneumoniae 
are able to internalise the organism480, initiate killing responses by NADPH oxidase 
activation40 and manage recruitment of other components of the immune system 
through cytokine signalling481. Defects in these behaviours cause detriment to the 
host. Failure of bacterial killing is seen in chronic granulomatous disease, where an 
inherited defect of NADPH oxidase activity is associated with recurrent 
infections482. 
The situation is complex, however: NADPH oxidase activity and (redox) cytokine 
signalling are connected (see Figure 1-3). Reactive oxygen species signalling in 
alveolar macrophages (from NADPH oxidase or extrinsic sources such as 
particulates) induces inflammatory responses though diverse pathways including 
NF-κB and AP1 associated transcription150, 483, calcium signalling255, redox sensitive 
MAPK cascades79, 484 and histone de-acetylation258. Failure of AM to provide 
adequate anti-inflammatory cytokine responses 485 or to dampen inflammatory 
signalling through apoptosis66, increase the mortality in animal models of 
pneumococcal pneumonia. Conversely, some anti-inflammatory signals, such as 
that from prostaglandin E2, can impair AM bacterial killing responses by inhibiting 
NADPH oxidase486. Aberrations in any of these signalling pathways might 
conceivably alter outcomes from bacterial infection through either insufficient or 
excessive responses.  
In knockout mouse models, gp91phox-/- mutations for NADPH oxidase have been 
used to investigate the relationship between ROS and antibacterial function. Such 
mice when challenged with Streptococcus pneumoniae exhibit better microbial killing 
with increased neutrophil influx and activation and higher levels of inflammatory 
cytokines including IL-6 and TNFα62. However, the same mouse model have 
generally lower inflammatory cytokine responses (including IL-6) when challenged 
with concentrated ambient particulate matter487. It is consistently shown that 
exaggerated responses to these particles in wild type mice cause inflammatory and 
oxidative stress effects which are detrimental to AM S. pneumoniae phagocytosis and 
survival from streptococcal pneumonia98 488. 
Prior exposure to ultrafine particles (those with diameter less than 100nm), 
however, confers survival benefit in a model of overwhelming pneumococcal 
infection, and is associated with lower inflammatory cytokine responses139. These 
responses are contrary to the increase found in vitro100, 102. The apparent 
contradiction might be due to the prior recruitment of neutrophils into the airway 
thus altering the kinetics of early infection.  
Overall, studies of alveolar macrophages suggest that acute particulate exposure 
causes exaggerated cytokine responses, reduced phagosomal killing, and altered 
susceptibility to pneumonia. These studies are consistent with data from cigarette 
smoke toxicity models where phagocytosis and killing of S. pneumoniae by AM is 
impaired. In these studies there are high levels of pulmonary inflammatory 
cytokine489. Alterations in these responses might be mediated through, or 
exaggerated by, oxidative stress, although the extent to which this occurs is unclear. 
Acute exposures to particulates from many sources are well studied in terms of their 
effect on redox balance, and cytokine response (see Table 1-2, Table 1-6 and Table 
1-7). Certainly, models of one-off exposure to wood smoke report increased 
inflammation and increased NF-κB activity in macrophages110 in part mediated 
through TLR4 receptors257. Chronic exposure to wood smoke shows a different 
effect in animal models. Rats after 70 days of wood smoke exposure have minimal 
changes in BAL concentrations of cytokines, and lower levels IL-1β than controls113. 
Cigarette smoking causes a hypo-responsive state in the ex vivo human alveolar 
macrophage, with blunted pro-inflammatory cytokine responses490; analogous data 
for other particulates is not available. Transcriptional profiling of smokers’ 
macrophages reveals “deactivated” phenotypes with less capacity for pro-
inflammatory response360. Analogous data for ambient particles is not available. 
Table 5-1 Selecting cytokine panel for analysis in alveolar macrophage stimulation 
experiments 
β κ

κ

α κ
κ

 α


 β  β
β


NF-κB pathways and ROS production are commonly connected – see section 1.2.3.6 
Based on these experimental findings, and firm associations with redox regulation, a 
panel of cytokines were chosen for examination. The justification for each is detailed 
in Table 5-1. 
 The results presented in this chapter examine hypotheses which address the effect 
of chronic particulate exposure on alveolar macrophage behaviour. Current 
understanding of chronic exposures have been detailed in section 1.2.3.5. 
1) Cytokine production in response to particulate challenge 
a) Lipopolysaccharide and wood smoke extract induce inflammatory cytokine 
release in ex vivo alveolar macrophages; these responses are enhanced in cells 
depleted of glutathione 
b) Alveolar macrophages previously exposed in vivo to high particulate 
burdens will have a less inflammatory cytokine release profile when 
stimulated with wood smoke extract ex vivo than AM with low in vivo 
exposure. i.e. negative feedback due to chronic exposure exists. 
2) Intraphagosomal function. Particulate burden in the alveolar macrophage is 
inversely associated with capacity to produce effective phagocytosis, oxidative 
burst and proteolytic function 
3) Alveolar macrophage surface marker phenotype may be polarised towards 
inflammatory /M1 type by exposure to LPS or by oxidative stress i.e. 
demonstrating increased CD86, HLA-DR, CCR7, CD11b and reduced CD206 
Further exploratory work is presented examining the effect of particulate within the 
alveolar macrophage on Nrf2 signalling. This was done to help understand if in vivo 
exposure to particulates was associated with upregulation of antioxidant response 
element related genes. 
 
 
For cytokine experiments, human alveolar macrophages (isolated from non-
smoking Malawians, see section 2.5) were incubated for 18 hours in RPMI-1640 with 
10% FCS at 1x106/well of a 24 well plate (Greiner Bio-One, UK). Where indicated in 
the results, this media was supplemented with buthionine sulfoximine 0.2mM (BSO, 
Sigma, UK) or BSO 0.2mM and N-acetylcysteine 2mM (Sigma, UK) in order to test 
for the effect of depletion of glutathione. Cells were then washed twice in media. 
Media was replaced fresh, with additional wood smoke extract 50µg/mL (see 
section 2.11 for preparation) or LPS 100ng/mL (Sigma, UK) as dictated by the 
exposure condition. After six hours, supernatants were removed and centrifuged at 
450g for 5 minutes to remove cellular debris. Supernatants were then stored at -80oC 
prior to analysis. Fresh media with identical additives was added to each well, and 
supernatants were similarly processed after 24 hours incubation. Concentrations of 
cytokine were determined by the fluorokine multianalyte profiling (MAP) platform 
using a Bio-Plex 200 machine (BioRad Laboratories). Cytokines were chosen due to 
represent chemokine and cytokine activities (pro and anti-inflammatory cytokines 
were both measured). Where multiple candidates for testing were obvious those 
with known or putative redox regulation86 were chosen (see Table 5-1). Six hour 
time points were used to define TNFα, IL-6, IL-1ra and IL-8 concentrations. Twenty-
four hour time points were used for RANTES, MCP-1 and IL-1β. These were based 
on preliminary data examining the optimum signal to background ratio for each 
cytokine at these time points (data not shown). 
 
The particulate burden of ex vivo alveolar macrophages was measured as described 
in section 2.10. 
 
The method for determining intraphagosomal capacity for oxidative burst and 
proteolytic function is described in section 2.19 with optimisation experiments 
detailed in section 3.8. Peripheral blood derived mononuclear cells were isolated by 
density centrifugation (see section 2.21). Cells were plated into 24 well plates at 
1.5x106/well and washed after 4 hours with fresh RPMI culture medium with 10% 
FCS. Medium was replaced with and without LPS 100ng/mL (test and control). Cells 
were analysed for oxidative burst capacity according to the protocol used for 
alveolar macrophages. 
 
Surface phenotypes in terms of M1/M2 polarisation were determined in ex vivo 
alveolar macrophages according to the protocol described in section 2.9. Data were 
acquired using an ADP CyAn flow cytometer with single fluorophore stained 
conditions in order to provide colour compensation data (for final method, see 
section 2.9). A minimum of 50000 events were acquired. For blocking experiments, 
106 cells in 1mL in in flow cytometry tubes were incubated with 3mg/mL mouse IgG 
(Caltag, Cat#10400) or control (PBS) for 30 minutes on ice and washed twice in PBS 
before the addition of phenotyping antibodies. 
For polarisation experiments, alveolar macrophages were plated into 24 well tissue 
culture plates (Greiner Bio-One, UK) at 106/well in 1mL of RPMI 1640 with 10% FCS. 
Where indicated. In test wells, LPS (100ng/mL) was added to culture medium in 
order to effect polarisation towards an M1 phenotype502. Cells were removed from 
the plate after 24 hours using citric saline as outlined in section 3.4.3. Thereafter, 
they were washed twice in PBS before re-suspension in flow cytometer sheath fluid 
for analysis. 
 
Western blotting was carried out as described in section 2.20. For experiments 
measuring the effect of wood smoke and LPS, ex vivo alveolar macrophages were 
used within 24 hours of isolation in adherent cell culture in RPMI 1640 + 10% FCS at 
a density of at 106 cells per well. LPS (100ng/mL) or wood smoke extract (50µg/mL) 
was added in media for six hours. At the end of incubation, cells were washed twice 
in PBS and then separated into cytoplasmic and nuclear fractions using the NE-PER 
nuclear extraction kit (Pierce, UK. Cat#78833) according to manufacturer’s 
instructions. Lysates were stored in RIPA buffer (Sigma, UK. Cat#R0278) with 0.5% 
protease inhibitor cocktail (Sigma, UK. Cat# P8340) at -80oC prior to analysis. 
Positive and negative controls for Nrf2 expression were obtained from Dr Ian 
Copple, University of Liverpool. Positive controls were RIPA buffer lysed HeLa 
cells which had been exposed to proteasome inhibitor MG132 for two hours at 
10µM. Negative controls were similarly treated with vehicle only (DMSO 0.1%). 
Protein concentrations within the samples were measured by Bradford assay (see 
section 2.15) in order to produce consistent loading of wells prior to electrophoresis. 
Macrophage lysate was used at 20µg per well, and controls at 10 µg/well. Molecular 
weight markers were used to confirm the presence of bound Nrf2 at 66kDa503. 
Densitometry was performed using the BioRad GS-800 scanner (BioRad, UK) and 
Quantify One v4.6.1 software (BioRad, UK). 
 
Cytokine concentrations were normalised by log transformation prior to analysis. 
This allowed baseline concentrations to be compared using one way ANOVA. 
Comparisons of wood smoke and LPS stimulated cells were compared to control 
values using paired t-tests of log transformed data. 
Log increases in cytokine concentration were tested for equal variances between 
groups using Bartlett’s test. In all cases for in vivo particulate exposure strata, 
variances were not equal by Bartlett’s test (p<0.01). This phenomenon 
(heteroscedasticity) is a violation of one of the assumptions of the ANOVA test, and 
therefore a non-parametric test was used for comparison of cytokine increases 
between particulate groups (i.e. low, medium and high carbon loaded 
macrophages). 
Data examining the relationship between particulate burden and intraphagosomal 
function, are described by scatterplots and goodness of fit to a linear regression 
model. For intraphagosomal function, pre-treatment effects on alveolar 
macrophages were assessed by paired t-test of log transformed data. 
For surface marker phenotyping, macrophages were identified by their forward and 
side scatter characteristics. Phenotypes were reported by log change in mean 
fluorescence intensities (MFI, using the geometric mean) or by the percentage of 
cells expressing a specific marker. Cells were defined as expressing a marker if their 
fluorescence in that channel exceeded the 98th centile of fluorescence in a paired but 
unstained sample. The latter measure was used when comparing phenotypes within 
the cohort of volunteers as this provided an internal comparator for each individual 
where between individual autofluorescence was variable.  
Nrf2 densitometry results were normalised to β-actin from the same blot. Values for 
individuals were reported as a proportion of the normalised negative control signal. 
For other experiments, treatment effects are reported as the proportion of 
normalised paired control value. 
Particulate burdens were log transformed in order to improve the normality of 
distribution. Correlations were then tested by fitting linear regression models with 
the exception of Nrf2. For Nrf2, three individuals had particulate burdens of zero: as 
log transformation was therefore not possible, the data were analysed by Spearman-
Rank test. 
  
Cytokine release from ex vivo alveolar macrophages stimulated with 
lipopolysaccharide (LPS) and wood smoke (WS) extract is summarised in Table 5-2. 
Results are also represented in graphs for clarity (Figure 5-2 and Figure 5-3). 
Significant increases in all cytokines were observed after LPS exposure. Wood 
smoke extract caused increased release of TNFα (p=0.012), IL-6 (p=0.034) and IL-8 
(p=0.0085), but no significant change in IL-1ra, IL-1β, RANTES or MCP-1. 
 
Data for alveolar macrophage cytokine response according to redox balance are 
shown in Table 5-3 (LPS stimulation) and Table 5-4 (wood smoke extract 
stimulation). Results are also represented in Figure 5-2 and Figure 5-3. A consistent 
feature of both LPS and wood smoke treated macrophages was a reduction in MCP-
1 production after treatment with BSO (6780pg/mL compared with baseline 
9910pg/mL for LPS [p=0.0023] and 905pg/mL compared with baseline 1590pg/mL 
for wood smoke treatment [p=0.012]). This effect due to LPS was partly offset by co-
treatment with N-acetylcysteine. There were no other observed effects of 
glutathione depletion. 
Toxicity of treatments might explain a lack of observed effect. However, BSO has 
been shown in section 0 to cause no increased release of lactate dehydrogenase 
when used as described here. It was observed microscopically that there was some 
cell detachment after LPS and BSO treatment. To test if this was disproportionately 
affecting treatment compared with control wells, culture medium was removed 
from the treatment wells at six hours and, as previously, centrifuged. After removal 
of the supernatant, the remaining pellet was tested for total protein content using 
the Bradford test. Results of this are shown in Figure 5-1. There was no difference in 
protein by treatment group (p=0.63). 
Figure 5-1 Total protein removed with culture medium in cytokine release experiments 
 
Bars represent mean and 95% confidence interval. n=6 for each condition.Statistical comparison used one 
way ANOVA. 
 
Data for twenty five individuals were available to compare cytokine responses to 
wood smoke extract according to in vivo particulate exposure. Results for cytokine 
release from their ex vivo alveolar macrophages treated with control (media only), 
wood smoke extract (50µg/mL) and lipopolysaccharide (100ng/mL) are shown in 
Figure 5-4. 
No significant differences were found in the production of any cytokine / 
chemokine according to the pre-existing particulate burden of the macrophages. 
 
Table 5-2 Cytokine release from alveolar macrophages stimulated ex vivo with LPS and wood smoke extract 
α
β*
Alveolar macrophages treated with media only (control), lipopolysacchraide (100ng/mL) or wood smoke particulates (50µg/mL). Geometric means given with 95% confidence intervals. p 
values represent results of paired t-tests comparing the given group with control values. n=25 for control and wood smoke conditions. n=8 forLPS. Cytokines were analysed at 6 hours 
except where marked * - here 24 hour stimulation was used. Cytokine concentrations given to 3 significant digits. 
  
Table 5-3 Effect of redox manipulation on cytokine release from HAM stimulated with LPS 
α
β*
Alveolar macrophages stimulated with lipopolysacchraide (100ng/mL) following 18h pretreatment with control (media only), 0.2mM buthionine sulfoximine (BSO) or 0.2mM BSO and 
1mM N-acetylcysteine (NAC). Data represent n=8 independent observations for each condition. Geometric means given with 95% confidence intervals. p values represent results of 
paired t-tests comparing the given group with control values. Cytokines were analysed at 6 hours except where marked * - here 24 hour stimulation was used. Cytokine concentrations 
given to 3 significant digits. 
  
Table 5-4 Effect of redox manipulation on cytokine release from HAM stimulated with wood smoke extract 
α
β*
Alveolar macrophages stimulated with wood smoke extract (50micog/mL) following 18h pretreatment with control (media only), 0.2mM buthionine sulfoximine (BSO) or 0.2mM BSO 
and 1mM N-acetylcysteine (NAC). Data represent n=8 independent observations for each condition. Geometric means given with 95% confidence intervals. p values represent results of 
paired t-tests comparing the given group with control values. Cytokines were analysed at 6 hours except where marked * - here 24 hour stimulation was used. Cytokine concentrations 
given to 3 significant digits. 
Figure 5-2 Effect of in vitro wood smoke particles and LPS on cytokine release from 
alveolar macrophages according to redox balance (TNFα, IL-6, IL-8, IL-1ra) 
 
Left panels: Wood smoke treated AM. Right panels: LPS treated AM  
Figure 5-3 Effect of in vitro wood smoke particles and LPS on cytokine release from 
alveolar macrophages according to redox balance (IL-1β, RANTES, MCP-1) 
 
Left panels: Wood smoke treated AM. Right panels: LPS treated AM  
Figure 5-4 Effect of in vitro wood smoke particles on cytokine release from alveolar 
macrophages according to varying in vivo particulate exposure 
 
Particulate burden of the alveolar macrophages has been logarithmically transformed to improve linearity. 
Cytokine changes are reported as log10-change in concencentration between control and treatment 
conditions. 
p-value indicates the probability that the slope of the linear regression model is horizontal i.e. there is no 
signnificant slope  
 For twenty-nine volunteers, data were available on intraphagosomal function and 
phagocytosis. These are presented in Figure 5-5. There was no relationship between 
particulate burden and phagocytosis rates, or proteolytic function. There was a 
significant negative correlation between particulate burden and oxidative burst 
capacity (p=0.024, r2 = 0.18). 
Figure 5-5 Phagocytosis and intraphagosomal function in ex vivo alveolar macrophages 
according to prior particulate burden 
 
(A) Phagocytosis is proportion of AM associated with silica bead as measured by flow cytometry 
(B) Oxidative burst activity index is the proportional increase in fluorescence of reporter fluor (H2DFF) 
compared with calibrator fluor [Alexa 405]. (C) Proteolytic activity index is similarly reported with DQ-
BSA reporter fluor. Particulate burden is logarithmically transformed, representing proportion of 
cytoplasm occupied by particulate matter as measured by digital image analysis. n=29. Linear regression 
model fitting is reported as the coefficient of determination (r2), and p value from Pearson’s correlation 
testing. 
 Particulates from biomass fuel combustion contain levels of endotoxin two orders of 
magnitude higher that those known to cause childhood respiratory disease83, 218. In 
view of the observation of lower oxidative burst in particulate laden macrophages, 
we hypothesised that on-going stimulation of the cells in vivo by such endotoxin 
might negatively impact phagosomal function. Such attenuated TLR responses have 
been shown in vitro with LPS induced cytokine response in PBMCs504. Similarly, in 
animal models of post-influenza infection, NF-κB mediated inflammatory response 
of alveolar macrophages is blunted, and neutrophil recruitment reduced without 
loss of cell viability505. 
To test the effect on oxidative burst, ex vivo alveolar macrophages were incubated 
for 20 hours with media alone (RPMI 1640 + 10% FCS), or with additional 
lipopolysaccharide 100ng/mL. Phagosomal function (phagocytosis and oxidative 
burst) was measured by flow cytometry as before. Results are shown in Figure 5-6. 
Both phagocytosis and oxidative burst were reduced by LPS pre-treatment 
(p=0.0035 and p=0.029 respectively). Adherent peripheral derived mononuclear cells 
treated identically showed a significant increase in oxidative burst (p=0.013), thus 
validating the method and reagent activity. For a single volunteer, enough cells 
were available for a time course experiment: ex vivo alveolar macrophages were 
treated with LPS in adherent cell culture for 0, 4, 8 or 20 hours. Oxidative burst 
activity indices were measured at each time point, and results shown in Figure 5-7. 
Figure 5-6 Phagosomal function in the alveolar macrophage after pre-stimulation with 
lipopolysaccharide 
 
Left panel: Phagocytosis rates in alveolar macrophages pretreated for 20 hours with media alone (open 
bars) or LPS (grey bars). Phagocytosis is expressed as a proportion of cells taking up silica beads) 
Right panel: Oxidative burst activity index with and without LPS pre-treatment. Monocyte treatment 
effect(positive control) performed under the same conditions using adherent peripheral blood mononuclear 
cells. 
Bars represent means with 95% confidence intervals. Statistical comparisons paired t-tests. n=12 for 
alveolar macrophage groups. n=3 for monocytes. 
Figure 5-7 Oxidative burst activity in ex vivo alveolar macrophages – the time course effect 
of LPS stimulation (exploratory analysis) 
 
n=1. Ex vivo alveolar macrophages were pre-treated with LPS for 0, 4, 8 or 20 hours with media alone 
(untreated, open bars) orLPS (solid bars). Oxidative burst was measured as previously at each time point. 
Further replicates of this experiment were not possible with primary cells due to insufficient cell numbers.  
 Redox equilibrium in cells may cause alterations in phenotype, as described in 
section 1.2.4. In order to test the hypothesis that activation status in human alveolar 
macrophages might be measured by surface markers, ex vivo alveolar macrophages 
in adherent cell culture were treated with control (media only) or with additional 
lipopolysaccharide (100ng/mL) for 24 hours. In all cases, expression of surface 
antigen as measured by flow cytometry followed a unimodal peak as shown by 
representative fluorescence histograms in Figure 5-9. Non-specific binding was not 
significant; after blocking with IgG no significant decrease in MFI was seen 
compared with paired, unblocked samples (see Figure 5-8). As illustrated here, 
significant autofluorescence in the detection channels was noted, especially using 
the 488nm excitation laser, and notably in the 520/40nm (“FITC”) and 575/26nm 
(“PE”) detection channels. 
Phenotype data for six independent experiments are shown in Figure 5-10, 
comparing that from LPS treated cells with control treated. 
In order to illustrate the changing phenotype of alveolar macrophages as a response 
to tissue culture, for a single volunteer, phenotyping was performed immediately 
after isolation of the cells (baseline), and after 6 and 24 hours of tissue culture (see 
Figure 5-11). These results are reported as exploratory analyses; data are available 
for only one volunteer, and statistical tests are not appropriate here. 
Down regulation of CD86, CD11b and HLA-DR is noted with upregulation of CCR7 
when comparing tissue cultured cells with those not grown in adherent ex vivo 
conditions. By contrast, and in keeping with data in Figure 5-10, the change in 
surface expression induced by LPS is minimal for all antigens tested. 
Figure 5-8 Effect of blocking non-specific binding sites on phenotype measurement in ex 
vivo alveolar macrophages 
 
Each bar represents paired samples treated with 3mg/mL of mouse IgG (shaded bars) or PBS control open 
bars) before phenotyping. n=1 
 
Figure 5-9 Representative histograms of flow cytometry measured cell fluorescence 
illustrating differential signal:background ratio according to fluorophore 
 
Top: Ex vivo alveolar macrophages unstained (left) and stained with anti-HLA-DR antibody conjugated 
to AF700 (right) 
Bottom: Ex vivo alveolar macrophages unstained (left) and stained with anti-CD86 antibody conjugated 
to FITC 
These data show the difficulty of low signal:noise ratio in the FITC channel, due to cellular 
autofluorescence. 
 
Figure 5-10 Lipopolysaccharide induced changes in surface antigen expression of ex vivo 
alveolar macrophages 
 
Left: Log change in geometric mean fluorescence intensity of alveolar macrophages treated with 
lipopolysaccharide (100ng/mL for 24 hours) comapred with antibody stained, untreated control.** = 
significantly differs from 0 by Wilcoxon matched pairs test (p<0.05) 
Right: Percentage cells expressing given antigen in stained, untreated control cells (open bars) and 
stained, LPS treated cells (grey bars). * = control and LPS values differ significantly by Wilcoxon 
matched pairs test (p<0.05) 
Bars represent median and whiskers 95% confidence intervals. n=6 for each comparison.  
Figure 5-11 Tissue culture induced changes in surface antigen expression of ex vivo alveolar 
macrophages 
 
Ex vivo alveolar macrophages underwent surface phenotype staining either directly after isolation from 
the voluntee (clear bars), or after 6hours (grey bars) or 24 hours (solid black bars) in tissue culture. At 24 
hours, phenotype was measured in both cells cultured in standard medium (solid black bars) and medium 
with addition LPS 100ng/mL (striped bars). n=1  
 
 Macrophages from eighteen non-smoking Malawian volunteers were available for 
phenotyping. These were quantified after 2 hours of adherent cell culture according 
to the protocols set out in sections 3.4.3 and 2.9 for detachment and staining 
respectively. The association between surface phenotype and carbon loading is 
illustrated in Figure 5-12. 
No statistical differences or trends were observed between categories of particulate 
loading in terms of CD86, CCR7, HLA-DR and CD206 expression. Considerable 
variation in expression was seen for CD86 and CCR7 and CD11b, although HLA-DR 
and CD206 were highly expressed in all volunteers; with only two exceptions these 
were expressed on more than 90% of all macrophages. 
Figure 5-12 Variation of surface antigen expression on alveolar macrophages according to 
particulate loading 
 
Bars represent median values. n=18 available for comparison. These are displayed by tertile of particulate 
density; groups are not equally represented because these tertiles are calcualted only once for the entire 
project in order to give some validity between assay types: n=7 (low); n=4 (medium); n=7 (high). 
p values are results of Kruskal Wallis tests. 
 
  
Ex vivo stimulation of alveolar macrophages for relative Nrf2 quantification was 
done on three individuals. A representative Western blot is shown in Figure 5-13.  
No further samples were available for analysis (Western blotting was performed in 
the UK after recruitment completed in Malawi). No statistical tests were done due to 
the low number of samples. Nrf2 levels in the nuclear fraction increased after 
treatment of cells with wood smoke extract, but not after LPS treatment. No such 
pattern was observed with cytoplasmic Nrf2 detection (see Figure 5-14). 
Figure 5-13 Western blot of Nrf2 in alveolar macrophages treated with LPS and wood smoke 
 
Ex vivo alveolar macrophages were treated for 6 hours with control (medium only), LPS (100ng/mL) or 
wood smoke extract (50µg/mL). Cells were fractionated into cytoplasmic and nuclear extracts Positive 
and negative controls were whole cell HeLa cell lysate with and without protesome inhibitor treatment 
respectively. In order to demonstrate Nrf2 presence, large loading volumes have been required especially 
for nuclear lysate; this has resulted in spill-over to blank lanes. 
 
Using Western blot to quantify total cellular Nrf2 was done for 24 non-selected 
consecutive volunteers; one blot is shown in Figure 5-15 for illustration. Adequate 
loading of cellular protein is demonstrated by blots of β-actin which derived 
stronger signal than from the controls. However, Nrf2 was considerably lower than 
in the control cell lysate, although was detectable in most lanes at the illustrated 
exposure. At longer exposures, non-specific bands appeared in the developed film. 
Densitometry was performed, with results normalised to the negative control. The 
relationship between total cellular Nrf2 within alveolar macrophages, and 
particulate loading is shown in Figure 5-16. There is a significant correlation 
between these two measurements (p=0.013). Further optimisation of the blotting 
was not possible due to limited sample volume: protein loading into the wells, and 
detection of Nrf-2 after electrophoresis is therefore suboptimal. These findings 
therefore require further corroboration. Detection of other Nrf-2 related products 
would be an ideal approach, but would require new samples.  
Figure 5-14 Densitometry of Nrf2 signal from ex vivo alveolar macrophages treated with LPS 
and wood smoke extract 
 
Ex vivo alveolar macrophages were treated for 6 hours with control (medium only), LPS (100ng/mL) or 
wood smoke extract (50µg/mL). Cells were fractionated into cytoplasmic and nuclear extracts. Data are 
reported as the density ratio of Nrf2 blot relative to β-actin. For each individual, LPS and WS signals are 
given as a proportion of the control value. 
 
Figure 5-15 Total cellular Nrf2 in ex vivo alveolar macrophages – variation and low 
expression 
 
Ex vivo alveolar macrophages were lysed in RIPA buffer with protease inhibitor. Western blots were 
carried out for 12 volunteers (labelled 1-12). Positive and negative controls were whole cell HeLa cell 
lysate with and without protesome inhibitor treatment respectively.Marker shows the molecular weight 
marker at 75kDa – Nrf2 is expected at around 66kDa 
Figure 5-16 Total cellular Nrf2 in ex vivo alveolar macrophages – relationship with 
particulate loading 
 
Ex vivo alveolar macrophages were lysed in RIPA buffer with protease inhibitor. p value is for Spearman-
Rank tes.  n=24. 
 
 
We noted increased TNFα, IL-6 and IL-8 after wood smoke extract exposure. This is 
a similar inflammatory profile in alveolar macrophages as in the THP-1 monocyte 
cell line82, although that study noted increased IL-1β in addition to TNFα and IL-8. 
Similar increases in IL-6 and IL-8 have been noted in A549 (epithelial) cell lines426 
and in serum after in vivo exposures to wood smoke amongst firefighters506. Results 
of environmental particulates using the same ex vivo stimulation methods and 
human cells also show increased IL-6, TNFα, IL-8. Notably, and in keeping with 
results here, IL-1β was unchanged although MCP-1 did rise97. 
The pattern of cytokine release strongly implicates NF-κB or AP-1 transcriptional 
activation. TNFα release is associated with NF-κB activation110 in laboratory study 
of wood smoke. Investigation of diesel particulates showed NF-κB or AP-1 activity 
mediated IL-8 increases depending on the particulate concentration (lower 
concentrations were NF-κB independent)507. IL-6 is also NF-κB dependent in 
ambient particulate studies508 and in endotoxin/LPS treatment219. However, 
differential effects are well known depending on particle source, type and 
composition 509: a consistent NF-κB related pathway would also produce rises in 
RANTES510 which were not observed here.  
 
In alveolar macrophages stimulated with either LPS or wood smoke extract, 
reducing glutathione availability with BSO was consistently associated with 
reduced MCP-1 concentration. For LPS treated cells, N-acetylcysteine partially 
corrected this towards control values. There is no evidence of increased cell toxicity 
or cell detachment with LPS or BSO treatment. This suggests that redox regulation 
has a role In MCP-1 release. 
MCP-1 is implicated by knockout models in protection against oxidative stress 
related damage associated with activated alveolar macrophages511. In pulmonary 
alveolar macrophages its release into supernatant follows acute inflammatory lung 
injury512. It has the potential to inhibit pro-inflammatory cytokine production, 
although due to its recruitment of monocytes (and, to a lesser extent neutrophils) it 
is pro-inflammatory in LPS induced lung inflammation513. Reduced MCP-1 
concentrations during oxidative stress may prevent lung injury caused by excessive 
inflammatory cell recruitment. 
Work reported here shows that wood smoke extract is capable of perturbing redox 
balance in ex vivo alveolar macrophages (see section 3.10). Despite the relatively 
high oxidative potential compared with LPS, wood smoke treatment does not have 
an additional effect on cytokine production. This is surprising, particularly IL6, IL-8 
and TNFα, for which in murine studies N-acetylcysteine has a mediating effect on 
LPS induced cytokine concentration in bronchoalveolar lavage fluid303, 514. The 
production of IL-8 in particular is strongly influenced by oxygen metabolites219, 303. 
In this study, glutathione levels after BSO treatment fell to 30.4% of control values 
(see Figure 3-20) which might be expected to exert a physiological effect. Gosset et 
al304 report more profound decreases (to 10% of control) associated with an increase 
in IL-8 and TNFα release. While the effectiveness of BSO in depleting glutathione 
might explain our observed lack of redox effect, Gosset et al note increases in IL-8 
after only 3 hour BSO treatment (with mean reduction in glutathione to 54.8% of 
control). These relative differences in intracellular glutathione concentration are 
similar to those noted between cigarette smokers and non-smokers (see 4.3.3.1), and 
represent physiologically relevant levels of oxidative stress. The lack of BSO effect 
on cytokine production observed here might therefore suggest a lack of relevance to 
the behaviour of the alveolar macrophage. Alternatively, in cells which are highly 
buffered against oxidative stress by enzymatic antioxidants such as glutathione 
peroxidase, it is possible that more profound derangements of redox balance 
(particularly an increase in oxidised glutathione) are necessary to elicit any effect on 
behaviour. 
Lastly, the experimental model is necessarily simplistic and cannot distinguish cell 
to cell variation in responses. It has been observed that uptake of particulates is 
highly heterogeneous: other macrophage responses, such as cytokine release, might 
be expected to vary considerably. 
 
We provide evidence against the hypothesis that the inflammatory response of 
alveolar macrophages is dampened by chronic particulate exposure: despite 
inducing an acute inflammatory response in alveolar macrophages, the released 
cytokine concentrations are unaffected by pre-exposure cell particulate burden. 
Chronic responses in humans to particulates from indoor air pollution include DNA 
damage due to oxidative stress.515, but inflammatory changes are not well 
documented outside of disease processes such as COPD516. In rabbits, after four 
weeks of daily PM10 exposure, there is increased airway cellularity and AM 
activation although no inflammatory cell influx517. In the same study, IL-6 
concentrations showed an initial increase but were insignificantly different from 
baseline by 3 weeks. This suggests a restorative mechanism to protect against 
chronic airway inflammation, although such evidence is not available for human 
exposures. A recent literature review on these effects in cigarette smoke suggested 
that even for this well investigated exposure “there exists no consensus, and no 
emerging trend line, of the reproducible effect(s) of cigarette smoke”86.  
Such in vitro challenge models are necessarily removed from real-world effects. 
However, here we used respirable fraction particles at concentrations which 
mimicked cellular appearances of in vivo exposure macrophages. These smoke 
particles were also produced from the same firewood sources as used by the 
exposed population, thus providing a relevant exposure model. Volunteers who 
provided bronchoalveolar lavage specimens had their indoor particulate exposures 
defined by questionnaire study; most had mixed exposure in the home to charcoal 
and wood burning stoves, and to paraffin lamps. As such, the origins of the 
particulate matter within the alveolar macrophages are variable and not defined by 
personal exposure monitoring. However, using particulate burden as a proxy 
measure of exposure is well accepted518. 
 
There is a specific defect in phagosomal function associated with increasing 
particulate loading of alveolar macrophages: oxidative burst capacity decreases, but 
proteolytic and phagocytic functions are preserved. Despite known physiological 
crosstalk between oxidative burst and proteolysis (NADPH oxidase inhibits 
macrophage proteolysis by creating an environment in which to reduce disulfide 
bonds519), the effect of particulate appears to be independently associated with the 
oxidative burst. This data here contradicts mouse models of chronic PM2.5 exposure 
which found increasing NADPH oxidase activity due to infiltration of bone marrow 
derived monocytes520. 
  
From these data, we are unable to define the biochemical mechanism behind this 
reduction in oxidative burst. There are several possibilities: 
1. It is possible that oxidative stress or upregulation of specific antioxidants 
might cause this. Neutrophil oxidative burst capacity is known to be reduced 
by chronic oxidative stress521. 
2. Changes in modifiers of NAPDH oxidase activity are also associated with 
particulate exposure. For example, NADPH oxidase assembly can be 
reduced by surfactant protein C in epithelial lining fluid which coats 
particulates prior to phagocytosis394. In cigarette smoke models, surfactants 
tend to be decreased522. If this is true for other particulates, the dampening 
effect on NADPH activity would be lost at higher exposures. 
3. Upregulation of cellular antioxidants may also inhibit NADPH oxidase 
activity but not abundance in phagocytes. For example, upregulation of 
detoxifying enzyme heme oxygenase 1 (HO-1) causes concentrations of its 
end product, bilirubin, to rise. This bilirubin mediates the impairment of 
NADPH activity at concentrations considerably below those where it acts as 
a direct antioxidant523. 
Methodological issues might explain our observations: 
1. Disproportionate light absorption by particulate are dealt with in section 
3.8.1, and are unlikely to have a strong enough effect to be measurable 
2. Culture makes AM more prone to produce oxidative burst524, and so each 
sample was assayed on the day of bronchoscopy, and is unlikely to explain 
the effect 
3. The falling oxidative burst in high particulate loads is an epiphenomenon 
resulting from lower intraphagosomal pH (DCFH fluorescence drops off 
below pH 6.0525). While this is physiologically possible in the early 
phagosome526, most oxidation is completed before the phagosomal pH falls 
this low45. The alternative hypothesis, that particulate laden cells have lower 
phagosomal pH also seems unlikely, and this suggests an enhanced function 
not in keeping with in vitro exposure experiments527. 
A reduction in oxidative burst capacity would suggest less robust bacterial killing 
mechanisms; such processes are key to pulmonary innate defence in the early stages 
of infection. NADPH oxidase is important in both killing responses, but also in 
limiting inflammatory responses. In mouse models, NADPH oxidase activity is 
required in order to limit NF-κB activity, and to cap the effect of LPS on pro-
inflammatory cascades; this protective response is in part mediated through 
upregulation of Nrf263. Our data provides novel evidence that innate pulmonary 
immunity is specifically impaired by in vivo particulate exposure. Significantly, this 
mechanism is consistent with epidemiological associations of increased pulmonary 
infection and indoor air pollution. Further work would be useful in examining the 
role of inflammatory and anti-inflammatory signalling pathways in those 
individuals highly exposed to particulates. We found no evidence of differences in 
cytokine release, but alteration in Nrf2 mediated antioxidant protection is possible 
(see section 5.4.7). 
 
Pre-treatment of alveolar macrophages with lipopolysaccharide reduced both 
oxidative burst and phagocytosis. Our preliminary data suggest that the effect of 
LPS on ex vivo alveolar macrophage oxidative burst changes over time; shorter 
treatments have an enhancing effect whereas longer time courses become 
detrimental to function. Previous studies have used lipopolysaccharide as a 
stimulus for oxidative burst, and short (2-6 hour) pre-treatment enhances 
superoxide production and phagocytosis528, 529, although a human challenge model 
has shown a negative effect of low dose inhaled LPS on granulocyte oxidative 
burst530. Using our model, measuring earlier time points may have been useful in 
clarifying the relationship between LPS and oxidative burst function; we were 
unable to do this due to low cell numbers. 
The non-specific effect on both phagocytosis and oxidative burst might represent a 
generalised toxic effect on cells in culture. While we did not measure this, other 
studies report no difference on macrophage viability at the same dose and time 
interval531. Our method for determining oxidative burst measures responses from 
cells taking up beads only, which is less likely to be altered by a general toxic effect. 
It is possible that more chronic LPS exposure has dampening effects on 
inflammatory response and therefore might explain our results. Observations on cell 
culture may not well reflect in vivo effects. Human challenge models might use 
natural exposure, which would be difficult to quantify and complex to control. 
Experimental human exposure to LPS has been performed in other contexts, but 
serial challenge presents a significant danger of severe pulmonary inflammatory 
response and controlled human data is unlikely to be safely obtainable530. Animal 
studies might provide a method for more rigorously testing this hypothesis. 
 
After ex vivo treatment with LPS, only CD206 on alveolar macrophages was seen to 
change in terms of median fluorescence intensity. There was no change in 
percentage of cells expressing CD206, although a fall in CD86 expression was noted. 
Interpreting the results of surface phenotyping work presented here is complicated. 
LPS should act as a strong stimulus towards M1 (classically activated) 
phenotypes360, although our data show a lack of consistent effect. It would be 
expected that expression of CD206 decreases, and that of CD86, CCR7, HLA-DR and 
CD11b increases. Notably, previous study of human monocyte cells demonstrated 
upregulation of HLA-DR after particulate carbon exposure532. This was postulated 
as an explanation for increased allergic sensitisation caused by some particulates; 
we found no evidence to support that in our study. That such consistent changes are 
not seen in our data suggests a number of explanations: the stimulus has been too 
weak; measurement was flawed; an external antagonistic influence was stronger 
than the LPS or that human macrophages ex vivo do not fit the current model of 
M1/M2 polarisation. 
The dose and time course used here is same throughout the project, and is similar to 
that used in other published work533. The additional use of IFNγ has been used by 
other groups534 when differentiating M1 macrophages from monocyte precursors, 
but this was not considered here. Exploratory work in Figure 5-11 suggests that 
tissue culture has a larger effect than LPS on the surface phenotype as measured by 
our panel. This produces a tendency away from M1 type activation as evidenced by 
lower CD86 and CD11b (traditionally M1 markers) and unchanged CD206. This 
effect might be anticipated although it is not well described in the literature. This is 
perhaps because use of human primary macrophage use is uncommon; researchers 
tend to focus on in vivo animal models where no tissue culture is required, or in in 
vitro models requiring the prior differentiation of macrophage precursors in the 
laboratory. Widely accepted M1 and M2 phenotypic markers used in murine studies 
have been found to be not useful in human research534. 
Significant problems in phenotyping human alveolar macrophages may have 
resulted from autofluorescence. This intrinsic cellular fluorescence is most obvious 
in the emission range 450-550nm and is due to upregulation of NADPH, lipofucins , 
flavins, protoporphyrins and ceroid pigments535. This phenomenon increases after 
cigarette smoke exposure, and is evident within 4 hours. For these data, the most 
likely to be affected was CD86 antigen (emission filter 530nm with 40nm tolerance). 
Unlike other phenotypic markers used for lymphocytes (such as CD4), the selected 
macrophage antigens represent more homogenous populations; this is seen as 
unimodal peaks for fluorescence histograms. For phenotyping purposes, and 
especially for those antigens conjugated to fluorophores affected by 
autofluorescence backgrounds, the antigens would ideally be highly expressed and 
the antibodies conjugated to a highly fluorescent product. The power to detect 
differences in M1 and M2 type cells was therefore limited by fluorophore choice. 
Data presented here for HLA-DR, CD11b and CD206 are more robust than for CD86 
and CCR7 due to their higher intensity of staining, but still do not consistently 
demonstrate M1 skewing after LPS treatment. The use of unlabelled primary 
antibody, and conjugation to a secondary antibody emitting light far outside the 
autofluorescence spectrum might mitigate against this problem. However, the 
number of antigens which can then by simultaneously labelled is reduced. More 
recently, arginase 1 has been suggested as an M2 phenotype marker, where changes 
in CD11b have also been noted in ex vivo human studies of cigarette smoke exposed 
alveolar macrophages536. 
 
We found that wood smoke extract increased the nuclear concentration of Nrf2 
compared with control, although samples were too few for statistical comparison. 
This observation is consistent with hypothesis of Nrf2 upregulation after 
administration with a known oxidant (wood smoke). Few papers have examined 
the effect of particulates in this context, and these focus on the relationship between 
Nrf2 genotype and propensity to develop particulate driven asthma247, 537. Nrf2 
upregulation is detectable in alveolar macrophages in mice models of cigarette 
smoke exposure. It protects against oxidative stress and the inflammatory and 
architectural changes538. This is likely to be mediated through IL-8 and other 
inflammatory cytokine responses; Nrf2 negatively influences these539. Nrf2 is also 
important in protecting against genotoxicity from organic carcinogens known to be 
present in wood smoke (e.g. benzo[a]pyrene)540.Knockout models are highly prone 
to emphysema, and heterologous bone marrow replacement with Nrf2 positive cells 
causes influx of new alveolar macrophages and a prevention of emphysema295 
suggesting a key role for the macrophage. 
In studies of sepsis, Nrf2 protects against excessive pulmonary inflammation and 
limits alveolar macrophage NF-κB and TNFα responses541, and enhances 
glutathione availability resulting in an overall survival benefit296. It seems likely that 
Nrf2 in alveolar macrophages is protective against acute inflammatory insults, and 
promotes successful anti-infective responses. Where there is prior oxidative stress, 
Nrf2 is protective against pulmonary bacterial infection, and this is partly mediated 
through glutathione upregulation542. 
If Nrf2 were to vary in human populations according to prior particulate exposure, 
this might have implications for innate immune defence in the lung. Genotypic 
polymorphisms in humans have been identified which express lower activity, and 
are associated with poorer outcomes from acute lung injury543. Studies relating 
exposure-related variation have not been done. 
Our data show an association of Nrf2 concentration with particulate burden in the 
macrophage; mechanistically, this is both plausible and fitting with the hypothesis 
that alveolar macrophages have levels of oxidative stress partially dependent on 
their particulate exposure. The in vitro evidence for this considerable (see section 
1.2.3.5 for a summary of the literature, and section 3.10 for results from this project). 
These, however, are the first in vivo data to show this association. 
In human models alveolar macrophages, Nrf2 has only been examined in relation to 
disease processes. Western blot and mRNA studies have shown decreasing levels in 
chronic cigarette smoke exposure544. This is the converse of our findings in which 
highly exposed macrophages had higher levels. The populations were, however, 
different: we have investigated healthy individuals. Bronchoscopic studies of the 
respiratory epithelium have documented increased Nrf2 translocation in “healthy” 
cigarette smokers545. Acute exposure to oxidants, including cigarette smoke544, cause 
increasing activation of Nrf2 in macrophages in the absence of disease. This feeds 
through to increases in antioxidant levels of thioredoxin reductase and other Nrf2 
modulated genes545. 
Relatively low levels of Nrf2 in alveolar macrophages were present in the samples 
taken, this is commonly seen compared with cell line studies, although alveolar 
macrophages and respiratory epithelium have relatively high Nrf2 levels compared 
with other parts of the lung in vivo546. An alternative and complementary approach, 
such as the use of real time PCR would allow more accurate quantification, and 
would not suffer from the problems of non-specific binding seen in Western blots 
during prolonged exposures. Ideally, this would be done in the same samples to 
increase confidence in the results.  
Nrf2 is controlled at multiple levels, including phosphorylation events which 
enhance its activity and nuclear translocation503. Whole cell measurement of Nrf2 is 
a simplified assay which does not take into account nuclear translocation and 
binding to the ARE, but is a reasonable summary measure of overall activity380. 
Protein stripping from existing Western blots could be done, with the membranes 
re-probed for downstream markers of Nrf2 activation including glutathione-S-
transferases, (GST), NAD(P)H quinone oxidoreductase (NQO1), and heme-
oxygenase 1 (HO-1) products547. This would confirm the functional consequence of 
Nrf2 activation. 
In summary, we have demonstrated an association in ex vivo alveolar macrophages 
between particulate exposure and a) reduced oxidative burst capacity and b) 
increased cellular Nrf2. In a stable state of exposure, chronic upregulation of 
antioxidants might impair NADPH oxidase activity as described above. We propose 
that while established as a mechanism to protect the self against excessive oxidative 
stress, this has potential detrimental effects on host defence in terms of bacterial 
killing. This hypothesis is summarized in Figure 5-17. 
Figure 5-17 Hypothesised pathway relating particulate induced antioxidant upregulation to 
reduction in NADPH oxidase activity 
 
1 Particulate material in the airway is known to directly cause release of ROS and RNS from epithelium 
2 Phagocytosis initates assembly and activation of NADPH oxidase 
3 Ferrous material also promotes hydroxyl radical (OH-) formation from hydrogen peroxide 
4 Both H2O2 and OH- leak from the phagolysosome and promote Nrf2 translocation to the nucleus 
5 Nrf2 enhances transcription of genes associated with the Antioxidant Response Element (ARE) 
6 HO-1 is known to inhibit NADPH oxidase activity 
 
  
We have addressed three overarching hypotheses within this project. 
1. Particulate exposure is associated with altered redox balance in the lung 
in both intracellular and extracellular compartments 
2. Redox balance in the alveolar macrophage alters innate immune function 
3. Particulate exposure is detrimental to alveolar macrophage function 
Alveolar macrophages may undergo considerable changes to their phenotype 
depending on the redox balance. This in turn is dependent on intracellular 
endogenous production of reactive oxygen and nitrogen species and their release in 
response to exogenous sources, such as inhaled particulates. 
 
We have confirmed earlier studies which show that the redox balance in monocytes 
and alveolar macrophages are considerably different. Both glutathione peroxidase 
and superoxide dismutase levels are lower in monocytes. The results of our study 
agree with previous work: comparison of AM and monocytes demonstrated higher 
SOD in the former, predominantly due to cytoplasmic forms192. Glutathione 
peroxidase is also more highly expressed in AM210. Total glutathione in monocytes198 
and human alveolar macrophages459 closely agreed with previous estimates. Taken 
together these results suggest that alveolar macrophages, being considerably larger 
than monocytes (4990µm3 vs 332-380 µm3),548, 549 have a higher concentration of 
intracellular glutathione. Our results are compatible with this: we noted a non-
significant difference between monocytes and HAM (10.71nmol/mg vs. 
20.09nmol/mg). 
The differences between monocytes and AM suggest that the upregulation of 
enzymatic antioxidants is necessary for HAM to function in the microenvironment 
of the lung. When numbers of alveolar macrophages are depleted due to infection, 
or particulate induced cell death, they are replenished both from parenchymal lung 
macrophages, and from influx of circulating monocytes. In the latter, this is likely to 
mean that the lung supports a population of “early” tissue phagocytes which have 
different (and less) buffering against oxidative stress.  
 
We have defined the redox balance of alveolar macrophages in three human 
cohorts. Previous comparisons have included non-smokers and those exposed to 
cigarette smoke, but this is the first study to establish differences in two non-
smoking, healthy human populations.  
In our study, intracellular glutathione concentrations were significantly lower in 
smokers compared with non-smokers in the UK, in agreement with previous 
work459. In a Malawian population highly exposed to inhalable particulates from 
biomass fuels, levels were non-significantly lower than UK non-smokers. 
Extracellular glutathione was raised in both the UK smokers and Malawian non-
smokers. This was a consistent antioxidant response in the Malawi group, as 
evidenced by higher rates of lipid peroxidation in HAM. 
Glutathione levels in smokers have been previously shown to be lower in AM and 
higher in acellular epithelial lining fluid than non-smokers459. In that study, 
expression of the glutamate cysteine ligase modulatory unit was decreased 
suggesting that de novo synthesis of glutathione was impaired by smoking, and that 
extracellular glutathione had an alternative (non AM) source. 
Our findings concur with these observations. Furthermore, we note that Malawians 
have a pattern of GSH both inside and outside the cell which is similar to cigarette 
smokers. Although circumstantial, the difference between Malawian and UK 
volunteers redox status in terms of glutathione and lipid peroxidation provides 
evidence that lifestyle and environmental influences can alter redox balance in the 
lung. It is likely, given the profound differences in particulate exposures, that indoor 
air pollution plays a contributory role in this. These are the first data to show 
significant variation in redox balance and oxidative damage in vivo between two 
populations of healthy humans. 
Our finding of ex vivo derangement of glutathione balance in human alveolar 
macrophages exposed to wood smoke extract provides a demonstration of plausible 
biological effect. We used wood smoke derived from the same source as that which 
is used by the local population, and endeavoured to control the dose in order that ex 
vivo and in vivo cytoplasmic particulate burdens were similar. We did not, however, 
demonstrate a dose response relationship between in vivo measures of glutathione 
and particulate burden in the alveolar macrophage. This may be explained by data 
from questionnaire study which showed that exposure to biomass fuel burning in 
the home was close to universal. It is possible that the exposure in Malawians may 
be sufficient to cause redox changes in nearly all volunteers. A similar low threshold 
has been seen in intervention trials: the RESPIRE study installed cleaner cook stoves 
and demonstrated a reduction in pneumonia, but this was most evident only with 
substantial reductions from the baseline exposure11. Another potential explanation 
for this is the relatively low exposure gradient seen in our volunteers compared 
with previous cohorts recruited from similar environs of Blantyre, Malawi361. It 
might be expected that studies requiring volunteers for BAL might suffer from this 
problem, and therefore misrepresent the population in general. It is also recognised 
that the measurement of AM cytoplasmic particulate is not necessarily a direct 
measurement of exposure: different combustion sources affect this independent of 
dose and in particular, kerosene smoke causes relatively more macrophage 
particulate “blackening” [Unpublished data from our group].  
 
We measured the proportion of total glutathione in HAM which was in the oxidised 
form. Despite a small total number of volunteers, within the Malawian group there 
is strong evidence of a subgroup of individuals with high GSSG to GSH ratios. 
Using a modelling approach, we have provided evidence that this is not simply 
artefact, but is likely to represent a real observed difference. Specifically: 1) that this 
measure in Malawians is more likely to be represented by a bimodal than a 
unimodal distribution and 2) there is no statistical evidence for the same 
distribution in the UK cohort. Multivariate analysis suggests a strong relationship 
between high oxidised glutathione and low total glutathione and glutathione 
peroxidase levels. 
The subgroup we have described will be predisposed to oxidative stress due to low 
antioxidant (GSH and GPx) capacity and therefore these individuals will have a 
higher risk of oxidative damage to HAM, and will also tend towards a pro-
inflammatory phenotype. This subgroup has not been previously described in 
humans, and should be investigated further. The three variables remaining in the 
multivariate model as predictors of GSSG to GSH ratio were: lighting with paraffin 
(negatively associated with high ratio); total glutathione (negatively associated); 
glutathione peroxidase (negatively associated). In interpreting these findings, we 
assume that the process of retrieving cells by bronchoscopy and lavage, is in itself a 
stressor and likely to cause short term changes in the glutathione i.e. that this output 
is a measurement of the propensity to oxidative stress within the HAM. 
Furthermore, the relationship of GSH, GSSG:GSH and GPx strongly suggests a 
consistent lack of antioxidant upregulation in the high GSSG:GSH subgroup. Our 
interpretation of these findings, assuming that none are subject to type 1 error, 
might be one of the following: 
1. That paraffin lighting prevents high GSSG to GSH ratio through 
upregulation of other antioxidants, perhaps through chronic oxidative stress 
in the lung leading to Nrf2 activation 
2. That alternative fuels cause relatively less upregulation than paraffin, or 
cause damage to GSH and GPx activity, leaving the cells less buffered 
against oxidative stress. This occurs in cigarette smokers, with whom the 
non-smoking Malawians have some common redox responses 
3. That another unmeasured factor within the Malawian population 
predisposes to oxidative stress in the macrophage. In this context, with a 
bimodal peak likely to represent reality, a genetic polymorphism or deletion 
might provide an explanation. Examples are GSTM1 and GSTT1 which are 
involved in conjugation of glutathione with toxic substances. Upon 
challenge with biomass fuels except paraffin, differences in these enzyme 
activities are unmasked and measurable as GSSG to GSH. Other metabolic 
steps which could conceivably be altered in this way are shown in Figure 
6-1. Specifically, γ-glutamyl-transferase which alters intracellular availability 
of glutathione subunits, and glutamate-cysteine-ligase which is the rate 
limiting step in glutathione formation. Measurement of a number of genetic 
polymorphisms might provide some useful information. For future studies, 
the implications of our findings are that, when subjected to measures to 
reduce levels of oxidative stress in the lung (for example by providing 
advanced cook stoves), individuals within a population are likely to show 
considerable heterogeneity of response. 
Figure 6-1 Glutathione metabolic pathways 
 
Simplified diagram of the metabolic pathways in the synthesis and use of glutathione. This describes 
enzymatic steps which might explain the observed bimodal peak of oxidised glutathione in human alveolar 
macrophages. See text for details. 
 
We found that selenium is positively associated with whole blood glutathione 
peroxidase activity. This is consistent with previous reports446. In our cohorts, the 
association was stronger in UK volunteers than in the Malawian group despite very 
similar mean plasma selenium concentrations. It is known that GPx activity is 
regulated at multiple points including: the effects of the Sec insertion sequence 
(SECIS, which is required in the mRNA of selenoproteins for full expression of 
selenocysteine residues); post-transcription methylation of tRNA; alteration of 
mRNA stability by adenosine; tyrosine kinase pathways; homocysteine levels. 
Oxidative stress and homocysteine may reduce SECIS effect250. This multi-point 
regulation allows for wide ranging stimuli to alter GPx activity, and makes single 
factor differences between the two populations very difficult to identify. The lack of 
relationship between selenium and GPx in HAM is likely to represent this 
phenomenon, and also a difference in proportions of GPx forms in these two 
compartments. 
From these results we can infer that interventions to increase GPx levels in vivo (by 
providing dietary selenium supplementation) will not succeed in elevating such 
levels in the lung. 
 
Our observation that intraphagosomal oxidative burst is reduced in macrophages 
with high particulate burden is novel. It appears that this abnormality is isolated to 
a specific pathway, as phagocytosis and proteolysis are unaffected. Furthermore, 
where LPS pre-stimulation usually increases oxidative burst in monocytes and 
monocyte derived macrophages, it may impair NADPH oxidase activity in HAM. 
Hypotheses to explain this phenomenon in a mechanistic context are laid out in 
5.4.4. The NADPH oxidase pathway might be affected at a number of points: altered 
trafficking and assembly of the NADPH oxidase subunits at the phagosome; 
reduced phosphorylation of the complex; reduced availability of the p40 subunit. 
The availability of antioxidants might influence NADPH oxidase activity. Although 
we found no direct evidence for this in terms of GPx and SOD levels in highly 
smoke exposed individuals, the increased Nrf2 in this subpopulation suggests 
upregulation. 
In vitro models might not be useful, as the phenomenon we have observed seems 
peculiar to in vivo exposure in humans. Using primary macrophages is difficult due 
to low numbers of cells, but a mouse model will only be useful if in vivo exposures 
can adequately reproduce the phenomena which we have observed. Further 
experiments would then usefully include comparison of smoke exposed and 
unexposed mice, examining: 
 Co-localisation of NADPH oxidase subunits and the phagosomal membrane, 
for example using fluorescent labelled antibodies to p47phox and LAMP to 
visualise the structures under confocal microscopy 
 The use of existing Nrf2 knockout murine models. It should be expected that 
the effect of smoke exposure would be relatively reduced in such mice, 
although the background NADPH oxidase activity would increase 
 Ex vivo manipulation of antioxidant concentrations, for example using 
specific enzyme blockers. However, these studies are difficult as the effect 
must be great enough to measure above background heterogeneity, but low 
enough to avoid significant toxicity. Our experience using BSO to reduce 
glutathione was that although reductions in availability were possible 
without such toxicity, downstream effects were difficult to measure 
The major finding, however, is that particulate exposure in vivo has been directly 
associated with impaired antibacterial action. Although our study was performed in 
adults, we propose that the cellular observations will be similar in children. In this 
age group, reduced macrophage function could plausibly explain the association of 
particulates with pneumonia and death6. 
Interventions to reduce indoor particulate exposure have recently been given 
greater political prominence, with organisations such as the Global Alliance for 
Clean Cookstoves (http://www.cleancookstoves.org/the-alliance/) campaigning for 
action, citing multiple advantages to improving cooking and lighting emissions: 
decreased deforestation with positive effects on the local ecosystem; combating 
climate change; decreasing costs to consumers by improving efficiency; 
empowerment of women; improving morbidity and mortality. Our data provide the 
first in vivo description of how such health benefits might occur, and highlight the 
on-going risk of disease in those 2.4 billion people exposed. While intervention 
studies are keenly needed to identify the most effective and cost-efficient means of 
decreasing emissions from domestic lighting and cooking appliances, it is clear that 
public health interventions will be needed on a massive scale. This study provides 
data on biological plausibility, and strengthens the case for action. 
 
We found phenotypes of human alveolar macrophages to be relatively 
unresponsive to LPS treatment. There was also no relationship with particulate 
load. Changes in surface antigens could be detected more easily during the first 24 
hours of adherent cell culture. This suggests that, where ex vivo phenotypes are 
measured, this should be done without intermediate in vitro cell culture.  
Our observations also serve to highlight several difficulties of working with human 
alveolar macrophages: autofluorescence and a relative lack of data on phenotype 
compared with mouse models. These experiments could be extended by using 
interferon-γ in addition to LPS in order to increase the strength of stimulus. 
However, where “natural” exposures in healthy populations are being compared, 
our stimuli exceeded the likely in vivo stimuli. Measurable alterations in the 
phenotype according to the M1/M2 paradigm are possible in disease processes, but 
their success in explaining variation in a healthy population will require more 
sophisticated approaches, and the additional measurement of intracellular 
functional parameters. 
 
In preliminary observations of intracellular Nrf2, we noted a positive correlation 
between Nrf2 concentrations and in vivo particulate exposure. This is expected from 
in vitro studies of concentrated ambient particles115 which showed both an 
upregulation response and a protective effect of Nrf2 in macrophages. In humans, 
these data represent novel confirmation of the relevance of this to alveolar 
macrophages. Confirmation of these observations should be performed, with 
measurements of ARE associated gene products. This would support Nrf2 data with 
downstream measurements of effect on the cell biology e.g. HO-1 or GCLC 
upregulation. These products are measurable using Western blot techniques; their 
cytoplasmic concentrations and stability are higher than Nrf2. 
If the findings are replicable, these data show that, unlike cigarette smoking which 
impairs Nrf2 activity544, the level of particulates inhaled by our volunteers caused an 
upregulation of protective responses. Nrf2 is implicated in protection from 
oxidative stress in animal studies, where it is key in minimising susceptibility to 
lung damage from cigarettes235. Functional polymorphisms in humans are also 
linked with increased risk of acute lung injury543. Our study shows that Nrf2 is likely 
to be a relevant area of study in understanding susceptibility to the effect of 
particulate exposure. 
 
Alveolar macrophages release selected cytokines after exposure to wood smoke 
particles at a dose which replicates a typical in vivo particulate burden. This includes 
rises in TNFα, IL-6 and IL-8. Prior in vivo exposures did not alter the LPS or wood 
smoke induced responses. Redox manipulation, by reducing intracellular 
glutathione, did not alter responses other than MCP-1, for which release was 
reduced. We did not replicate the only previous study of HAMs which showed, 
after glutathione depletion, increased production of TNFα and IL-8 in response to 
LPS304.  
We expected that recurrent in vivo challenge events with particulates would down-
regulate subsequent responses and therefore reduce the potential for pulmonary 
damage as a result of chronic low level inflammation. We did not observe this effect. 
There are no human studies with which to compare our results. Chronic exposure to 
PM2.5 in mice has shown exaggerated inflammatory profiles from monocytes, which 
are in part mediated through the effect of lipid peroxidation on TLR4 and NADPH 
oxidase pathways520. In this study, there was an increase in lung MCP-1 associated 
with NADPH p47phox phosphorylation which the authors hypothesised led to 
pulmonary influx of monocytes. The effect on alveolar macrophages was not 
recorded: to reconcile our results with this study requires that other (endothelial 
and epithelial) cells play a greater role in cytokine production than AM, and that 
AM have somewhat down-regulated NADPH oxidase activity as a compensatory 
measure. In another model however, rabbits exposed to repeated tracheal 
instillation of urban PM10 had raised systemic inflammatory responses after six 
weeks of exposure517: IL-6 correlated with the proportion of AMs containing 
particulate matter. 
While systemic inflammatory effects of pulmonary particulate exposure are not in 
doubt, the source of inflammatory mediators is not yet clear. In the context of the 
limited literature, it seems from our data that AM have dampened NADPH oxidase 
responses to chronic particulate exposure, but behave similarly in acute and chronic 
exposures with respect to cytokine release. This may represent a specific blunting of 
the pro-inflammatory response expected after repeated exposure. 
 
Intervention with antioxidants in human populations has been studied in the 
context of both prevention and treatment of pneumonia. These arise from the 
observation of whole body depletion of some antioxidants during infection, and the 
subsequent suggestion that replacement might have a normalising (therefore 
beneficial) effect. Results have tended to be disappointing, including a detrimental 
effect in some subgroups (for example, vitamin E supplementation in smokers). As 
described in section 1.2.4, oxidative stress leads to signalling changes, and an 
upregulation of pathways such as Nrf2 which buffer against cellular damage. 
Assuming that delivery of antioxidants to the necessary compartments is possible, 
altering the cellular redox balance with antioxidants is likely to have results which 
are difficult to predict. Desensitisation of pathways relating to inflammation and 
apoptosis can occur; while this will reduce oxidative stress, the overall functional 
effect on the AM might be detrimental. This may be a reason why interventions to 
manipulate of intracellular thiols have been ineffective. There is some suggestion 
that a more targeted approach may be more successful. For example Nrf2 agonism 
in mouse models of COPD and in ex vivo HAM improves bacterial clearance317, but 
no studies on humans have been done.  
Given the public health importance of both exposure (biomass smoke combustion) 
and effect (decreased innate immune function), human studies in the context of 
exposure reduction interventions would be most fruitful. Before and after 
comparisons of individuals taking part in, for example cook stove interventions, 
would test the relevance of our findings with respect to plausible improvements in 
particulate levels. 
 
  
 
 
# Script and mathematical modelling by Prof Peter Diggle (25 September 2011) 
# Comments by Peter Diggle preceded by PD: 
# All other annotation of script by Jamie Rylance, and preceeded by JR: 
 
 
# JR: Read data from CSV file 
# JR: contains two columns: [1] Site (integer 1= Liverpool non-smokers 
# JR:       2=Malawians) 
# JR:                       [2] GSH ratio (floating point) 
 
data<-read.csv("GSHdata_cleaned.csv",header=T) 
names(data) 
data<-data[!is.na(data$gshratio),] 
dim(data) 
gshrange<-range(data$gshratio) 
 
 
# JR: Set up plot for cumulative distribution scatter plots for both cohorts 
 
plot(gshrange,c(0,1),type="n",xlab="Oxidised glutathione ratio (%)",ylab="cumulative 
proportion") 
 
 
# JR: Separate arrays are created for each group: 'x' for UK non-smokers 
# JR:                                             'y' for Malawians 
 
# JR: Variables 'nx' and 'ny' are the number of observations 
# JR: in their respective arrays 
 
x<-data$gshratio[data$site==1] 
nx<-length(x) 
 
y<-data$gshratio[data$site==2] 
ny<-length(y) 
 
 
# JR: Data are sorted into arrays as above, and plotted in order 
# JR: pch 19 = filled circle for UK non-smokers 
# JR: pch 21 = open circle for Malawian non-smokers 
 
points(sort(x),(1:nx)/nx, pch=19, col=gray(0)) 
points(sort(y),(1:ny)/ny, pch=21, col=gray(0)) 
 
# PD: cumulative plots - better for small data-sets than histograms because 
# PD: no need to choose bin-width 
 
# JR: Variables 'mux' and 'muy' are means of UK non-smokers 
# JR: and Malawaian cohorts respectively 
 
# JR: Variables 'sdx' and 'sdy' are their respective standard deviations  
 
mux<-mean(x) 
sdx<-sqrt(var(x)) 
muy<-mean(y) 
sdy<-sqrt(var(y)) 
 
# JR: Array 'px' is an array of points to be plotted at intervals of 0.1 
# JR: along the x axis 
 
# JR: lty=1 = UK group in solid line 
# JR: lty=2 = Malawian group in dotted line 
# JR: Lines are drawn following a normal distriubution around each 
# JR: cohort mean with given SD 
 
px<-1+0.1*(0:145) 
lines(px,pnorm(px,mux,sdx),col=gray(0), lwd=3, lty=1) 
lines(px,pnorm(px,muy,sdy),col=gray(0), lwd=3, lty=2) 
 
# JR: UK cohort approximates normal distribution 
# JR: Considerable deviation from normal in the Malawi cohort 
 
 
# PD: define log-likelihood functions for simple Normal and for 
# PD: two-component Normal mixture 
 
# JR: f1 is the simple normal distribution 
# JR: f2 is the combined function of two normal distributions 
 
 f1<-function(x,mu,sigma) { 
     sum(dnorm(x,mu,sigma,log=T)) 
     } 
 f2<-function(x,mu1,sigma1,mu2,sigma2,p) { 
     sum(log(p*dnorm(x,mu1,sigma1)+(1-p)*dnorm(x,mu2,sigma2))) 
     } 
 
# PD: define various log-likelihood functions that might be of interest 
# PD: L1: Malawi is completely different to Liverpool 
 
 L1<-function(x,y,mu1,sigma1,mu2,sigma2,mu3,sigma3,p) { 
  f1(x,mu1,sigma1)+f2(y,mu2,sigma2,mu3,sigma3,p) 
  } 
 
# PD: L0: Malawi is mix of Liverpool plus something different 
 L0<-function(x,y,mu1,sigma1,mu2,sigma2,p) { 
     f1(x,mu1,sigma1)+f2(y,mu1,sigma1,mu2,sigma2,p) 
     } 
 
# PD: Maximum liklihood estimation for Liverpool 
 muhat<-mean(x) 
 sigmahat<-sqrt(nx*var(x)/(nx-1)) 
 maxL.liv<-f1(x,muhat,sigmahat) 
 
# JR: Maximum liklihood for this = -25.81514 
 
 
 
# JR: ### MODEL 1 ### 
 
# PD: MLE for Malawi, assuming completely different from UK 
 
 p.init<-0.5 
 
 mu1.init<-muhat 
 sigma1.init<-sigmahat 
 
 mu2.init<-mu1.init 
 sigma2.init<-sigma1.init 
 
 mu3.init<-(mean(y)-p.init*mu2.init)/(1-p.init) 
 sigma3.init<-sigma1.init 
 
param<-log(c(mu1.init,sigma1.init,mu2.init,sigma2.init,mu3.init,sigma3.init,p.init)) 
 print.progress<-F 
 
 fn1<-function(param) { 
     ep<-exp(param) 
     mu1<-ep[1] 
     sigma1<-ep[2] 
     mu2<-ep[3] 
     sigma2<-ep[4] 
     mu3<-ep[5] 
     sigma3<-ep[6] 
     p<-ep[7] 
     logL<-L1(x,y,mu1,sigma1,mu2,sigma2,mu3,sigma3,p) 
     if (print.progress) print(round(c(ep,logL),3)) 
  -logL 
    } 
 
# JR: Iteration continues to refine this model (up to 500 times) 
 result1<-optim(param,fn1,control=list(maxit=500))  
 maxL.both<--result1$value 
 
# JR: Maximum liklihood for this = maxL.both = -124.174 
 
 thetahat<-exp(result1$par) 
 round(thetahat,3) 
 
# PD: [1] 3.879 2.062 2.747 1.051 8.550 3.331 0.732 
 
# JR: Results of this model 'thetahat' suggest: 
# JR:  UK mean  = 3.879 
# JR:  UK SD    = 2.062 
# JR: and where Malawi group has two normally distributed component 'sub' populations 
# JR:  Malawi mean [1] = 2.747 
# JR:  Malawi SD   [1] = 1.051 
# JR:  Malawi mean [2] = 8.550 
# JR:  Malawi SD   [2] = 3.331 
# JR: and that of the overall Malawi group 
# JR:  component   [1] represents 0.732 of the total ie. 73.2% 
   
 
# JR: ### MODEL 2 ### 
 
# PD: for Malawi assuming Normally distributed 
 
 mu2hat<-mean(y) 
 sigma2hat<-sqrt(ny*var(y)/(ny-1)) 
 maxL0.mal<-f1(y,mu2hat,sigma2hat) 
 
# JR: Maximum liklihood for this = maxL0.mal = -116.5128 
 
# JR: Greater Likelihood Ratio Test (GLRT) for Malawi Normal vs Malawi mixture 
 
 dev<-2*(maxL.both-(maxL0.mal+maxL.liv)) 
 
# PD: GLRT output = dev = 11.63861 
 
 p<-1-pchisq(dev,3) 
 
# PD: p<0.0001 
 
# JR: Reject the null hypothesis ie. that there is no better fit of the 
# JR: Malawi mixture model compared with the normally distributed model 
 
 
 
# JR: ### MODEL 3 ### 
 
# PD: for combined data, assuming one component of UK same as Malawi 
 
 fn2<-function(param) { 
     ep<-exp(param) 
     mu1<-ep[1] 
     sigma1<-ep[2] 
     mu2<-ep[3] 
     sigma2<-ep[4] 
     p<-ep[5] 
     logL<-L1(x,y,mu1,sigma1,mu1,sigma1,mu2,sigma2,p) 
     if (print.progress) print(round(c(ep,logL),3)) 
     -logL 
 } 
 
 mu1.init<-thetahat[1] 
 sigma1.init<-thetahat[2] 
 mu2.init<-thetahat[3] 
 sigma2.init<-thetahat[4] 
 p.init<-1-thetahat[7] 
 param<-log(c(mu1.init,sigma1.init,mu2.init,sigma2.init,p.init)) 
 result2<-optim(param,fn2,control=list(maxit=5000))  
 thetahat2<-exp(result2$par) 
 maxL.both.constrained<--result2$value 
 dev<-2*(maxL.both-maxL.both.constrained) 
 
# JR: Model output = dev = 11.63861 
 
 p<-1-pchisq(dev,2) 
 # PD: p=0.002969669 
 
# JR: Reject the null hypothesis ie. that there is no difference between 
 the UK cohort and one component of the Malawi cohort 
 
 
# PD: Maximum Likelihood Estimate MLE's for Malawi only 
# PD: (since no parameters in common with UK) 
 fn3<-function(param) { 
     ep<-exp(param) 
     mu1<-ep[1] 
     sigma1<-ep[2] 
     mu2<-ep[3] 
     sigma2<-ep[4] 
     p<-ep[5] 
     logL<-f2(y,mu1,sigma1,mu2,sigma2,p) 
     if (print.progress) print(round(c(ep,logL),3)) 
     -logL 
    } 
 param<-log(thetahat[3:7]) 
 result3<-optim(param,fn3,control=list(maxit=5000))  
 thetahat3<-exp(result3$par) 
 
 
 
# PD: Highly significant evidence for: 
# PD: (a) Malawi is a mixture of two component Normals 
# PD: (b) Neither of the two Malawi component distributions is equal 
# PD:      to the UK distribution 
# 
 
 
# JR: Then plot the model against the original data 
 
 x<-0.1*(10:150) 
 F.liv<-pnorm(x,3.879,2.062) 
 
 F.mal<-0.732*pnorm(x,2.747,1.0581)+(1-0.732)*pnorm(x,8.550,3.331) 
 
 lines(x,F.liv,lwd=2,col="red", lty=1) 
 lines(x,F.mal,lwd=2,col="red", lty=2) 
 
write.csv(x, file="output.csv") 
write.csv(F.mal, file="output2.csv") 
 
# JR: Script ends 
 
 
          
           
⇔              
      
  
  
  (
     
       
 
             
)
   
 
 1. Rudan I, Boschi-Pinto C, Biloglav Z, Mulholland K, Campbell H. Epidemiology and 
etiology of childhood pneumonia. Bull World Health Organ 2008; 86(5): 408-16. 
2. Jones N, Huebner R, Khoosal M, Crewe-Brown H, Klugman K. The impact of HIV on 
Streptococcus pneumoniae bacteraemia in a South African population. AIDS 1998; 
12(16): 2177-84. 
3. Nuorti JP, Butler JC, Farley MM, et al. Cigarette smoking and invasive pneumococcal 
disease. Active Bacterial Core Surveillance Team. N Engl J Med 2000; 342(10): 681-9. 
4. Coles CL, Fraser D, Givon-Lavi N, et al. Nutritional status and diarrheal illness as 
independent risk factors for alveolar pneumonia. Am J Epidemiol 2005; 162(10): 999-1007. 
5. Emmelin A, Wall S. Indoor air pollution: a poverty-related cause of mortality among the 
children of the world. Chest 2007; 132(5): 1615-23. 
6. Dherani M, Pope D, Mascarenhas M, Smith KR, Weber M, Bruce N. Indoor air pollution 
from unprocessed solid fuel use and pneumonia risk in children aged under five years: 
a systematic review and meta-analysis. Bull World Health Organ 2008; 86(5): 390-8C. 
7. Mulholland K. Perspectives on the burden of pneumonia in children. Vaccine 2007; 
25(13): 2394-7. 
8. Pope CA, 3rd, Ezzati M, Dockery DW. Fine-particulate air pollution and life expectancy 
in the United States. N Engl J Med 2009; 360(4): 376-86. 
9. Torres-Duque C, Maldonado D, Perez-Padilla R, Ezzati M, Viegi G. Biomass fuels and 
respiratory diseases: a review of the evidence. Proc Am Thorac Soc 2008; 5(5): 577-90. 
10. Ezzati M, Kammen D. Indoor air pollution from biomass combustion and acute 
respiratory infections in Kenya: an exposure-response study. Lancet 2001; 358(9282): 619-
24. 
11. Smith KR, McCracken JP, Weber MW, et al. Effect of reduction in household air 
pollution on childhood pneumonia in Guatemala (RESPIRE): a randomised controlled 
trial. Lancet 2011; 378(9804): 1717-26. 
12. Hoffmann JA, Kafatos FC, Janeway CA, Ezekowitz RA. Phylogenetic perspectives in 
innate immunity. Science 1999; 284(5418): 1313-8. 
13. Delves PJ, Roitt IM. Roitt's essential immunology. 12th ed. Chichester, West Sussex ; 
Hoboken, NJ: Wiley-Blackwell; 2011. 
14. Zwilling BS, Eisenstein TK. Macrophage-pathogen interactions. New York: M. Dekker; 
1994. 
15. Medzhitov R, Schneider DS, Soares MP. Disease tolerance as a defense strategy. Science 
2012; 335(6071): 936-41. 
16. Van der Schans CP. Bronchial mucus transport. Respir Care 2007; 52(9): 1150-6; 
discussion 6-8. 
17. Ganz T. Defensins: antimicrobial peptides of innate immunity. Nat Rev Immunol 2003; 
3(9): 710-20. 
18. Zipfel PF, Skerka C. Complement regulators and inhibitory proteins. Nat Rev Immunol 
2009; 9(10): 729-40. 
19. Stuart LM, Ezekowitz RA. Phagocytosis and comparative innate immunity: learning on 
the fly. Nat Rev Immunol 2008; 8(2): 131-41. 
20. Underhill DM, Goodridge HS. Information processing during phagocytosis. Nat Rev 
Immunol 2012; 12(7): 492-502. 
21. Soehnlein O, Lindbom L. Phagocyte partnership during the onset and resolution of 
inflammation. Nat Rev Immunol 2010; 10(6): 427-39. 
22. Anjilvel S, Asgharian B. A multiple-path model of particle deposition in the rat lung. 
Fundamental and applied toxicology : official journal of the Society of Toxicology 1995; 28(1): 
41-50. 
23. Heyder J. Deposition of inhaled particles in the human respiratory tract and 
consequences for regional targeting in respiratory drug delivery. Proc Am Thorac Soc 
2004; 1(4): 315-20. 
24. Gordon SB, Read RC. Macrophage defences against respiratory tract infections. British 
medical bulletin 2002; 61: 45-61. 
25. Karimi R, Tornling G, Grunewald J, Eklund A, Skold CM. Cell recovery in 
bronchoalveolar lavage fluid in smokers is dependent on cumulative smoking history. 
PLoS One 2012; 7(3): e34232. 
26. Meyer KC, Soergel P. Variation of bronchoalveolar lymphocyte phenotypes with age in 
the physiologically normal human lung. Thorax 1999; 54(8): 697-700. 
27. Burkitt HG, Young B, Heath JW, Wheater PR. Wheater's functional histology : a text and 
colour atlas. 3rd ed. Edinburgh ; New York: Churchill Livingstone; 1993. 
28. Trisolini R, Lazzari Agli L, Cancellieri A, et al. Bronchoalveolar lavage findings in 
severe community-acquired pneumonia due to Legionella pneumophila serogroup 1. 
Respir Med 2004; 98(12): 1222-6. 
29. Lam JK, Liang W, Chan HK. Pulmonary delivery of therapeutic siRNA. Adv Drug Deliv 
Rev 2012; 64(1): 1-15. 
30. Garcia-Suarez Mdel M, Florez N, Astudillo A, et al. The role of pneumolysin in 
mediating lung damage in a lethal pneumococcal pneumonia murine model. Respir Res 
2007; 8: 3. 
31. van der Poll T, Opal SM. Pathogenesis, treatment, and prevention of pneumococcal 
pneumonia. Lancet 2009; 374(9700): 1543-56. 
32. Bogaert D, De Groot R, Hermans PW. Streptococcus pneumoniae colonisation: the key 
to pneumococcal disease. Lancet Infect Dis 2004; 4(3): 144-54. 
33. Bentley SD, Aanensen DM, Mavroidi A, et al. Genetic analysis of the capsular 
biosynthetic locus from all 90 pneumococcal serotypes. PLoS genetics 2006; 2(3): e31. 
34. Hirst RA, Kadioglu A, O'Callaghan C, Andrew PW. The role of pneumolysin in 
pneumococcal pneumonia and meningitis. Clin Exp Immunol 2004; 138(2): 195-201. 
35. Kadioglu A, Weiser JN, Paton JC, Andrew PW. The role of Streptococcus pneumoniae 
virulence factors in host respiratory colonization and disease. Nat Rev Microbiol 2008; 
6(4): 288-301. 
36. Davis KM, Nakamura S, Weiser JN. Nod2 sensing of lysozyme-digested peptidoglycan 
promotes macrophage recruitment and clearance of S. pneumoniae colonization in mice. 
J Clin Invest 2011; 121(9): 3666-76. 
37. Rubins JB. Alveolar macrophages: wielding the double-edged sword of inflammation. 
Am J Respir Crit Care Med 2003; 167(2): 103-4. 
38. Taut K, Winter C, Briles DE, et al. Macrophage Turnover Kinetics in the Lungs of Mice 
Infected with Streptococcus pneumoniae. Am J Respir Cell Mol Biol 2008; 38(1): 105-13. 
39. Flannagan RS, Jaumouille V, Grinstein S. The cell biology of phagocytosis. Annual review 
of pathology 2012; 7: 61-98. 
40. Gordon SB, Irving GR, Lawson RA, Lee ME, Read RC. Intracellular trafficking and 
killing of Streptococcus pneumoniae by human alveolar macrophages are influenced by 
opsonins. Infect Immun 2000; 68(4): 2286-93. 
41. Taylor PR, Martinez-Pomares L, Stacey M, Lin HH, Brown GD, Gordon S. Macrophage 
receptors and immune recognition. Annual review of immunology 2005; 23: 901-44. 
42. Arredouani MS, Palecanda A, Koziel H, et al. MARCO is the major binding receptor for 
unopsonized particles and bacteria on human alveolar macrophages. J Immunol 2005; 
175(9): 6058-64. 
43. Thakur SA, Hamilton RF, Jr., Holian A. Role of scavenger receptor a family in lung 
inflammation from exposure to environmental particles. Journal of immunotoxicology 
2008; 5(2): 151-7. 
44. Pluddemann A, Mukhopadhyay S, Gordon S. The interaction of macrophage receptors 
with bacterial ligands. Expert reviews in molecular medicine 2006; 8(28): 1-25. 
45. Vieira OV, Botelho RJ, Grinstein S. Phagosome maturation: aging gracefully. Biochem J 
2002; 366(Pt 3): 689-704. 
46. Fang FC. Antimicrobial reactive oxygen and nitrogen species: concepts and 
controversies. Nat Rev Microbiol 2004; 2(10): 820-32. 
47. Nauseef WM. Assembly of the phagocyte NADPH oxidase. Histochem Cell Biol 2004; 
122(4): 277-91. 
48. Cross AR. p40(phox) Participates in the activation of NADPH oxidase by increasing the 
affinity of p47(phox) for flavocytochrome b(558). Biochem J 2000; 349(Pt 1): 113-7. 
49. Flannagan RS, Cosio G, Grinstein S. Antimicrobial mechanisms of phagocytes and 
bacterial evasion strategies. Nat Rev Microbiol 2009; 7(5): 355-66. 
50. Toews GB, Vial WC, Dunn MM, et al. The accessory cell function of human alveolar 
macrophages in specific T cell proliferation. J Immunol 1984; 132(1): 181-6. 
51. Guth AM, Janssen WJ, Bosio CM, Crouch EC, Henson PM, Dow SW. Lung environment 
determines unique phenotype of alveolar macrophages. Am J Physiol Lung Cell Mol 
Physiol 2009; 296(6): L936-46. 
52. Gong JL, McCarthy KM, Rogers RA, Schneeberger EE. Interstitial lung macrophages 
interact with dendritic cells to present antigenic peptides derived from particulate 
antigens to T cells. Immunology 1994; 81(3): 343-51. 
53. Opitz B, van Laak V, Eitel J, Suttorp N. Innate immune recognition in infectious and 
noninfectious diseases of the lung. Am J Respir Crit Care Med 2010; 181(12): 1294-309. 
54. Koppe U, Suttorp N, Opitz B. Recognition of Streptococcus pneumoniae by the innate 
immune system. Cellular microbiology 2012; 14(4): 460-6. 
55. Schmeck B, Zahlten J, Moog K, et al. Streptococcus pneumoniae-induced p38 MAPK-
dependent phosphorylation of RelA at the interleukin-8 promotor. J Biol Chem 2004; 
279(51): 53241-7. 
56. Verstak B, Nagpal K, Bottomley SP, Golenbock DT, Hertzog PJ, Mansell A. MyD88 
adapter-like (Mal)/TIRAP interaction with TRAF6 is critical for TLR2- and TLR4-
mediated NF-kappaB proinflammatory responses. J Biol Chem 2009; 284(36): 24192-203. 
57. Malley R, Henneke P, Morse SC, et al. Recognition of pneumolysin by Toll-like receptor 
4 confers resistance to pneumococcal infection. Proc Natl Acad Sci U S A 2003; 100(4): 
1966-71. 
58. Dessing MC, Florquin S, Paton JC, van der Poll T. Toll-like receptor 2 contributes to 
antibacterial defence against pneumolysin-deficient pneumococci. Cellular microbiology 
2008; 10(1): 237-46. 
59. Kong X, Thimmulappa R, Kombairaju P, Biswal S. NADPH oxidase-dependent reactive 
oxygen species mediate amplified TLR4 signaling and sepsis-induced mortality in Nrf2-
deficient mice. J Immunol 2010; 185(1): 569-77. 
60. Anrather J, Racchumi G, Iadecola C. NF-kappaB regulates phagocytic NADPH oxidase 
by inducing the expression of gp91phox. J Biol Chem 2006; 281(9): 5657-67. 
61. Dewas C, Dang PM, Gougerot-Pocidalo MA, El-Benna J. TNF-alpha induces 
phosphorylation of p47(phox) in human neutrophils: partial phosphorylation of 
p47phox is a common event of priming of human neutrophils by TNF-alpha and 
granulocyte-macrophage colony-stimulating factor. J Immunol 2003; 171(8): 4392-8. 
62. Marriott HM, Hellewell PG, Whyte MK, Dockrell DH. Contrasting roles for reactive 
oxygen species and nitric oxide in the innate response to pulmonary infection with 
Streptococcus pneumoniae. Vaccine 2007; 25(13): 2485-90. 
63. Segal BH, Han W, Bushey JJ, et al. NADPH oxidase limits innate immune responses in 
the lungs in mice. PLoS One 2010; 5(3): e9631. 
64. Jenner RG, Young RA. Insights into host responses against pathogens from 
transcriptional profiling. Nat Rev Microbiol 2005; 3(4): 281-94. 
65. Nau GJ, Richmond JF, Schlesinger A, Jennings EG, Lander ES, Young RA. Human 
macrophage activation programs induced by bacterial pathogens. Proc Natl Acad Sci U S 
A 2002; 99(3): 1503-8. 
66. Marriott HM, Hellewell PG, Cross SS, Ince PG, Whyte MK, Dockrell DH. Decreased 
alveolar macrophage apoptosis is associated with increased pulmonary inflammation in 
a murine model of pneumococcal pneumonia. J Immunol 2006; 177(9): 6480-8. 
67. Erwig LP, Henson PM. Immunological consequences of apoptotic cell phagocytosis. Am 
J Pathol 2007; 171(1): 2-8. 
68. Marriott HM, Mitchell TJ, Dockrell DH. Pneumolysin: a double-edged sword during the 
host-pathogen interaction. Curr Mol Med 2008; 8(6): 497-509. 
69. Fadok VA, Bratton DL, Konowal A, Freed PW, Westcott JY, Henson PM. Macrophages 
that have ingested apoptotic cells in vitro inhibit proinflammatory cytokine production 
through autocrine/paracrine mechanisms involving TGF-beta, PGE2, and PAF. J Clin 
Invest 1998; 101(4): 890-8. 
70. Dockrell DH, Marriott HM, Prince LR, et al. Alveolar macrophage apoptosis contributes 
to pneumococcal clearance in a resolving model of pulmonary infection. J Immunol 2003; 
171(10): 5380-8. 
71. Natarajan S, Kim J, Remick DG. Chronic pulmonary LPS tolerance induces selective 
immunosuppression while maintaining the neutrophilic response. Shock 2010; 33(2): 
162-9. 
72. Langenback EG, Bergofsky EH, Halpern JG, Foster WM. Supramicron-sized particle 
clearance from alveoli: route and kinetics. J Appl Physiol 1990; 69(4): 1302-8. 
73. Oberdorster G, Oberdorster E, Oberdorster J. Nanotoxicology: an emerging discipline 
evolving from studies of ultrafine particles. Environ Health Perspect 2005; 113(7): 823-39. 
74. Renwick LC, Brown D, Clouter A, Donaldson K. Increased inflammation and altered 
macrophage chemotactic responses caused by two ultrafine particle types. Occup 
Environ Med 2004; 61(5): 442-7. 
75. Stoeger T, Reinhard C, Takenaka S, et al. Instillation of Six Different Ultrafine Carbon 
Particles Indicates a Surface Area Threshold Dose for Acute Lung Inflammation in Mice. 
Environ Health Perspect 2006; 114(3): 328-33. 
76. Beck-Speier I, Dayal N, Karg E, et al. Oxidative stress and lipid mediators induced in 
alveolar macrophages by ultrafine particles. Free Radic Biol Med 2005; 38(8): 1080-92. 
77. Tao F, Gonzalez-Flecha B, Kobzik L. Reactive oxygen species in pulmonary 
inflammation by ambient particulates. Free Radic Biol Med 2003; 35(4): 327-40. 
78. Pinel-Marie ML, Sparfel L, Desmots S, Fardel O. Aryl hydrocarbon receptor-dependent 
induction of the NADPH oxidase subunit NCF1/p47 phox expression leading to 
priming of human macrophage oxidative burst. Free Radic Biol Med 2009; 47(6): 825-34. 
79. Chin BY, Choi ME, Burdick MD, Strieter RM, Risby TH, Choi AM. Induction of 
apoptosis by particulate matter: role of TNF-alpha and MAPK. Am J Physiol 1998; 275(5 
Pt 1): L942-9. 
80. WHO. Global health risks: Mortality and burden of disease attributable to selecte major 
risks. Geneva: WHO; 2009. 
81. Fullerton DG, Bruce N, Gordon SB. Indoor air pollution from biomass fuel smoke is a 
major health concern in the developing world. Trans R Soc Trop Med Hyg 2008; 102(9): 
843-51. 
82. Kocbach A, Namork E, Schwarze PE. Pro-inflammatory potential of wood smoke and 
traffic-derived particles in a monocytic cell line. Toxicology 2008; 247(2-3): 123-32. 
83. Semple S, Devakumar D, Fullerton DG, et al. Airborne Endotoxin Concentrations in 
Homes Burning Biomass Fuel. Environ Health Perspect 2010. 
84. Imrich A, Ning Y, Lawrence J, et al. Alveolar macrophage cytokine response to air 
pollution particles: oxidant mechanisms. Toxicol Appl Pharmacol 2007; 218(3): 256-64. 
85. Mehta H, Nazzal K, Sadikot RT. Cigarette smoking and innate immunity. Inflamm Res 
2008; 57(11): 497-503. 
86. Smith LA, Paszkiewicz GM, Hutson AD, Pauly JL. Inflammatory response of lung 
macrophages and epithelial cells to tobacco smoke: a literature review of ex vivo 
investigations. Immunol Res 2010; 46(1-3): 94-126. 
87. Naeher LP, Brauer M, Lipsett M, et al. Woodsmoke health effects: a review. Inhal Toxicol 
2007; 19(1): 67-106. 
88. Bitterle E, Karg E, Schroeppel A, et al. Dose-controlled exposure of A549 epithelial cells 
at the air-liquid interface to airborne ultrafine carbonaceous particles. Chemosphere 2006; 
65(10): 1784-90. 
89. Rothen-Rutishauser BM, Kiama SG, Gehr P. A three-dimensional cellular model of the 
human respiratory tract to study the interaction with particles. Am J Respir Cell Mol Biol 
2005; 32(4): 281-9. 
90. Kocbach A, Herseth JI, Lag M, Refsnes M, Schwarze PE. Particles from wood smoke and 
traffic induce differential pro-inflammatory response patterns in co-cultures. Toxicol 
Appl Pharmacol 2008. 
91. Barregard L, Sallsten G, Andersson L, et al. Experimental exposure to wood smoke: 
effects on airway inflammation and oxidative stress. Occup Environ Med 2008; 65(5): 319-
24. 
92. Saksena S, Thompson L, Smith KR. Database of Husehold Air Pollution Studies in 
Developing Countries, Protection ofthe Human Environment. Geneva: WHO; 2003. 
93. Huang YC, Li Z, Harder SD, Soukup JM. Apoptotic and inflammatory effects induced 
by different particles in human alveolar macrophages. Inhal Toxicol 2004; 16(14): 863-78. 
94. Ning Y, Imrich A, Goldsmith CA, Qin G, Kobzik L. Alveolar macrophage cytokine 
production in response to air particles in vitro: role of endotoxin. J Toxicol Environ Health 
A 2000; 59(3): 165-80. 
95. Becker S, Soukup JM, Gallagher JE. Differential particulate air pollution induced oxidant 
stress in human granulocytes, monocytes and alveolar macrophages. Toxicol In Vitro 
2002; 16(3): 209-18. 
96. Urch B, Speck M, Corey P, et al. Concentrated ambient fine particles and not ozone 
induce a systemic interleukin-6 response in humans. Inhal Toxicol 2010; 22(3): 210-8. 
97. Goto Y, Ishii H, Hogg JC, et al. Particulate matter air pollution stimulates monocyte 
release from the bone marrow. Am J Respir Crit Care Med 2004; 170(8): 891-7. 
98. Sigaud S, Goldsmith CA, Zhou H, et al. Air pollution particles diminish bacterial 
clearance in the primed lungs of mice. Toxicol Appl Pharmacol 2007; 223(1): 1-9. 
99. Monn C, Becker S. Cytotoxicity and induction of proinflammatory cytokines from 
human monocytes exposed to fine (PM2.5) and coarse particles (PM10-2.5) in outdoor 
and indoor air. Toxicol Appl Pharmacol 1999; 155(3): 245-52. 
100. Becker S, Soukup JM, Gilmour MI, Devlin RB. Stimulation of human and rat alveolar 
macrophages by urban air particulates: effects on oxidant radical generation and 
cytokine production. Toxicol Appl Pharmacol 1996; 141(2): 637-48. 
101. Imrich A, Ning YY, Koziel H, Coull B, Kobzik L. Lipopolysaccharide priming amplifies 
lung macrophage tumor necrosis factor production in response to air particles. Toxicol 
Appl Pharmacol 1999; 159(2): 117-24. 
102. Imrich A, Ning Y, Kobzik L. Insoluble components of concentrated air particles mediate 
alveolar macrophage responses in vitro. Toxicol Appl Pharmacol 2000; 167(2): 140-50. 
103. Shaw CA, Robertson S, Miller MR, et al. Diesel exhaust particulate--exposed 
macrophages cause marked endothelial cell activation. Am J Respir Cell Mol Biol 2011; 
44(6): 840-51. 
104. Pourazar J, Frew AJ, Blomberg A, et al. Diesel exhaust exposure enhances the expression 
of IL-13 in the bronchial epithelium of healthy subjects. Respir Med 2004; 98(9): 821-5. 
105. Fahy O, Senechal S, Pene J, et al. Diesel exposure favors Th2 cell recruitment by 
mononuclear cells and alveolar macrophages from allergic patients by differentially 
regulating macrophage-derived chemokine and IFN-gamma-induced protein-10 
production. J Immunol 2002; 168(11): 5912-9. 
106. Mundandhara SD, Becker S, Madden MC. Effects of diesel exhaust particles on human 
alveolar macrophage ability to secrete inflammatory mediators in response to 
lipopolysaccharide. Toxicol In Vitro 2006; 20(5): 614-24. 
107. Yin XJ, Dong CC, Ma JY, Roberts JR, Antonini JM, Ma JK. Suppression of phagocytic 
and bactericidal functions of rat alveolar macrophages by the organic component of 
diesel exhaust particles. J Toxicol Environ Health A 2007; 70(10): 820-8. 
108. Harder V, Gilmour P, Lentner B, et al. Cardiovascular responses in unrestrained WKY 
rats to inhaled ultrafine carbon particles. Inhal Toxicol 2005; 17(1): 29-42. 
109. Li XY, Brown D, Smith S, MacNee W, Donaldson K. Short-term inflammatory responses 
following intratracheal instillation of fine and ultrafine carbon black in rats. Inhal Toxicol 
1999; 11(8): 709-31. 
110. Leonard SS, Wang S, Shi X, Jordan BS, Castranova V, Dubick MA. Wood smoke 
particles generate free radicals and cause lipid peroxidation, DNA damage, NFkappaB 
activation and TNF-alpha release in macrophages. Toxicology 2000; 150(1-3): 147-57. 
111. Samuelsen M, Cecilie Nygaard U, Lovik M. Particles from wood smoke and road traffic 
differently affect the innate immune system of the lung. Inhal Toxicol 2009; 21(11): 943-51. 
112. Seagrave J, McDonald JD, Reed MD, Seilkop SK, Mauderly JL. Responses to subchronic 
inhalation of low concentrations of diesel exhaust and hardwood smoke measured in rat 
bronchoalveolar lavage fluid. Inhal Toxicol 2005; 17(12): 657-70. 
113. Tesfaigzi Y, McDonald JD, Reed MD, et al. Low-level subchronic exposure to wood 
smoke exacerbates inflammatory responses in allergic rats. Toxicol Sci 2005; 88(2): 505-13. 
114. Shukla A, Timblin C, BeruBe K, et al. Inhaled particulate matter causes expression of 
nuclear factor (NF)-kappaB-related genes and oxidant-dependent NF-kappaB activation 
in vitro. Am J Respir Cell Mol Biol 2000; 23(2): 182-7. 
115. Li YJ, Takizawa H, Azuma A, et al. Disruption of Nrf2 enhances susceptibility to airway 
inflammatory responses induced by low-dose diesel exhaust particles in mice. Clinical 
immunology 2008; 128(3): 366-73. 
116. Kafoury RM, Madden MC. Diesel exhaust particles induce the over expression of tumor 
necrosis factor-alpha (TNF-alpha) gene in alveolar macrophages and failed to induce 
apoptosis through activation of nuclear factor-kappaB (NF-kappaB). International journal 
of environmental research and public health 2005; 2(1): 107-13. 
117. Zelikoff JT, Chen LC, Cohen MD, et al. Effects of inhaled ambient particulate matter on 
pulmonary antimicrobial immune defense. Inhal Toxicol 2003; 15(2): 131-50. 
118. Bachoual R, Boczkowski J, Goven D, et al. Biological effects of particles from the paris 
subway system. Chem Res Toxicol 2007; 20(10): 1426-33. 
119. Arimoto T, Kadiiska MB, Sato K, Corbett J, Mason RP. Synergistic production of lung 
free radicals by diesel exhaust particles and endotoxin. Am J Respir Crit Care Med 2005; 
171(4): 379-87. 
120. Behndig AF, Mudway IS, Brown JL, et al. Airway antioxidant and inflammatory 
responses to diesel exhaust exposure in healthy humans. Eur Respir J 2006; 27(2): 359-65. 
121. Fick RB, Jr., Paul ES, Merrill WW, Reynolds HY, Loke JS. Alterations in the antibacterial 
properties of rabbit pulmonary macrophages exposed to wood smoke. Am Rev Respir 
Dis 1984; 129(1): 76-81. 
122. Ghio AJ, Soukup JM, Case M, et al. Exposure to wood smoke particles produces 
inflammation in healthy volunteers. Occup Environ Med 2012; 69(3): 170-5. 
123. Lal K, Dutta KK, Vachhrajani KD, Gupta GS, Srivastava AK. Histomorphological 
changes in lung of rats following exposure to wood smoke. Indian J Exp Biol 1993; 31(9): 
761-4. 
124. Barlow PG, Brown DM, Donaldson K, MacCallum J, Stone V. Reduced alveolar 
macrophage migration induced by acute ambient particle (PM10) exposure. Cell Biol 
Toxicol 2008; 24(3): 243-52. 
125. Gillissen A, Becher B, Vacca G, Dueck R, Juergens U. Chemotactic Effects of Diesel 
Exhaust Particles on the Interaction between Macrophage and Neutrophilic 
Granulocytes.  American Thoracic Society Conference. San Diego; 2009. 
126. Demarest GB, Hudson LD, Altman LC. Impaired alveolar macrophage chemotaxis in 
patients with acute smoke inhalation. Am Rev Respir Dis 1979; 119(2): 279-86. 
127. Zhou H, Kobzik L. Effect of concentrated ambient particles on macrophage 
phagocytosis and killing of Streptococcus pneumoniae. Am J Respir Cell Mol Biol 2007; 
36(4): 460-5. 
128. Castranova V, Bowman L, Reasor MJ, Lewis T, Tucker J, Miles PR. The response of rat 
alveolar macrophages to chronic inhalation of coal dust and/or diesel exhaust. Environ 
Res 1985; 36(2): 405-19. 
129. Lundborg M, Johansson A, Lastbom L, Camner P. Ingested aggregates of ultrafine 
carbon particles and interferon-gamma impair rat alveolar macrophage function. 
Environ Res 1999; 81(4): 309-15. 
130. Lundborg M, Johard U, Lastbom L, Gerde P, Camner P. Human alveolar macrophage 
phagocytic function is impaired by aggregates of ultrafine carbon particles. Environ Res 
2001; 86(3): 244-53. 
131. Aljurayyan AN, Fullerton DG, Barrett S, Gordon SB. Human macrophage model of 
biomass smoke exposure shows impaired ingestion of Streptococcus pneumoniae.  
British Thoracic Society Winter Meeting. London: BMJ; 2011. 
132. Labedzka M, Gulyas H, Gercken G. Zymosan-induced chemiluminescence of alveolar 
macrophages: depression by inorganic dust constituents. Arch Environ Contam Toxicol 
1991; 21(1): 51-7. 
133. Sawyer K, Mundandhara S, Ghio AJ, Madden MC. The effects of ambient particulate 
matter on human alveolar macrophage oxidative and inflammatory responses. J Toxicol 
Environ Health A 2010; 73(1): 41-57. 
134. Beck-Speier I, Dayal N, Karg E, et al. Agglomerates of ultrafine particles of elemental 
carbon and TiO2 induce generation of lipid mediators in alveolar macrophages. Environ 
Health Perspect 2001; 109 Suppl 4: 613-8. 
135.Zelikoff JT, Chen LC, Cohen MD, Schlesinger RB. The toxicology of inhaled woodsmoke. 
J Toxicol Environ Health B Crit Rev 2002; 5(3): 269-82. 
136. Antonini JM, Roberts JR, Jernigan MR, Yang HM, Ma JY, Clarke RW. Residual oil fly ash 
increases the susceptibility to infection and severely damages the lungs after pulmonary 
challenge with a bacterial pathogen. Toxicol Sci 2002; 70(1): 110-9. 
137. Lundborg M, Bouhafs R, Gerde P, et al. Aggregates of ultrafine particles modulate lipid 
peroxidation and bacterial killing by alveolar macrophages. Environ Res 2007; 104(2): 
250-7. 
138. Jakab GJ. The toxicologic interactions resulting from inhalation of carbon black and 
acrolein on pulmonary antibacterial and antiviral defenses. Toxicol Appl Pharmacol 1993; 
121(2): 167-75. 
139. Tellabati A, Fernandes VE, Teichert F, et al. Acute exposure of mice to high-dose 
ultrafine carbon black decreases susceptibility to pneumococcal pneumonia. Part Fibre 
Toxicol 2010; 7: 30. 
140. Ramos C, Cisneros J, Gonzalez-Avila G, Becerril C, Ruiz V, Montano M. Increase of 
matrix metalloproteinases in woodsmoke-induced lung emphysema in guinea pigs. 
Inhal Toxicol 2009; 21(2): 119-32. 
141. Danielsen PH, Loft S, Jacobsen NR, et al. Oxidative stress, inflammation, and DNA 
damage in rats after intratracheal instillation or oral exposure to ambient air and wood 
smoke particulate matter. Toxicol Sci 2010; 118(2): 574-85. 
142. Halliwell B, Gutteridge J. Free Radicals in Biology and Medicine. Oxford: Oxford 
University Press; 1999. 
143. Valko M, Leibfritz D, Moncol J, Cronin MT, Mazur M, Telser J. Free radicals and 
antioxidants in normal physiological functions and human disease. Int J Biochem Cell Biol 
2007; 39(1): 44-84. 
144. Rahman I, Yang SR, Biswas SK. Current concepts of redox signaling in the lungs. 
Antioxid Redox Signal 2006; 8(3-4): 681-9. 
145. Mazzoli-Rocha F, Fernandes S, Einicker-Lamas M, Zin WA. Roles of oxidative stress in 
signaling and inflammation induced by particulate matter. Cell Biol Toxicol 2010; 26(5): 
481-98. 
146. Iles KE, Forman HJ. Macrophage signaling and respiratory burst. Immunol Res 2002; 
26(1-3): 95-105. 
147. Kirkham P. Oxidative stress and macrophage function: a failure to resolve the 
inflammatory response. Biochem Soc Trans 2007; 35(Pt 2): 284-7. 
148. Schafer FQ, Buettner GR. Redox environment of the cell as viewed through the redox 
state of the glutathione disulfide/glutathione couple. Free Radic Biol Med 2001; 30(11): 
1191-212. 
149. Thannickal VJ, Fanburg BL. Reactive oxygen species in cell signaling. Am J Physiol Lung 
Cell Mol Physiol 2000; 279(6): L1005-28. 
150. Forman HJ, Torres M. Reactive oxygen species and cell signaling: respiratory burst in 
macrophage signaling. Am J Respir Crit Care Med 2002; 166(12 Pt 2): S4-8. 
151. Martinovich GG, Cherenkevich SN, Sauer H. Intracellular redox state: towards 
quantitative description. Eur Biophys J 2005; 34(7): 937-42. 
152. Kelly FJ, Blomberg A, Frew A, Holgate ST, Sandstrom T. Antioxidant kinetics in lung 
lavage fluid following exposure of humans to nitrogen dioxide. Am J Respir Crit Care 
Med 1996; 154(6 Pt 1): 1700-5. 
153. Kirkinezos IG, Moraes CT. Reactive oxygen species and mitochondrial diseases. Semin 
Cell Dev Biol 2001; 12(6): 449-57. 
154. Hukkanen J, Pelkonen O, Hakkola J, Raunio H. Expression and regulation of xenobiotic-
metabolizing cytochrome P450 (CYP) enzymes in human lung. Crit Rev Toxicol 2002; 
32(5): 391-411. 
155. Test ST, Weiss SJ. Quantitative and temporal characterization of the extracellular H2O2 
pool generated by human neutrophils. J Biol Chem 1984; 259(1): 399-405. 
156. Chance B, Sies H, Boveris A. Hydroperoxide metabolism in mammalian organs. Physiol 
Rev 1979; 59(3): 527-605. 
157. Pechkovsky DV, Zissel G, Stamme C, et al. Human alveolar epithelial cells induce nitric 
oxide synthase-2 expression in alveolar macrophages. Eur Respir J 2002; 19(4): 672-83. 
158. Antonenkov VD, Grunau S, Ohlmeier S, Hiltunen JK. Peroxisomes are oxidative 
organelles. Antioxid Redox Signal 2010; 13(4): 525-37. 
159. Sheppard FR, Kelher MR, Moore EE, McLaughlin NJ, Banerjee A, Silliman CC. 
Structural organization of the neutrophil NADPH oxidase: phosphorylation and 
translocation during priming and activation. J Leukoc Biol 2005; 78(5): 1025-42. 
160. Sies H. Strategies of antioxidant defense. Eur J Biochem 1993; 215(2): 213-9. 
161. Szabo C, Ischiropoulos H, Radi R. Peroxynitrite: biochemistry, pathophysiology and 
development of therapeutics. Nat Rev Drug Discov 2007; 6(8): 662-80. 
162. Horton JK, Meredith MJ, Bend JR. Glutathione biosynthesis from sulfur-containing 
amino acids in enriched populations of Clara and type II cells and macrophages freshly 
isolated from rabbit lung. J Pharmacol Exp Ther 1987; 240(2): 376-80. 
163. Vogt MT, Thomas C, Vassallo CL, Basford RE, Gee JB. Glutathione-dependent 
peroxidative metabolism in the alveolar macrophage. J Clin Invest 1971; 50(2): 401-10. 
164. Li N, Wang M, Oberley TD, Sempf JM, Nel AE. Comparison of the pro-oxidative and 
proinflammatory effects of organic diesel exhaust particle chemicals in bronchial 
epithelial cells and macrophages. J Immunol 2002; 169(8): 4531-41. 
165. Dauletbaev N, Rickmann J, Viel K, Buhl R, Wagner TO, Bargon J. Glutathione in 
induced sputum of healthy individuals and patients with asthma. Thorax 2001; 56(1): 13-
8. 
166. Chang J, Jaeschke H, Randerath K. Effect of Ni(II) on tissue hydrogen peroxide content 
in mice as inferred from glutathione and glutathione disulfide measurements. Life Sci 
1994; 55(23): 1789-96. 
167. Kumar VH, Patel A, Swartz DD, et al. Exposure to supplemental oxygen and its effects 
on oxidative stress and antioxidant enzyme activity in term newborn lambs. Pediatr Res 
2010; 67(1): 66-71. 
168. Comhair SA, Thomassen MJ, Erzurum SC. Differential induction of extracellular 
glutathione peroxidase and nitric oxide synthase 2 in airways of healthy individuals 
exposed to 100% O(2) or cigarette smoke. Am J Respir Cell Mol Biol 2000; 23(3): 350-4. 
169. Deneke SM, Fanburg BL. Regulation of cellular glutathione. Am J Physiol 1989; 257(4 Pt 
1): L163-73. 
170. Cantin AM, North SL, Hubbard RC, Crystal RG. Normal alveolar epithelial lining fluid 
contains high levels of glutathione. J Appl Physiol 1987; 63(1): 152-7. 
171. Hanigan MH, Ricketts WA. Extracellular glutathione is a source of cysteine for cells that 
express gamma-glutamyl transpeptidase. Biochemistry 1993; 32(24): 6302-6. 
172. Jean JC, Liu Y, Joyce-Brady M. The importance of gamma-glutamyl transferase in lung 
glutathione homeostasis and antioxidant defense. Biofactors 2003; 17(1-4): 161-73. 
173. Jean JC, Liu Y, Brown LA, Marc RE, Klings E, Joyce-Brady M. Gamma-glutamyl 
transferase deficiency results in lung oxidant stress in normoxia. Am J Physiol Lung Cell 
Mol Physiol 2002; 283(4): L766-76. 
174. Seres T, Knickelbein RG, Warshaw JB, Johnston RB, Jr. The phagocytosis-associated 
respiratory burst in human monocytes is associated with increased uptake of 
glutathione. J Immunol 2000; 165(6): 3333-40. 
175. Rouzer CA, Scott WA, Griffith OW, Hamill AL, Cohn ZA. Glutathione metabolism in 
resting and phagocytizing peritoneal macrophages. J Biol Chem 1982; 257(4): 2002-8. 
176. Seelig GF, Simondsen RP, Meister A. Reversible dissociation of gamma-
glutamylcysteine synthetase into two subunits. J Biol Chem 1984; 259(15): 9345-7. 
177. Comhair SA, Bhathena PR, Farver C, Thunnissen FB, Erzurum SC. Extracellular 
glutathione peroxidase induction in asthmatic lungs: evidence for redox regulation of 
expression in human airway epithelial cells. FASEB J 2001; 15(1): 70-8. 
178. Rahman I, Smith CA, Lawson MF, Harrison DJ, MacNee W. Induction of gamma-
glutamylcysteine synthetase by cigarette smoke is associated with AP-1 in human 
alveolar epithelial cells. FEBS Lett 1996; 396(1): 21-5. 
179. Takahashi Y, Oakes SM, Williams MC, Takahashi S, Miura T, Joyce-Brady M. Nitrogen 
dioxide exposure activates gamma-glutamyl transferase gene expression in rat lung. 
Toxicol Appl Pharmacol 1997; 143(2): 388-96. 
180. Lieberman MW, Wiseman AL, Shi ZZ, et al. Growth retardation and cysteine deficiency 
in gamma-glutamyl transpeptidase-deficient mice. Proc Natl Acad Sci U S A 1996; 93(15): 
7923-6. 
181. Jounblat R, Clark H, Eggleton P, Hawgood S, Andrew PW, Kadioglu A. The role of 
surfactant protein D in the colonisation of the respiratory tract and onset of bacteraemia 
during pneumococcal pneumonia. Respir Res 2005; 6: 126. 
182. Yang F, Coalson JJ, Bobb HH, Carter JD, Banu J, Ghio AJ. Resistance of 
hypotransferrinemic mice to hyperoxia-induced lung injury. Am J Physiol 1999; 277(6 Pt 
1): L1214-23. 
183. Pacht ER, Davis WB. Role of transferrin and ceruloplasmin in antioxidant activity of 
lung epithelial lining fluid. J Appl Physiol 1988; 64(5): 2092-9. 
184. Yang F, Friedrichs WE, deGraffenried L, et al. Cellular expression of ceruloplasmin in 
baboon and mouse lung during development and inflammation. Am J Respir Cell Mol 
Biol 1996; 14(2): 161-9. 
185. Cantin AM, Fells GA, Hubbard RC, Crystal RG. Antioxidant macromolecules in the 
epithelial lining fluid of the normal human lower respiratory tract. J Clin Invest 1990; 
86(3): 962-71. 
186. Skoza L, Snyder A, Kikkawa Y. Ascorbic acid in bronchoalveolar wash. Lung 1983; 
161(2): 99-109. 
187. Nowak D, Piasecka G, Antczak A, Pietras T. Effect of ascorbic acid on hydroxyl radical 
generation by chemical, enzymatic and cellular systems. Importance for antioxidant 
prevention of pulmonary emphysema. Biomed Biochim Acta 1991; 50(3): 265-72. 
188. May JM, Huang J, Qu ZC. Macrophage uptake and recycling of ascorbic acid: response 
to activation by lipopolysaccharide. Free Radic Biol Med 2005; 39(11): 1449-59. 
189. Stocker R, Yamamoto Y, McDonagh AF, Glazer AN, Ames BN. Bilirubin is an 
antioxidant of possible physiological importance. Science 1987; 235(4792): 1043-6. 
190. Sun G, Crissman K, Norwood J, Richards J, Slade R, Hatch GE. Oxidative interactions of 
synthetic lung epithelial lining fluid with metal-containing particulate matter. Am J 
Physiol Lung Cell Mol Physiol 2001; 281(4): L807-15. 
191. Zelko IN, Mariani TJ, Folz RJ. Superoxide dismutase multigene family: a comparison of 
the CuZn-SOD (SOD1), Mn-SOD (SOD2), and EC-SOD (SOD3) gene structures, 
evolution, and expression. Free Radic Biol Med 2002; 33(3): 337-49. 
192. Rister M, Baehner RL. A comparative study of superoxide dismutase activity in 
polymorphonuclear leukocytes, monocytes, and alveolar macrophages of the guinea pig. 
J Cell Physiol 1976; 87(3): 345-55. 
193. Kim H, Morimoto Y, Ogami A, et al. Differential expression of EC-SOD, Mn-SOD and 
CuZn-SOD in rat lung exposed to crystalline silica. Journal of occupational health 2007; 
49(3): 242-8. 
194. Smith LJ, Shamsuddin M, Sporn PH, Denenberg M, Anderson J. Reduced superoxide 
dismutase in lung cells of patients with asthma. Free Radic Biol Med 1997; 22(7): 1301-7. 
195. Flohe L, Brand I. Kinetics of glutathione peroxidase. Biochim Biophys Acta 1969; 191(3): 
541-9. 
196. Ogura Y. Catalase activity at high concentration of hydrogen peroxide. Arch Biochem 
Biophys 1955; 57(2): 288-300. 
197. Haugen TS, Skjonsberg OH, Kahler H, Lyberg T. Production of oxidants in alveolar 
macrophages and blood leukocytes. Eur Respir J 1999; 14(5): 1100-5. 
198. Pietarinen-Runtti P, Lakari E, Raivio KO, Kinnula VL. Expression of antioxidant 
enzymes in human inflammatory cells. Am J Physiol Cell Physiol 2000; 278(1): C118-25. 
199. Asayama K, Yokota S, Dobashi K, et al. Immunolocalization of cellular glutathione 
peroxidase in adult rat lungs and quantitative analysis after postembedding 
immunogold labeling. Histochem Cell Biol 1996; 105(5): 383-9. 
200. Arthur JR. The glutathione peroxidases. Cellular and molecular life sciences : CMLS 2000; 
57(13-14): 1825-35. 
201. Serfass RE, Ganther HE. Effects of dietary selenium and tocopherol on glutathione 
peroxidase and superoxide dismutase activities in rat phagocytes. Life Sci 1976; 19(8): 
1139-44. 
202. Sies H, Sharov VS, Klotz LO, Briviba K. Glutathione peroxidase protects against 
peroxynitrite-mediated oxidations. A new function for selenoproteins as peroxynitrite 
reductase. J Biol Chem 1997; 272(44): 27812-7. 
203. Chiba N, Imai H, Narashima K, et al. Cellular glutathione peroxidase as a predominant 
scavenger of hydroperoxyeicosatetraenoic acids in rabbit alveolar macrophages. Biol 
Pharm Bull 1999; 22(10): 1047-51. 
204. Avissar N, Finkelstein JN, Horowitz S, et al. Extracellular glutathione peroxidase in 
human lung epithelial lining fluid and in lung cells. Am J Physiol 1996; 270(2 Pt 1): L173-
82. 
205. El-Chemaly S, Salathe M, Baier S, Conner GE, Forteza R. Hydrogen peroxide-
scavenging properties of normal human airway secretions. Am J Respir Crit Care Med 
2003; 167(3): 425-30. 
206. Comhair SA, Erzurum SC. The regulation and role of extracellular glutathione 
peroxidase. Antioxid Redox Signal 2005; 7(1-2): 72-9. 
207. Bjornstedt M, Xue J, Huang W, Akesson B, Holmgren A. The thioredoxin and 
glutaredoxin systems are efficient electron donors to human plasma glutathione 
peroxidase. J Biol Chem 1994; 269(47): 29382-4. 
208. Lei XG, Evenson JK, Thompson KM, Sunde RA. Glutathione peroxidase and 
phospholipid hydroperoxide glutathione peroxidase are differentially regulated in rats 
by dietary selenium. J Nutr 1995; 125(6): 1438-46. 
209. Imai H, Nakagawa Y. Biological significance of phospholipid hydroperoxide 
glutathione peroxidase (PHGPx, GPx4) in mammalian cells. Free Radic Biol Med 2003; 
34(2): 145-69. 
210. Carter AB, Tephly LA, Venkataraman S, et al. High levels of catalase and glutathione 
peroxidase activity dampen H2O2 signaling in human alveolar macrophages. Am J 
Respir Cell Mol Biol 2004; 31(1): 43-53. 
211. Watson WH, Yang X, Choi YE, Jones DP, Kehrer JP. Thioredoxin and its role in 
toxicology. Toxicol Sci 2004; 78(1): 3-14. 
212. Maestrelli P, El Messlemani AH, De Fina O, et al. Increased expression of heme 
oxygenase (HO)-1 in alveolar spaces and HO-2 in alveolar walls of smokers. Am J Respir 
Crit Care Med 2001; 164(8 Pt 1): 1508-13. 
213. Li N, Venkatesan MI, Miguel A, et al. Induction of heme oxygenase-1 expression in 
macrophages by diesel exhaust particle chemicals and quinones via the antioxidant-
responsive element. J Immunol 2000; 165(6): 3393-401. 
214. Ferris CD, Jaffrey SR, Sawa A, et al. Haem oxygenase-1 prevents cell death by regulating 
cellular iron. Nat Cell Biol 1999; 1(3): 152-7. 
215. Li N, Sioutas C, Cho A, et al. Ultrafine particulate pollutants induce oxidative stress and 
mitochondrial damage. Environ Health Perspect 2003; 111(4): 455-60. 
216. Schins RP, Lightbody JH, Borm PJ, Shi T, Donaldson K, Stone V. Inflammatory effects of 
coarse and fine particulate matter in relation to chemical and biological constituents. 
Toxicol Appl Pharmacol 2004; 195(1): 1-11. 
217. Ghio AJ, Suliman HB, Carter JD, Abushamaa AM, Folz RJ. Overexpression of 
extracellular superoxide dismutase decreases lung injury after exposure to oil fly ash. 
Am J Physiol Lung Cell Mol Physiol 2002; 283(1): L211-8. 
218. Dales R, Miller D, Ruest K, Guay M, Judek S. Airborne endotoxin is associated with 
respiratory illness in the first 2 years of life. Environ Health Perspect 2006; 114(4): 610-4. 
219. Ndengele MM, Muscoli C, Wang ZQ, Doyle TM, Matuschak GM, Salvemini D. 
Superoxide potentiates NF-kappaB activation and modulates endotoxin-induced 
cytokine production in alveolar macrophages. Shock 2005; 23(2): 186-93. 
220. Li XY, Gilmour PS, Donaldson K, MacNee W. In vivo and in vitro proinflammatory 
effects of particulate air pollution (PM10). Environ Health Perspect 1997; 105 Suppl 5: 
1279-83. 
221. Pradhan A, Waseem M, Dogra S, Khanna AK, Kaw JL. Alterations in bronchoalveolar 
lavage constituents, oxidant/antioxidant status, and lung histology following 
intratracheal instillation of respirable suspended particulate matter. J Environ Pathol 
Toxicol Oncol 2005; 24(1): 19-32. 
222. Norwood J, Jr., Ledbetter AD, Doerfler DL, Hatch GE. Residual oil fly ash inhalation in 
guinea pigs: influence of absorbate and glutathione depletion. Toxicol Sci 2001; 61(1): 
144-53. 
223. Al-Humadi NH, Siegel PD, Lewis DM, et al. Alteration of intracellular cysteine and 
glutathione levels in alveolar macrophages and lymphocytes by diesel exhaust particle 
exposure. Environ Health Perspect 2002; 110(4): 349-53. 
224. Arif JM, Khan SG, Ahmad I, Joshi LD, Rahman Q. Effect of kerosene and its soot on the 
chrysotile-mediated toxicity to the rat alveolar macrophages. Environ Res 1997; 72(2): 
151-61. 
225. Wilson MR, Lightbody JH, Donaldson K, Sales J, Stone V. Interactions between ultrafine 
particles and transition metals in vivo and in vitro. Toxicol Appl Pharmacol 2002; 184(3): 
172-9. 
226. Zhong CY, Zhou YM, Smith KR, et al. Oxidative injury in the lungs of neonatal rats 
following short-term exposure to ultrafine iron and soot particles. J Toxicol Environ 
Health A 2010; 73(12): 837-47. 
227. Zhou YM, Zhong CY, Kennedy IM, Leppert VJ, Pinkerton KE. Oxidative stress and 
NFkappaB activation in the lungs of rats: a synergistic interaction between soot and iron 
particles. Toxicol Appl Pharmacol 2003; 190(2): 157-69. 
228. Sehlstedt M, Dove R, Boman C, et al. Antioxidant airway responses following 
experimental exposure to wood smoke in man. Part Fibre Toxicol 2010; 7: 21. 
229. Rhoden CR, Ghelfi E, Gonzalez-Flecha B. Pulmonary inflammation by ambient air 
particles is mediated by superoxide anion. Inhal Toxicol 2008; 20(1): 11-5. 
230. Rouse RL, Murphy G, Boudreaux MJ, Paulsen DB, Penn AL. Soot nanoparticles promote 
biotransformation, oxidative stress, and inflammation in murine lungs. Am J Respir Cell 
Mol Biol 2008; 39(2): 198-207. 
231. Van Winkle LS, Chan JK, Anderson DS, et al. Age specific responses to acute inhalation 
of diffusion flame soot particles: cellular injury and the airway antioxidant response. 
Inhal Toxicol 2010; 22 Suppl 2: 70-83. 
232. Wallenborn JG, Schladweiler MC, Nyska A, et al. Cardiopulmonary responses of Wistar 
Kyoto, spontaneously hypertensive, and stroke-prone spontaneously hypertensive rats 
to particulate matter (PM) exposure. J Toxicol Environ Health A 2007; 70(22): 1912-22. 
233. Sagai M, Saito H, Ichinose T, Kodama M, Mori Y. Biological effects of diesel exhaust 
particles. I. In vitro production of superoxide and in vivo toxicity in mouse. Free Radic 
Biol Med 1993; 14(1): 37-47. 
234. Sunil VR, Patel KJ, Mainelis G, et al. Pulmonary effects of inhaled diesel exhaust in aged 
mice. Toxicol Appl Pharmacol 2009; 241(3): 283-93. 
235. Rengasamy A, Barger MW, Kane E, Ma JK, Castranova V, Ma JY. Diesel exhaust 
particle-induced alterations of pulmonary phase I and phase II enzymes of rats. J Toxicol 
Environ Health A 2003; 66(2): 153-67. 
236. Olker C, Siese A, Stumpf S, Muller B, Gemsa D, Garn H. Impaired superoxide radical 
production by bronchoalveolar lavage cells from NO(2)-exposed rats. Free Radic Biol 
Med 2004; 37(7): 977-87. 
237. van Bree L, Rietjens I, Alink GM, Dormans J, Marra M, Rombout P. Biochemical and 
morphological changes in lung tissue and isolated lung cells of rats induced by short-
term nitrogen dioxide exposure. Hum Exp Toxicol 2000; 19(7): 392-401. 
238. Danielsen PH, Moller P, Jensen KA, et al. Oxidative stress, DNA damage, and 
inflammation induced by ambient air and wood smoke particulate matter in human 
A549 and THP-1 cell lines. Chem Res Toxicol 2011; 24(2): 168-84. 
239. Mondal K, Stephen Haskill J, Becker S. Adhesion and pollution particle-induced oxidant 
generation is neither necessary nor sufficient for cytokine induction in human alveolar 
macrophages. Am J Respir Cell Mol Biol 2000; 22(2): 200-8. 
240. Kaul N, Forman HJ. Activation of NF kappa B by the respiratory burst of macrophages. 
Free Radic Biol Med 1996; 21(3): 401-5. 
241. Rojanasakul Y, Ye J, Chen F, et al. Dependence of NF-kappaB activation and free radical 
generation on silica-induced TNF-alpha production in macrophages. Mol Cell Biochem 
1999; 200(1-2): 119-25. 
242. Gozal E, Forman HJ, Torres M. ADP stimulates the respiratory burst without activation 
of ERK and AKT in rat alveolar macrophages. Free Radic Biol Med 2001; 31(5): 679-87. 
243. Kobzik L. Lung macrophage uptake of unopsonized environmental particulates. Role of 
scavenger-type receptors. J Immunol 1995; 155(1): 367-76. 
244. Kobzik L, Godleski JJ, Brain JD. Oxidative metabolism in the alveolar macrophage: 
analysis by flow cytometry. J Leukoc Biol 1990; 47(4): 295-303. 
245. Persson HL, Vainikka LK. TNF-alpha preserves lysosomal stability in macrophages: a 
potential defense against oxidative lung injury. Toxicol Lett 2010; 192(2): 261-7. 
246. Kinnula VL. Focus on antioxidant enzymes and antioxidant strategies in smoking 
related airway diseases. Thorax 2005; 60(8): 693-700. 
247. Li N, Nel AE. Role of the Nrf2-mediated signaling pathway as a negative regulator of 
inflammation: implications for the impact of particulate pollutants on asthma. Antioxid 
Redox Signal 2006; 8(1-2): 88-98. 
248. Cho HY, Reddy SP, Kleeberger SR. Nrf2 defends the lung from oxidative stress. Antioxid 
Redox Signal 2006; 8(1-2): 76-87. 
249. Lin W, Wu RT, Wu T, Khor TO, Wang H, Kong AN. Sulforaphane suppressed LPS-
induced inflammation in mouse peritoneal macrophages through Nrf2 dependent 
pathway. Biochem Pharmacol 2008; 76(8): 967-73. 
250. Lei XG, Cheng WH, McClung JP. Metabolic regulation and function of glutathione 
peroxidase-1. Annu Rev Nutr 2007; 27: 41-61. 
251. Zamamiri-Davis F, Lu Y, Thompson JT, et al. Nuclear factor-kappaB mediates over-
expression of cyclooxygenase-2 during activation of RAW 264.7 macrophages in 
selenium deficiency. Free Radic Biol Med 2002; 32(9): 890-7. 
252. Duong C, Seow HJ, Bozinovski S, Crack PJ, Anderson GP, Vlahos R. Glutathione 
peroxidase-1 protects against cigarette smoke-induced lung inflammation in mice. Am J 
Physiol Lung Cell Mol Physiol 2010; 299(3): L425-33. 
253. Long H, Shi T, Borm PJ, et al. ROS-mediated TNF-alpha and MIP-2 gene expression in 
alveolar macrophages exposed to pine dust. Part Fibre Toxicol 2004; 1(1): 3. 
254. Tollefson AK, Oberley-Deegan RE, Butterfield KT, et al. Endogenous enzymes (NOX 
and ECSOD) regulate smoke-induced oxidative stress. Free Radic Biol Med 2010; 49(12): 
1937-46. 
255. Brown DM, Donaldson K, Borm PJ, et al. Calcium and ROS-mediated activation of 
transcription factors and TNF-alpha cytokine gene expression in macrophages exposed 
to ultrafine particles. Am J Physiol Lung Cell Mol Physiol 2004; 286(2): L344-53. 
256. Brown DM, Hutchison L, Donaldson K, Stone V. The effects of PM10 particles and 
oxidative stress on macrophages and lung epithelial cells: modulating effects of calcium-
signaling antagonists. Am J Physiol Lung Cell Mol Physiol 2007; 292(6): L1444-51. 
257. Soukup JM, Becker S. Human alveolar macrophage responses to air pollution 
particulates are associated with insoluble components of coarse material, including 
particulate endotoxin. Toxicol Appl Pharmacol 2001; 171(1): 20-6. 
258. Donaldson K, Stone V, Borm PJ, et al. Oxidative stress and calcium signaling in the 
adverse effects of environmental particles (PM10). Free Radic Biol Med 2003; 34(11): 1369-
82. 
259. Delacourt C, d'Ortho MP, Macquin-Mavier I, et al. Oxidant-antioxidant balance in 
alveolar macrophages from newborn rats. Eur Respir J 1996; 9(12): 2517-24. 
260. Harvey CJ, Thimmulappa RK, Singh A, et al. Nrf2-regulated glutathione recycling 
independent of biosynthesis is critical for cell survival during oxidative stress. Free Radic 
Biol Med 2009; 46(4): 443-53. 
261. Bass R, Ruddock LW, Klappa P, Freedman RB. A major fraction of endoplasmic 
reticulum-located glutathione is present as mixed disulfides with protein. J Biol Chem 
2004; 279(7): 5257-62. 
262. Seres T, Ravichandran V, Moriguchi T, Rokutan K, Thomas JA, Johnston RB, Jr. Protein 
S-thiolation and dethiolation during the respiratory burst in human monocytes. A 
reversible post-translational modification with potential for buffering the effects of 
oxidant stress. J Immunol 1996; 156(5): 1973-80. 
263. Pineda-Molina E, Klatt P, Vazquez J, et al. Glutathionylation of the p50 subunit of NF-
kappaB: a mechanism for redox-induced inhibition of DNA binding. Biochemistry 2001; 
40(47): 14134-42. 
264. Klatt P, Molina EP, De Lacoba MG, et al. Redox regulation of c-Jun DNA binding by 
reversible S-glutathiolation. FASEB J 1999; 13(12): 1481-90. 
265. Hoppe G, Chai YC, Crabb JW, Sears J. Protein s-glutathionylation in retinal pigment 
epithelium converts heat shock protein 70 to an active chaperone. Exp Eye Res 2004; 
78(6): 1085-92. 
266. Vangheluwe P, Raeymaekers L, Dode L, Wuytack F. Modulating sarco(endo)plasmic 
reticulum Ca2+ ATPase 2 (SERCA2) activity: cell biological implications. Cell Calcium 
2005; 38(3-4): 291-302. 
267. Schroeder BO, Wu Z, Nuding S, et al. Reduction of disulphide bonds unmasks potent 
antimicrobial activity of human beta-defensin 1. Nature 2011; 469(7330): 419-23. 
268. Staal FJ, Roederer M, Herzenberg LA. Intracellular thiols regulate activation of nuclear 
factor kappa B and transcription of human immunodeficiency virus. Proc Natl Acad Sci 
U S A 1990; 87(24): 9943-7. 
269. Yin Z, Ivanov VN, Habelhah H, Tew K, Ronai Z. Glutathione S-transferase p elicits 
protection against H2O2-induced cell death via coordinated regulation of stress kinases. 
Cancer Res 2000; 60(15): 4053-7. 
270. Reynaert NL, van der Vliet A, Guala AS, et al. Dynamic redox control of NF-kappaB 
through glutaredoxin-regulated S-glutathionylation of inhibitory kappaB kinase beta. 
Proc Natl Acad Sci U S A 2006; 103(35): 13086-91. 
271. Aesif SW, Kuipers I, Anathy V, et al. Ablation of Glutaredoxin-1 Attenuates 
Lipopolysaccharide-Induced Lung Inflammation and Alveolar Macrophage Activation. 
Am J Respir Cell Mol Biol 2010. 
272. Giustarini D, Rossi R, Milzani A, Colombo R, Dalle-Donne I. S-glutathionylation: from 
redox regulation of protein functions to human diseases. J Cell Mol Med 2004; 8(2): 201-
12. 
273. Gallogly MM, Mieyal JJ. Mechanisms of reversible protein glutathionylation in redox 
signaling and oxidative stress. Curr Opin Pharmacol 2007; 7(4): 381-91. 
274. Gloire G, Piette J. Redox regulation of nuclear post-translational modifications during 
NF-kappaB activation. Antioxid Redox Signal 2009; 11(9): 2209-22. 
275. Oliveira-Marques V, Marinho HS, Cyrne L, Antunes F. Role of hydrogen peroxide in 
NF-kappaB activation: from inducer to modulator. Antioxid Redox Signal 2009; 11(9): 
2223-43. 
276. Pepperl S, Dorger M, Ringel F, Kupatt C, Krombach F. Hyperoxia upregulates the NO 
pathway in alveolar macrophages in vitro: role of AP-1 and NF-kappaB. Am J Physiol 
Lung Cell Mol Physiol 2001; 280(5): L905-13. 
277. Monick MM, Carter AB, Hunninghake GW. Human alveolar macrophages are 
markedly deficient in REF-1 and AP-1 DNA binding activity. J Biol Chem 1999; 274(25): 
18075-80. 
278. Schenk H, Klein M, Erdbrugger W, Droge W, Schulze-Osthoff K. Distinct effects of 
thioredoxin and antioxidants on the activation of transcription factors NF-kappa B and 
AP-1. Proc Natl Acad Sci U S A 1994; 91(5): 1672-6. 
279. Suzuki YJ, Forman HJ, Sevanian A. Oxidants as stimulators of signal transduction. Free 
Radic Biol Med 1997; 22(1-2): 269-85. 
280. Liu H, Zhang H, Iles KE, et al. The ADP-stimulated NADPH oxidase activates the ASK-
1/MKK4/JNK pathway in alveolar macrophages. Free Radic Res 2006; 40(8): 865-74. 
281. Bindoli A, Fukuto JM, Forman HJ. Thiol chemistry in peroxidase catalysis and redox 
signaling. Antioxid Redox Signal 2008; 10(9): 1549-64. 
282. Arner ES, Holmgren A. Physiological functions of thioredoxin and thioredoxin 
reductase. Eur J Biochem 2000; 267(20): 6102-9. 
283. Iversen R, Andersen PA, Jensen KS, Winther JR, Sigurskjold BW. Thiol-disulfide 
exchange between glutaredoxin and glutathione. Biochemistry 2010; 49(4): 810-20. 
284. Peltoniemi M, Kaarteenaho-Wiik R, Saily M, et al. Expression of glutaredoxin is highly 
cell specific in human lung and is decreased by transforming growth factor-beta in vitro 
and in interstitial lung diseases in vivo. Hum Pathol 2004; 35(8): 1000-7. 
285. Sekhar KR, Rachakonda G, Freeman ML. Cysteine-based regulation of the CUL3 
adaptor protein Keap1. Toxicol Appl Pharmacol 2010; 244(1): 21-6. 
286. Yamamoto T, Suzuki T, Kobayashi A, et al. Physiological significance of reactive 
cysteine residues of Keap1 in determining Nrf2 activity. Mol Cell Biol 2008; 28(8): 2758-70. 
287. Huang HC, Nguyen T, Pickett CB. Phosphorylation of Nrf2 at Ser-40 by protein kinase 
C regulates antioxidant response element-mediated transcription. J Biol Chem 2002; 
277(45): 42769-74. 
288. Cho HY, Reddy SP, Debiase A, Yamamoto M, Kleeberger SR. Gene expression profiling 
of NRF2-mediated protection against oxidative injury. Free Radic Biol Med 2005; 38(3): 
325-43. 
289. Erickson AM, Nevarea Z, Gipp JJ, Mulcahy RT. Identification of a variant antioxidant 
response element in the promoter of the human glutamate-cysteine ligase modifier 
subunit gene. Revision of the ARE consensus sequence. J Biol Chem 2002; 277(34): 30730-
7. 
290. Sasaki H, Sato H, Kuriyama-Matsumura K, et al. Electrophile response element-
mediated induction of the cystine/glutamate exchange transporter gene expression. J 
Biol Chem 2002; 277(47): 44765-71. 
291. Singh A, Rangasamy T, Thimmulappa RK, et al. Glutathione peroxidase 2, the major 
cigarette smoke-inducible isoform of GPX in lungs, is regulated by Nrf2. Am J Respir Cell 
Mol Biol 2006; 35(6): 639-50. 
292. Leonard MO, Kieran NE, Howell K, et al. Reoxygenation-specific activation of the 
antioxidant transcription factor Nrf2 mediates cytoprotective gene expression in 
ischemia-reperfusion injury. FASEB J 2006; 20(14): 2624-6. 
293. Kobayashi M, Yamamoto M. Nrf2-Keap1 regulation of cellular defense mechanisms 
against electrophiles and reactive oxygen species. Adv Enzyme Regul 2006; 46: 113-40. 
294. Cho HY, Jedlicka AE, Reddy SP, et al. Role of NRF2 in protection against hyperoxic lung 
injury in mice. Am J Respir Cell Mol Biol 2002; 26(2): 175-82. 
295. Ishii Y, Itoh K, Morishima Y, et al. Transcription factor Nrf2 plays a pivotal role in 
protection against elastase-induced pulmonary inflammation and emphysema. J 
Immunol 2005; 175(10): 6968-75. 
296. Thimmulappa RK, Lee H, Rangasamy T, et al. Nrf2 is a critical regulator of the innate 
immune response and survival during experimental sepsis. J Clin Invest 2006; 116(4): 
984-95. 
297. Lee HR, Cho JM, Shin DH, et al. Adaptive response to GSH depletion and resistance to 
L-buthionine-(S,R)-sulfoximine: involvement of Nrf2 activation. Mol Cell Biochem 2008; 
318(1-2): 23-31. 
298. Harvey CJ, Thimmulappa RK, Sethi S, et al. Nrf2-dependent Immunomodulation By 
Sulforaphane Improves Bacterial Phagocytosis In COPD Macrophages And Inhibits 
Bacterial Burden And Inflammation In Cigarette Smoke-exposed Mice. Am J Respir Crit 
Care Med 2010; 181(1_MeetingAbstracts): A3828-. 
299. Yang H, Magilnick N, Lee C, et al. Nrf1 and Nrf2 regulate rat glutamate-cysteine ligase 
catalytic subunit transcription indirectly via NF-kappaB and AP-1. Mol Cell Biol 2005; 
25(14): 5933-46. 
300. Goven D, Boutten A, Lecon-Malas V, Boczkowski J, Bonay M. Prolonged cigarette 
smoke exposure decreases heme oxygenase-1 and alters Nrf2 and Bach1 expression in 
human macrophages: roles of the MAP kinases ERK(1/2) and JNK. FEBS Lett 2009; 
583(21): 3508-18. 
301. Muller L, Riediker M, Wick P, Mohr M, Gehr P, Rothen-Rutishauser B. Oxidative stress 
and inflammation response after nanoparticle exposure: differences between human 
lung cell monocultures and an advanced three-dimensional model of the human 
epithelial airways. J R Soc Interface 2010; 7 Suppl 1: S27-40. 
302. Victor VM, Rocha M, De la Fuente M. Regulation of macrophage function by the 
antioxidant N-acetylcysteine in mouse-oxidative stress by endotoxin. Int 
Immunopharmacol 2003; 3(1): 97-106. 
303. Antonicelli F, Brown D, Parmentier M, et al. Regulation of LPS-mediated inflammation 
in vivo and in vitro by the thiol antioxidant Nacystelyn. Am J Physiol Lung Cell Mol 
Physiol 2004; 286(6): L1319-27. 
304. Gosset P, Wallaert B, Tonnel AB, Fourneau C. Thiol regulation of the production of 
TNF-alpha, IL-6 and IL-8 by human alveolar macrophages. Eur Respir J 1999; 14(1): 98-
105. 
305. Xiao GG, Wang M, Li N, Loo JA, Nel AE. Use of proteomics to demonstrate a 
hierarchical oxidative stress response to diesel exhaust particle chemicals in a 
macrophage cell line. J Biol Chem 2003; 278(50): 50781-90. 
306. Cuschieri J, Maier RV. Oxidative stress, lipid rafts, and macrophage reprogramming. 
Antioxid Redox Signal 2007; 9(9): 1485-97. 
307. Ceylan E, Kocyigit A, Gencer M, Aksoy N, Selek S. Increased DNA damage in patients 
with chronic obstructive pulmonary disease who had once smoked or been exposed to 
biomass. Respir Med 2006; 100(7): 1270-6. 
308. Erridge C, Kennedy S, Spickett CM, Webb DJ. Oxidized phospholipid inhibition of toll-
like receptor (TLR) signaling is restricted to TLR2 and TLR4: roles for CD14, LPS-
binding protein, and MD2 as targets for specificity of inhibition. J Biol Chem 2008; 
283(36): 24748-59. 
309. Kagan VE, Borisenko GG, Serinkan BF, et al. Appetizing rancidity of apoptotic cells for 
macrophages: oxidation, externalization, and recognition of phosphatidylserine. Am J 
Physiol Lung Cell Mol Physiol 2003; 285(1): L1-17. 
310. Risom L, Moller P, Loft S. Oxidative stress-induced DNA damage by particulate air 
pollution. Mutat Res 2005; 592(1-2): 119-37. 
311. Mehta M, Chen LC, Gordon T, Rom W, Tang MS. Particulate matter inhibits DNA 
repair and enhances mutagenesis. Mutat Res 2008; 657(2): 116-21. 
312. Pittet LA, Quinton LJ, Yamamoto K, et al. Earliest Innate Immune Responses Require 
Macrophage RelA during Pneumococcal Pneumonia. Am J Respir Cell Mol Biol 2011. 
313. Drost EM, Skwarski KM, Sauleda J, et al. Oxidative stress and airway inflammation in 
severe exacerbations of COPD. Thorax 2005; 60(4): 293-300. 
314. Kariya C, Chu HW, Huang J, Leitner H, Martin RJ, Day BJ. Mycoplasma pneumoniae 
infection and environmental tobacco smoke inhibit lung glutathione adaptive responses 
and increase oxidative stress. Infect Immun 2008; 76(10): 4455-62. 
315. Brown LA, Ping XD, Harris FL, Gauthier TW. Glutathione availability modulates 
alveolar macrophage function in the chronic ethanol-fed rat. Am J Physiol Lung Cell Mol 
Physiol 2007; 292(4): L824-32. 
316. Gutierrez P, Closa D, Piner R, Bulbena O, Menendez R, Torres A. Macrophage 
activation in exacerbated COPD with and without community-acquired pneumonia. Eur 
Respir J 2010; 36(2): 285-91. 
317. Harvey CJ, Thimmulappa RK, Sethi S, et al. Targeting Nrf2 Signaling Improves Bacterial 
Clearance by Alveolar Macrophages in Patients with COPD and in a Mouse Model. Sci 
Transl Med 2011; 3(78): 78ra32. 
318. Mushtaq N, Ezzati M, Hall L, et al. Adhesion of Streptococcus pneumoniae to human 
airway epithelial cells exposed to urban particulate matter. J Allergy Clin Immunol 2011; 
127(5): 1236-42 e2. 
319. Haegens A, Heeringa P, van Suylen RJ, et al. Myeloperoxidase deficiency attenuates 
lipopolysaccharide-induced acute lung inflammation and subsequent cytokine and 
chemokine production. J Immunol 2009; 182(12): 7990-6. 
320. Leeper-Woodford SK, Detmer K. Acute hypoxia increases alveolar macrophage tumor 
necrosis factor activity and alters NF-kappaB expression. Am J Physiol 1999; 276(6 Pt 1): 
L909-16. 
321. Cemek M, Caksen H, Bayiroglu F, Cemek F, Dede S. Oxidative stress and enzymic-non-
enzymic antioxidant responses in children with acute pneumonia. Cell Biochem Funct 
2006; 24(3): 269-73. 
322. Umeki S, Sumi M, Niki Y, Soejima R. Concentrations of superoxide dismutase and 
superoxide anion in blood of patients with respiratory infections and compromised 
immune systems. Clin Chem 1987; 33(12): 2230-3. 
323. Velasquez-Melendez G, Okani ET, Kiertsman B, Roncada MJ. Vitamin A status in 
children with pneumonia. Eur J Clin Nutr 1995; 49(5): 379-84. 
324. Vijayamalini M, Manoharan S. Lipid peroxidation, vitamins C, E and reduced 
glutathione levels in patients with pulmonary tuberculosis. Cell Biochem Funct 2004; 
22(1): 19-22. 
325. Suresh D, Annam V, Pratibha K, Hamsaveena. Immunological correlation of oxidative 
stress markers in tuberculosis patients. International Journal of Biological & Medical 
Research 2010; 1(4): 185-7. 
326. Duflo F, Debon R, Goudable J, Chassard D, Allaouchiche B. Alveolar and serum 
oxidative stress in ventilator-associated pneumonia. Br J Anaesth 2002; 89(2): 231-6. 
327. Thimmulappa RK, Scollick C, Traore K, et al. Nrf2-dependent protection from LPS 
induced inflammatory response and mortality by CDDO-Imidazolide. Biochem Biophys 
Res Commun 2006; 351(4): 883-9. 
328. Shi XL, Shi ZH, Huang H, Zhu HG, Zhou P, Ju D. Therapeutic effect of recombinant 
human catalase on H1N1 influenza-induced pneumonia in mice. Inflammation 2010; 
33(3): 166-72. 
329. Kagan VE, Gleiss B, Tyurina YY, et al. A role for oxidative stress in apoptosis: oxidation 
and externalization of phosphatidylserine is required for macrophage clearance of cells 
undergoing Fas-mediated apoptosis. J Immunol 2002; 169(1): 487-99. 
330. Sanmun D, Witasp E, Jitkaew S, et al. Involvement of a functional NADPH oxidase in 
neutrophils and macrophages during programmed cell clearance: implications for 
chronic granulomatous disease. Am J Physiol Cell Physiol 2009; 297(3): C621-31. 
331. Richens TR, Linderman DJ, Horstmann SA, et al. Cigarette smoke impairs clearance of 
apoptotic cells through oxidant-dependent activation of RhoA. Am J Respir Crit Care Med 
2009; 179(11): 1011-21. 
332. Moon C, Lee YJ, Park HJ, Chong YH, Kang JL. N-acetylcysteine inhibits RhoA and 
promotes apoptotic cell clearance during intense lung inflammation. Am J Respir Crit 
Care Med 2010; 181(4): 374-87. 
333. Roth DE, Richard SA, Black RE. Zinc supplementation for the prevention of acute lower 
respiratory infection in children in developing countries: meta-analysis and meta-
regression of randomized trials. Int J Epidemiol 2010; 39(3): 795-808. 
334. Hemila H, Louhiala P. Vitamin C for preventing and treating pneumonia. Cochrane 
Database Syst Rev 2007; (1): CD005532. 
335. Ni J, Wei J, Wu T. Vitamin A for non-measles pneumonia in children. Cochrane Database 
Syst Rev 2005; (3): CD003700. 
336. Manaseki-Holland S, Maroof Z, Bruce J, et al. Effect on the incidence of pneumonia of 
vitamin D supplementation by quarterly bolus dose to infants in Kabul: a randomised 
controlled superiority trial. Lancet 2012; 379(9824): 1419-27. 
337. Hemila H, Virtamo J, Albanes D, Kaprio J. Vitamin E and beta-carotene 
supplementation and hospital-treated pneumonia incidence in male smokers. Chest 
2004; 125(2): 557-65. 
338. Hemila H, Kaprio J. Vitamin E supplementation may transiently increase tuberculosis 
risk in males who smoke heavily and have high dietary vitamin C intake. Br J Nutr 2008; 
100(4): 896-902. 
339. Chao J, Donham P, van Rooijen N, Wood JG, Gonzalez NC. MCP-1/CCL2 Released from 
Alveolar Macrophages Mediates the Systemic Inflammation of Acute Alveolar Hypoxia. 
Am J Respir Cell Mol Biol 2010. 
340. Gonzalez NC, Allen J, Blanco VG, Schmidt EJ, van Rooijen N, Wood JG. Alveolar 
macrophages are necessary for the systemic inflammation of acute alveolar hypoxia. J 
Appl Physiol 2007; 103(4): 1386-94. 
341. Bunnell E, Pacht ER. Oxidized glutathione is increased in the alveolar fluid of patients 
with the adult respiratory distress syndrome. Am Rev Respir Dis 1993; 148(5): 1174-8. 
342. Imai Y, Kuba K, Neely GG, et al. Identification of oxidative stress and Toll-like receptor 
4 signaling as a key pathway of acute lung injury. Cell 2008; 133(2): 235-49. 
343. Moradi M, Mojtahedzadeh M, Mandegari A, et al. The role of glutathione-S-transferase 
polymorphisms on clinical outcome of ALI/ARDS patient treated with N-acetylcysteine. 
Respir Med 2009; 103(3): 434-41. 
344. Nathens AB, Neff MJ, Jurkovich GJ, et al. Randomized, prospective trial of antioxidant 
supplementation in critically ill surgical patients. Ann Surg 2002; 236(6): 814-22. 
345. Berger MM, Eggimann P, Heyland DK, et al. Reduction of nosocomial pneumonia after 
major burns by trace element supplementation: aggregation of two randomised trials. 
Crit Care 2006; 10(6): R153. 
346. Heavner DL, Morgan WT, Sears SB, Richardson JD, Byrd GD, Ogden MW. Effect of 
creatinine and specific gravity normalization techniques on xenobiotic biomarkers in 
smokers' spot and 24-h urines. J Pharm Biomed Anal 2006; 40(4): 928-42. 
347. Fullerton DG, Jere K, Jambo K, et al. Domestic smoke exposure is associated with 
alveolar macrophage particulate load. Trop Med Int Health 2009; 14(3): 349-54. 
348. Fullerton DG, Semple S, Kalambo F, et al. Biomass fuel use and indoor air pollution in 
homes in Malawi. Occup Environ Med 2009; 66(11): 777-83. 
349. Jambo KC, Sepako E, Fullerton DG, et al. Bronchoalveolar CD4+ T cell responses to 
respiratory antigens are impaired in HIV-infected adults. Thorax 2011; 66(5): 375-82. 
350. Mwandumba HC, Bertel Squire S, White SA, et al. Association between sputum smear 
status and local immune responses at the site of disease in HIV-infected patients with 
pulmonary tuberculosis. Tuberculosis 2008; 88(1): 58-63. 
351. British Thoracic Society guidelines on diagnostic flexible bronchoscopy. Thorax 2001; 56 
Suppl 1: i1-21. 
352. Anderson ME. Determination of glutathione and glutathione disulfide in biological 
samples. Methods Enzymol 1985; 113: 548-55. 
353. Tietze F. Enzymic method for quantitative determination of nanogram amounts of total 
and oxidized glutathione: applications to mammalian blood and other tissues. Anal 
Biochem 1969; 27(3): 502-22. 
354. Delves HT, Sieniawska CE. Simple Method for the Accurate Determination of Selenium 
in Serum by Using Inductively Coupled Plasma Mass Spectrometry. Journal of Analytical 
Atomic Spectrometry 1997; 12(3): 387-9. 
355. Sieniawska CM, R. Delves, HT. Determination of total selenium in serum, whole blood 
and erythrocytes by ICP-MS. Journal of Analytical Atomic Spectometry 1999; 14: 109-12. 
356. Rouxel O, Ludden J, Carignan J, Marin L, Fouquet Y. Natural variations of Se isotopic 
composition determined by hydride generation multiple collector inductively coupled 
plasma mass spectrometry. Geochimica et Cosmochimica Acta 2002; 66(18): 3191-9. 
357. Lolmede K, Campana L, Vezzoli M, et al. Inflammatory and alternatively activated 
human macrophages attract vessel-associated stem cells, relying on separate HMGB1- 
and MMP-9-dependent pathways. J Leukoc Biol 2009; 85(5): 779-87. 
358. Benoit M, Desnues B, Mege JL. Macrophage polarization in bacterial infections. J 
Immunol 2008; 181(6): 3733-9. 
359. Mantovani A, Sica A, Sozzani S, Allavena P, Vecchi A, Locati M. The chemokine system 
in diverse forms of macrophage activation and polarization. Trends Immunol 2004; 
25(12): 677-86. 
360. Shaykhiev R, Krause A, Salit J, et al. Smoking-dependent reprogramming of alveolar 
macrophage polarization: implication for pathogenesis of chronic obstructive 
pulmonary disease. J Immunol 2009; 183(4): 2867-83. 
361. Fullerton DG. Indoor air pollution from biomass fuel smoke and its effects on 
respiratory health, in a population at risk of HIV related pneumonia. University of 
Liverpool: University of Liverpool; 2011. 
362. Scott JA, Hall AJ, Muyodi C, et al. Aetiology, outcome, and risk factors for mortality 
among adults with acute pneumonia in Kenya. Lancet 2000; 355(9211): 1225-30. 
363. Berry AM, Ogunniyi AD, Miller DC, Paton JC. Comparative virulence of Streptococcus 
pneumoniae strains with insertion-duplication, point, and deletion mutations in the 
pneumolysin gene. Infect Immun 1999; 67(2): 981-5. 
364. Miles AA, Misra SS, Irwin JO. The estimation of the bactericidal power of the blood. The 
Journal of hygiene 1938; 38(6): 732-49. 
365. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin 
phenol reagent. J Biol Chem 1951; 193(1): 265-75. 
366. Pomory CM. Color development time of the Lowry protein assay. Anal Biochem 2008; 
378(2): 216-7. 
367. Saville DJ. Basic statistics and the inconsistency of multiple comparison procedures. 
Canadian journal of experimental psychology = Revue canadienne de psychologie experimentale 
2003; 57(3): 167-75. 
368. Corradini D. Handbook of HPLC. 2nd ed. Boca Raton: Taylor & Francis; 2010. 
369. Gutteridge JM. Iron promoters of the Fenton reaction and lipid peroxidation can be 
released from haemoglobin by peroxides. FEBS Lett 1986; 201(2): 291-5. 
370. Gutteridge JM. Lipid peroxidation and antioxidants as biomarkers of tissue damage. 
Clin Chem 1995; 41(12 Pt 2): 1819-28. 
371. Fukunaga K, Yoshida M, Nakazono N. A simple, rapid, highly sensitive and 
reproducible quantification method for plasma malondialdehyde by high-performance 
liquid chromatography. Biomedical chromatography : BMC 1998; 12(5): 300-3. 
372. Chirico S. High-performance liquid chromatography-based thiobarbituric acid tests. 
Methods Enzymol 1994; 233: 314-8. 
373. Underhill C, Goldstein D, Gorbounova VA, et al. A randomized phase II trial of 
pemetrexed plus irinotecan (ALIRI) versus leucovorin-modulated 5-FU plus irinotecan 
(FOLFIRI) in first-line treatment of locally advanced or metastatic colorectal cancer. 
Oncology 2007; 73(1-2): 9-20. 
374. Kinchen JM, Ravichandran KS. Phagosome maturation: going through the acid test. 
Nature reviews Molecular cell biology 2008; 9(10): 781-95. 
375. VanderVen BC, Yates RM, Russell DG. Intraphagosomal measurement of the magnitude 
and duration of the oxidative burst. Traffic 2009; 10(4): 372-8. 
376. Hermanson GT. Bioconjugate techniques. San Diego: Academic Press; 1996. 
377. Villeneuve NF, Lau A, Zhang DD. Regulation of the Nrf2-Keap1 antioxidant response 
by the ubiquitin proteasome system: an insight into cullin-ring ubiquitin ligases. 
Antioxid Redox Signal 2010; 13(11): 1699-712. 
378. Theodore M, Kawai Y, Yang J, et al. Multiple nuclear localization signals function in the 
nuclear import of the transcription factor Nrf2. J Biol Chem 2008; 283(14): 8984-94. 
379. Kensler TW, Wakabayashi N, Biswal S. Cell survival responses to environmental 
stresses via the Keap1-Nrf2-ARE pathway. Annual review of pharmacology and toxicology 
2007; 47: 89-116. 
380. Copple IM. The keap1-nrf2 cell defense pathway - a promising therapeutic target? 
Advances in pharmacology 2012; 63: 43-79. 
381. Boyum A. Separation of leukocytes from blood and bone marrow. Introduction. 
Scandinavian journal of clinical and laboratory investigation Supplementum 1968; 97: 7. 
382. Yeo C, Saunders N, Locca D, et al. Ficoll-Paque versus Lymphoprep: a comparative 
study of two density gradient media for therapeutic bone marrow mononuclear cell 
preparations. Regenerative medicine 2009; 4(5): 689-96. 
383. Wahl LM, Wahl SM, Smythies LE, Smith PD. Isolation of human monocyte populations. 
Current protocols in immunology / edited by John E Coligan  [et al] 2006; Chapter 7: Unit 7 
6A. 
384. Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG. Research electronic data 
capture (REDCap)--a metadata-driven methodology and workflow process for 
providing translational research informatics support. Journal of biomedical informatics 
2009; 42(2): 377-81. 
385. Brehe JE, Burch HB. Enzymatic assay for glutathione. Anal Biochem 1976; 74(1): 189-97. 
386. Monostori P, Wittmann G, Karg E, Turi S. Determination of glutathione and glutathione 
disulfide in biological samples: an in-depth review. Journal of chromatography B, 
Analytical technologies in the biomedical and life sciences 2009; 877(28): 3331-46. 
387. Pankow W, Neumann K, Ruschoff J, von Wichert P. Human alveolar macrophages: 
comparison of cell size, autofluorescence, and HLA-DR antigen expression in smokers 
and nonsmokers. Cancer detection and prevention 1995; 19(3): 268-73. 
388. Landsman L, Jung S. Lung macrophages serve as obligatory intermediate between 
blood monocytes and alveolar macrophages. J Immunol 2007; 179(6): 3488-94. 
389. Vallejo CG, Lagunas R. Interferences by sulfhydryl, disulfide reagents and potassium 
ions on protein determination by Lowry's method. Anal Biochem 1970; 36(1): 207-12. 
390. Nielsen H. Isolation and functional activity of human blood monocytes after adherence 
to plastic surfaces: comparison of different detachment methods. Acta pathologica, 
microbiologica, et immunologica Scandinavica Section C, Immunology 1987; 95(2): 81-4. 
391. Aoshiba K, Yasuda K, Yasui S, Tamaoki J, Nagai A. Serine proteases increase oxidative 
stress in lung cells. Am J Physiol Lung Cell Mol Physiol 2001; 281(3): L556-64. 
392. Drummen GP, van Liebergen LC, Op den Kamp JA, Post JA. C11-BODIPY(581/591), an 
oxidation-sensitive fluorescent lipid peroxidation probe: (micro)spectroscopic 
characterization and validation of methodology. Free Radic Biol Med 2002; 33(4): 473-90. 
393. MacDonald ML, Murray IV, Axelsen PH. Mass spectrometric analysis demonstrates that 
BODIPY 581/591 C11 overestimates and inhibits oxidative lipid damage. Free Radic Biol 
Med 2007; 42(9): 1392-7. 
394. Crowther JE, Kutala VK, Kuppusamy P, et al. Pulmonary surfactant protein a inhibits 
macrophage reactive oxygen intermediate production in response to stimuli by 
reducing NADPH oxidase activity. J Immunol 2004; 172(11): 6866-74. 
395. Wardman P. Fluorescent and luminescent probes for measurement of oxidative and 
nitrosative species in cells and tissues: progress, pitfalls, and prospects. Free Radic Biol 
Med 2007; 43(7): 995-1022. 
396. Cathcart R, Schwiers E, Ames BN. Detection of picomole levels of hydroperoxides using 
a fluorescent dichlorofluorescein assay. Anal Biochem 1983; 134(1): 111-6. 
397. Kooy NW, Royall JA, Ischiropoulos H. Oxidation of 2',7'-dichlorofluorescin by 
peroxynitrite. Free Radic Res 1997; 27(3): 245-54. 
398. Brubacher JL, Bols NC. Chemically de-acetylated 2',7'-dichlorodihydrofluorescein 
diacetate as a probe of respiratory burst activity in mononuclear phagocytes. J Immunol 
Methods 2001; 251(1-2): 81-91. 
399. Imrich A, Ning YY, Kobzik L. Intracellular oxidant production and cytokine responses 
in lung macrophages: evaluation of fluorescent probes. J Leukoc Biol 1999; 65(4): 499-507. 
400. Benov L, Sztejnberg L, Fridovich I. Critical evaluation of the use of hydroethidine as a 
measure of superoxide anion radical. Free Radic Biol Med 1998; 25(7): 826-31. 
401. Rothe G, Valet G. Flow cytometric analysis of respiratory burst activity in phagocytes 
with hydroethidine and 2',7'-dichlorofluorescin. J Leukoc Biol 1990; 47(5): 440-8. 
402. Crow JP. Dichlorodihydrofluorescein and dihydrorhodamine 123 are sensitive 
indicators of peroxynitrite in vitro: implications for intracellular measurement of 
reactive nitrogen and oxygen species. Nitric oxide : biology and chemistry / official journal of 
the Nitric Oxide Society 1997; 1(2): 145-57. 
403. Elbim C, Lizard G. Flow cytometric investigation of neutrophil oxidative burst and 
apoptosis in physiological and pathological situations. Cytometry Part A : the journal of 
the International Society for Analytical Cytology 2009; 75(6): 475-81. 
404. Stolk J, Hiltermann TJ, Dijkman JH, Verhoeven AJ. Characteristics of the inhibition of 
NADPH oxidase activation in neutrophils by apocynin, a methoxy-substituted catechol. 
Am J Respir Cell Mol Biol 1994; 11(1): 95-102. 
405. Vejrazka M, Micek R, Stipek S. Apocynin inhibits NADPH oxidase in phagocytes but 
stimulates ROS production in non-phagocytic cells. Biochim Biophys Acta 2005; 1722(2): 
143-7. 
406. Riganti C, Costamagna C, Bosia A, Ghigo D. The NADPH oxidase inhibitor apocynin 
(acetovanillone) induces oxidative stress. Toxicol Appl Pharmacol 2006; 212(3): 179-87. 
407. Patton GW, Paciga JE, Shelley SA. NR8383 alveolar macrophage toxic growth arrest by 
hydrogen peroxide is associated with induction of growth-arrest and DNA damage-
inducible genes GADD45 and GADD153. Toxicol Appl Pharmacol 1997; 147(1): 126-34. 
408. Buchmuller-Rouiller Y, Corrandin SB, Smith J, et al. Role of glutathione in macrophage 
activation: effect of cellular glutathione depletion on nitrite production and 
leishmanicidal activity. Cellular immunology 1995; 164(1): 73-80. 
409. Venketaraman V, Dayaram YK, Talaue MT, Connell ND. Glutathione and 
nitrosoglutathione in macrophage defense against Mycobacterium tuberculosis. Infect 
Immun 2005; 73(3): 1886-9. 
410. Legrand C, Bour JM, Jacob C, et al. Lactate dehydrogenase (LDH) activity of the 
cultured eukaryotic cells as marker of the number of dead cells in the medium 
[corrected]. J Biotechnol 1992; 25(3): 231-43. 
411. Maruf Hossain AM, Park S, Kim JS, Park K. Volatility and mixing states of ultrafine 
particles from biomass burning. Journal of hazardous materials 2012; 205-206: 189-97. 
412. Lin CC, Huang KL, Tsai JH, W.J. L, Chen SJ, Lin SK. Characteristics of water-soluble 
ions and carbon in fine and coarse particles collected near an open burning site.  
Atmospheric Environment. 
413. BD Biosciences. BD Fluorescence Spectrum Viewer. 2012. 
414. Antunes F, Cadenas E. Cellular titration of apoptosis with steady state concentrations of 
H(2)O(2): submicromolar levels of H(2)O(2) induce apoptosis through Fenton chemistry 
independent of the cellular thiol state. Free Radic Biol Med 2001; 30(9): 1008-18. 
415. Molecular Probes. Amine reactive OxyBURST reagents.  Molecular Probes,; 2001. 
416. Needham LA, Davidson AH, Bawden LJ, et al. Drug targeting to monocytes and 
macrophages using esterase-sensitive chemical motifs. J Pharmacol Exp Ther 2011; 339(1): 
132-42. 
417. Rahman I, MacNee W. Lung glutathione and oxidative stress: implications in cigarette 
smoke-induced airway disease. Am J Physiol 1999; 277(6 Pt 1): L1067-88. 
418. Fitzpatrick AM, Teague WG, Burwell L, Brown MS, Brown LA. Glutathione oxidation is 
associated with airway macrophage functional impairment in children with severe 
asthma. Pediatr Res 2011; 69(2): 154-9. 
419. Masri FA, Comhair SA, Dostanic-Larson I, et al. Deficiency of lung antioxidants in 
idiopathic pulmonary arterial hypertension. Clinical and translational science 2008; 1(2): 
99-106. 
420. Dauletbaev N, Viel K, Buhl R, Wagner TO, Bargon J. Glutathione and glutathione 
peroxidase in sputum samples of adult patients with cystic fibrosis. Journal of cystic 
fibrosis : official journal of the European Cystic Fibrosis Society 2004; 3(2): 119-24. 
421. Behr J, Degenkolb B, Beinert T, Krombach F, Vogelmeier C. Pulmonary glutathione 
levels in acute episodes of Farmer's lung. Am J Respir Crit Care Med 2000; 161(6): 1968-71. 
422. Pacht ER, Diaz P, Clanton T, Hart J, Gadek JE. Alveolar fluid glutathione decreases in 
asymptomatic HIV-seropositive subjects over time. Chest 1997; 112(3): 785-8. 
423. Avissar NE, Reed CK, Cox C, Frampton MW, Finkelstein JN. Ozone, but not nitrogen 
dioxide, exposure decreases glutathione peroxidases in epithelial lining fluid of human 
lung. Am J Respir Crit Care Med 2000; 162(4 Pt 1): 1342-7. 
424. Abbate C, Giorgianni C, Brecciaroli R, et al. Changes induced by exposure of the human 
lung to glass fiber-reinforced plastic. Environ Health Perspect 2006; 114(11): 1725-9. 
425. Becker S, Mundandhara S, Devlin RB, Madden M. Regulation of cytokine production in 
human alveolar macrophages and airway epithelial cells in response to ambient air 
pollution particles: further mechanistic studies. Toxicol Appl Pharmacol 2005; 207(2 
Suppl): 269-75. 
426. Karlsson HL, Ljungman AG, Lindbom J, Moller L. Comparison of genotoxic and 
inflammatory effects of particles generated by wood combustion, a road simulator and 
collected from street and subway. Toxicol Lett 2006; 165(3): 203-11. 
427. Riddervold IS, Bonlokke JH, Olin AC, et al. Effects of wood smoke particles from wood-
burning stoves on the respiratory health of atopic humans. Part Fibre Toxicol 2012; 9(1): 
12. 
428. Forchhammer L, Moller P, Riddervold IS, et al. Controlled human wood smoke 
exposure: oxidative stress, inflammation and microvascular function. Part Fibre Toxicol 
2012; 9: 7. 
429. Pourazar J, Mudway IS, Samet JM, et al. Diesel exhaust activates redox-sensitive 
transcription factors and kinases in human airways. Am J Physiol Lung Cell Mol Physiol 
2005; 289(5): L724-30. 
430. Mudway IS, Stenfors N, Duggan ST, et al. An in vitro and in vivo investigation of the 
effects of diesel exhaust on human airway lining fluid antioxidants. Arch Biochem 
Biophys 2004; 423(1): 200-12. 
431. Salvi S, Blomberg A, Rudell B, et al. Acute inflammatory responses in the airways and 
peripheral blood after short-term exposure to diesel exhaust in healthy human 
volunteers. Am J Respir Crit Care Med 1999; 159(3): 702-9. 
432. Malhotra D, Thimmulappa R, Navas-Acien A, et al. Decline in NRF2-regulated 
antioxidants in chronic obstructive pulmonary disease lungs due to loss of its positive 
regulator, DJ-1. Am J Respir Crit Care Med 2008; 178(6): 592-604. 
433. Golde DW, Byers LA, Finley TN. Proliferative capacity of human alveolar macrophage. 
Nature 1974; 247(440): 373-5. 
434. Nakata K, Gotoh H, Watanabe J, et al. Augmented proliferation of human alveolar 
macrophages after allogeneic bone marrow transplantation. Blood 1999; 93(2): 667-73. 
435. Kurmi OP, Semple S, Simkhada P, Smith WC, Ayres JG. COPD and chronic bronchitis 
risk of indoor air pollution from solid fuel: a systematic review and meta-analysis. 
Thorax 2010; 65(3): 221-8. 
436. Manthalu G, Nkhoma D, Kuyeli S. Simple versus composite indicators of socioeconomic 
status in resource allocation formulae: the case of the district resource allocation formula 
in Malawi. BMC health services research 2010; 10: 6. 
437. van der Vaart H, Postma DS, Timens W, ten Hacken NH. Acute effects of cigarette 
smoke on inflammation and oxidative stress: a review. Thorax 2004; 59(8): 713-21. 
438. Miller MR, Hankinson J, Brusasco V, et al. Standardisation of spirometry. Eur Respir J 
2005; 26(2): 319-38. 
439. Miller MR, Quanjer PH, Swanney MP, Ruppel G, Enright PL. Interpreting lung function 
data using 80% predicted and fixed thresholds misclassifies more than 20% of patients. 
Chest 2011; 139(1): 52-9. 
440. Ward C, Thien F, Secombe J, Gollant S, Walters EH. Bronchoalveolar lavage fluid urea 
as a measure of pulmonary permeability in healthy smokers. Eur Respir J 2000; 15(2): 
285-90. 
441. Barditch-Crovo P, Svobodova V, Lietman P. Apparent deficiency of glutathionine in the 
PBMC's of people with AIDS depends on method of expression. J Acquir Immune Defic 
Syndr Hum Retrovirol 1995; 8(3): 313-4. 
442. National Statistical Office. Malawi Demographic and Health Survey 2010. Zomba, 
Malawi.; 2011. 
443. Streiner DL, Norman GR. Correction for multiple testing: is there a resolution? Chest 
2011; 140(1): 16-8. 
444. R Foundation. R: A language and environment for statistical computing and graphics. 
2.15.0 ed; 2010. 
445. Diggle P, Chetwynd A. Statistics and scientific method : an introduction for students 
and researchers. New York: Oxford University Press; 2011. 
446. Thomson CD, Rea HM, Doesburg VM, Robinson MF. Selenium concentrations and 
glutathione peroxidase activities in whole blood of New Zealand residents. Br J Nutr 
1977; 37(3): 457-60. 
447. Allan CB, Lacourciere GM, Stadtman TC. Responsiveness of selenoproteins to dietary 
selenium. Annu Rev Nutr 1999; 19: 1-16. 
448. Ashton K, Hooper L, Harvey LJ, Hurst R, Casgrain A, Fairweather-Tait SJ. Methods of 
assessment of selenium status in humans: a systematic review. Am J Clin Nutr 2009; 
89(6): 2025S-39S. 
449. Li J, Pritchard DK, Wang X, et al. cDNA microarray analysis reveals fundamental 
differences in the expression profiles of primary human monocytes, monocyte-derived 
macrophages, and alveolar macrophages. J Leukoc Biol 2007; 81(1): 328-35. 
450. Gould NS, Min E, Gauthier S, Chu HW, Martin R, Day BJ. Aging adversely affects the 
cigarette smoke-induced glutathione adaptive response in the lung. Am J Respir Crit Care 
Med 2010; 182(9): 1114-22. 
451. Kelly FJ. Oxidative stress: its role in air pollution and adverse health effects. Occup 
Environ Med 2003; 60(8): 612-6. 
452. Jones DP, Mody VC, Jr., Carlson JL, Lynn MJ, Sternberg P, Jr. Redox analysis of human 
plasma allows separation of pro-oxidant events of aging from decline in antioxidant 
defenses. Free Radic Biol Med 2002; 33(9): 1290-300. 
453. Ramirez-Venegas A, Sansores RH, Perez-Padilla R, et al. Survival of patients with 
chronic obstructive pulmonary disease due to biomass smoke and tobacco. Am J Respir 
Crit Care Med 2006; 173(4): 393-7. 
454. Regalado J, Perez-Padilla R, Sansores R, et al. The effect of biomass burning on 
respiratory symptoms and lung function in rural Mexican women. Am J Respir Crit Care 
Med 2006; 174(8): 901-5. 
455. Tashkin DP, Clark VA, Coulson AH, et al. Comparison of lung function in young 
nonsmokers and smokers before and after initiation of the smoking habit. A prospective 
study. Am Rev Respir Dis 1983; 128(1): 12-6. 
456. Reed WW, Diehl LF. Leukopenia, neutropenia, and reduced hemoglobin levels in 
healthy American blacks. Arch Intern Med 1991; 151(3): 501-5. 
457. Kocyigit A, Erel O, Gur S. Effects of tobacco smoking on plasma selenium, zinc, copper 
and iron concentrations and related antioxidative enzyme activities. Clin Biochem 2001; 
34(8): 629-33. 
458. Ghayour-Mobarhan M, Taylor A, New SA, Lamb DJ, Ferns GA. Determinants of serum 
copper, zinc and selenium in healthy subjects. Annals of clinical biochemistry 2005; 42(Pt 
5): 364-75. 
459. Neurohr C, Lenz AG, Ding I, Leuchte H, Kolbe T, Behr J. Glutamate-cysteine ligase 
modulatory subunit in BAL alveolar macrophages of healthy smokers. Eur Respir J 2003; 
22(1): 82-7. 
460. Garbin U, Fratta Pasini A, Stranieri C, et al. Cigarette smoking blocks the protective 
expression of Nrf2/ARE pathway in peripheral mononuclear cells of young heavy 
smokers favouring inflammation. PLoS One 2009; 4(12): e8225. 
461. Nichenametla SN, Ellison I, Calcagnotto A, Lazarus P, Muscat JE, Richie JP, Jr. 
Functional significance of the GAG trinucleotide-repeat polymorphism in the gene for 
the catalytic subunit of gamma-glutamylcysteine ligase. Free Radic Biol Med 2008; 45(5): 
645-50. 
462. Jung KA, Kwak MK. The Nrf2 system as a potential target for the development of 
indirect antioxidants. Molecules 2010; 15(10): 7266-91. 
463. Brigelius-Flohe R. Tissue-specific functions of individual glutathione peroxidases. Free 
Radic Biol Med 1999; 27(9-10): 951-65. 
464. Kulkarni NS, Prudon B, Panditi SL, Abebe Y, Grigg J. Carbon loading of alveolar 
macrophages in adults and children exposed to biomass smoke particles. Sci Total 
Environ 2005; 345(1-3): 23-30. 
465. Piacentini S, Polimanti R, Porreca F, Martinez-Labarga C, De Stefano GF, Fuciarelli M. 
GSTT1 and GSTM1 gene polymorphisms in European and African populations. 
Molecular biology reports 2011; 38(2): 1225-30. 
466. Reddy P, Naidoo RN, Robins TG, et al. GSTM1 and GSTP1 gene variants and the effect 
of air pollutants on lung function measures in South African children. Am J Ind Med 
2012. 
467. Schwartz J. Air pollution and daily mortality: a review and meta analysis. Environ Res 
1994; 64(1): 36-52. 
468. Aunan K, Pan XC. Exposure-response functions for health effects of ambient air 
pollution applicable for China -- a meta-analysis. Sci Total Environ 2004; 329(1-3): 3-16. 
469. Schwartz J, Zanobetti A. Using meta-smoothing to estimate dose-response trends across 
multiple studies, with application to air pollution and daily death. Epidemiology 2000; 
11(6): 666-72. 
470. Pope CA, 3rd. Respiratory hospital admissions associated with PM10 pollution in Utah, 
Salt Lake, and Cache Valleys. Arch Environ Health 1991; 46(2): 90-7. 
471. Zmirou D, Schwartz J, Saez M, et al. Time-series analysis of air pollution and cause-
specific mortality. Epidemiology 1998; 9(5): 495-503. 
472. Filleul L, Le Tertre A, Baldi I, Tessier JF. Difference in the relation between daily 
mortality and air pollution among elderly and all-ages populations in southwestern 
France. Environ Res 2004; 94(3): 249-53. 
473. Lacasana M, Esplugues A, Ballester F. Exposure to ambient air pollution and prenatal 
and early childhood health effects. Eur J Epidemiol 2005; 20(2): 183-99. 
474. Dockery DW, Speizer FE, Stram DO, Ware JH, Spengler JD, Ferris BG, Jr. Effects of 
inhalable particles on respiratory health of children. Am Rev Respir Dis 1989; 139(3): 587-
94. 
475. Dockery DW. Epidemiologic evidence of cardiovascular effects of particulate air 
pollution. Environ Health Perspect 2001; 109 Suppl 4: 483-6. 
476. Ezzati M, Kammen DM. The health impacts of exposure to indoor air pollution from 
solid fuels in developing countries: knowledge, gaps, and data needs. Environ Health 
Perspect 2002; 110(11): 1057-68. 
477. Pandey MR, Boleij JS, Smith KR, Wafula EM. Indoor air pollution in developing 
countries and acute respiratory infection in children. Lancet 1989; 1(8635): 427-9. 
478. WHO. The global burden of disease: 2004 update. Geneva: WHO Press; 2008. 
479. Wardlaw T, Salama P, Johansson EW, Mason E. Pneumonia: the leading killer of 
children. Lancet 2006; 368(9541): 1048-50. 
480. Kurosaka K, Takahashi M, Watanabe N, Kobayashi Y. Silent cleanup of very early 
apoptotic cells by macrophages. J Immunol 2003; 171(9): 4672-9. 
481. Xu F, Droemann D, Rupp J, et al. Modulation of the inflammatory response to 
Streptococcus pneumoniae in a model of acute lung tissue infection. Am J Respir Cell Mol 
Biol 2008; 39(5): 522-9. 
482. Assari T. Chronic Granulomatous Disease; fundamental stages in our understanding of 
CGD. Medical immunology 2006; 5: 4. 
483. Jimenez LA, Drost EM, Gilmour PS, et al. PM(10)-exposed macrophages stimulate a 
proinflammatory response in lung epithelial cells via TNF-alpha. Am J Physiol Lung Cell 
Mol Physiol 2002; 282(2): L237-48. 
484. Kawasaki S, Takizawa H, Takami K, et al. Benzene-extracted components are important 
for the major activity of diesel exhaust particles: effect on interleukin-8 gene expression 
in human bronchial epithelial cells. Am J Respir Cell Mol Biol 2001; 24(4): 419-26. 
485. Knapp S, Leemans JC, Florquin S, et al. Alveolar macrophages have a protective 
antiinflammatory role during murine pneumococcal pneumonia. Am J Respir Crit Care 
Med 2003; 167(2): 171-9. 
486. Serezani CH, Chung J, Ballinger MN, Moore BB, Aronoff DM, Peters-Golden M. 
Prostaglandin E2 suppresses bacterial killing in alveolar macrophages by inhibiting 
NADPH oxidase. Am J Respir Cell Mol Biol 2007; 37(5): 562-70. 
487. Becher R, Bucht A, Ovrevik J, et al. Involvement of NADPH oxidase and iNOS in rodent 
pulmonary cytokine responses to urban air and mineral particles. Inhal Toxicol 2007; 
19(8): 645-55. 
488. Hatch GE, Boykin E, Graham JA, et al. Inhalable particles and pulmonary host defense: 
in vivo and in vitro effects of ambient air and combustion particles. Environ Res 1985; 
36(1): 67-80. 
489. Phipps JC, Aronoff DM, Curtis JL, Goel D, O'Brien E, Mancuso P. Cigarette smoke 
exposure impairs pulmonary bacterial clearance and alveolar macrophage complement-
mediated phagocytosis of Streptococcus pneumoniae. Infect Immun 2010; 78(3): 1214-20. 
490. Chen H, Cowan MJ, Hasday JD, Vogel SN, Medvedev AE. Tobacco smoking inhibits 
expression of proinflammatory cytokines and activation of IL-1R-associated kinase, p38, 
and NF-kappaB in alveolar macrophages stimulated with TLR2 and TLR4 agonists. J 
Immunol 2007; 179(9): 6097-106. 
491. McKusick-Nathans Institute of Genetic Medicine JHUB, MD),. Online Mendelian 
Inheritance in Man, OMIM®. 
492. Iyer SS, Accardi CJ, Ziegler TR, et al. Cysteine redox potential determines pro-
inflammatory IL-1beta levels. PLoS One 2009; 4(3): e5017. 
493. Kuhn AM, Tzieply N, Schmidt MV, et al. Antioxidant signaling via Nrf2 counteracts 
lipopolysaccharide-mediated inflammatory responses in foam cell macrophages. Free 
Radic Biol Med 2011; 50(10): 1382-91. 
494. Mukaida N. Pathophysiological roles of interleukin-8/CXCL8 in pulmonary diseases. 
Am J Physiol Lung Cell Mol Physiol 2003; 284(4): L566-77. 
495. Simone RE, Russo M, Catalano A, et al. Lycopene inhibits NF-κB-mediated IL-8 
expression and changes redox and PPARgamma signalling in cigarette smoke-
stimulated macrophages. PLoS One 2011; 6(5): e19652. 
496. Haddad JJ, Saade NE, Safieh-Garabedian B. Redox regulation of TNF-alpha 
biosynthesis: augmentation by irreversible inhibition of gamma-glutamylcysteine 
synthetase and the involvement of an IkappaB-alpha/NF-kappaB-independent pathway 
in alveolar epithelial cells. Cell Signal 2002; 14(3): 211-8. 
497. Haddad JJ, Fahlman CS. Redox- and oxidant-mediated regulation of interleukin-10: an 
anti-inflammatory, antioxidant cytokine? Biochem Biophys Res Commun 2002; 297(2): 163-
76. 
498. Palacio JR, Markert UR, Martinez P. Anti-inflammatory properties of N-acetylcysteine 
on lipopolysaccharide-activated macrophages. Inflamm Res 2011; 60(7): 695-704. 
499. Pagliei S, Ghezzi P, Bizzarri C, et al. Thioredoxin specifically cross-desensitizes 
monocytes to MCP-1. European cytokine network 2002; 13(2): 261-7. 
500. Desai A, Huang X, Warren JS. Intracellular glutathione redox status modulates MCP-1 
expression in pulmonary granulomatous vasculitis. Laboratory investigation; a journal of 
technical methods and pathology 1999; 79(7): 837-47. 
501. Hashimoto S, Gon Y, Matsumoto K, Takeshita I, MacHino T, Horie T. Intracellular 
glutathione regulates tumour necrosis factor-alpha-induced p38 MAP kinase activation 
and RANTES production by human bronchial epithelial cells. Clin Exp Allergy 2001; 
31(1): 144-51. 
502. Mosser DM, Edwards JP. Exploring the full spectrum of macrophage activation. Nat Rev 
Immunol 2008; 8(12): 958-69. 
503. Pi J, Bai Y, Reece JM, et al. Molecular mechanism of human Nrf2 activation and 
degradation: role of sequential phosphorylation by protein kinase CK2. Free Radic Biol 
Med 2007; 42(12): 1797-806. 
504. Annenkov AY, Baranova FS. Lipopolysaccharide-dependent and lipopolysaccharide-
independent pathways of monocyte desensitisation to lipopolysaccharides. J Leukoc Biol 
1991; 50(3): 215-22. 
505. Didierlaurent A, Goulding J, Patel S, et al. Sustained desensitization to bacterial Toll-like 
receptor ligands after resolution of respiratory influenza infection. J Exp Med 2008; 
205(2): 323-9. 
506. Swiston JR, Davidson W, Attridge S, Li GT, Brauer M, van Eeden SF. Wood smoke 
exposure induces a pulmonary and systemic inflammatory response in firefighters. Eur 
Respir J 2008; 32(1): 129-38. 
507. Tal TL, Simmons SO, Silbajoris R, et al. Differential transcriptional regulation of IL-8 
expression by human airway epithelial cells exposed to diesel exhaust particles. Toxicol 
Appl Pharmacol 2010; 243(1): 46-54. 
508. Quay JL, Reed W, Samet J, Devlin RB. Air pollution particles induce IL-6 gene 
expression in human airway epithelial cells via NF-kappaB activation. Am J Respir Cell 
Mol Biol 1998; 19(1): 98-106. 
509. Kocbach Bolling A, Pagels J, Yttri KE, et al. Health effects of residential wood smoke 
particles: the importance of combustion conditions and physicochemical particle 
properties. Part Fibre Toxicol 2009; 6: 29. 
510. Werts C, le Bourhis L, Liu J, et al. Nod1 and Nod2 induce CCL5/RANTES through the 
NF-kappaB pathway. Eur J Immunol 2007; 37(9): 2499-508. 
511. Okuma T, Terasaki Y, Sakashita N, et al. MCP-1/CCR2 signalling pathway regulates 
hyperoxia-induced acute lung injury via nitric oxide production. International journal of 
experimental pathology 2006; 87(6): 475-83. 
512. Brieland JK, Jones ML, Clarke SJ, Baker JB, Warren JS, Fantone JC. Effect of acute 
inflammatory lung injury on the expression of monocyte chemoattractant protein-1 
(MCP-1) in rat pulmonary alveolar macrophages. Am J Respir Cell Mol Biol 1992; 7(2): 
134-9. 
513. van Zoelen MA, Verstege MI, Draing C, et al. Endogenous MCP-1 promotes lung 
inflammation induced by LPS and LTA. Molecular immunology 2011; 48(12-13): 1468-76. 
514. Gatti S, Faggioni R, Echtenacher B, Ghezzi P. Role of tumour necrosis factor and reactive 
oxygen intermediates in lipopolysaccharide-induced pulmonary oedema and lethality. 
Clin Exp Immunol 1993; 91(3): 456-61. 
515. Mukherjee B, Dutta A, Roychoudhury S, Ray MR. Chronic inhalation of biomass smoke 
is associated with DNA damage in airway cells: involvement of particulate pollutants 
and benzene. J Appl Toxicol 2011. 
516. Maier KL, Alessandrini F, Beck-Speier I, et al. Health effects of ambient particulate 
matter--biological mechanisms and inflammatory responses to in vitro and in vivo 
particle exposures. Inhal Toxicol 2008; 20(3): 319-37. 
517. Tamagawa E, Bai N, Morimoto K, et al. Particulate matter exposure induces persistent 
lung inflammation and endothelial dysfunction. Am J Physiol Lung Cell Mol Physiol 2008; 
295(1): L79-85. 
518. Kulkarni N, Pierse N, Rushton L, Grigg J. Carbon in airway macrophages and lung 
function in children. N Engl J Med 2006; 355(1): 21-30. 
519. Rybicka JM, Balce DR, Khan MF, Krohn RM, Yates RM. NADPH oxidase activity 
controls phagosomal proteolysis in macrophages through modulation of the lumenal 
redox environment of phagosomes. Proc Natl Acad Sci U S A 2010; 107(23): 10496-501. 
520. Kampfrath T, Maiseyeu A, Ying Z, et al. Chronic fine particulate matter exposure 
induces systemic vascular dysfunction via NADPH oxidase and TLR4 pathways. Circ 
Res 2011; 108(6): 716-26. 
521. Amer J, Fibach E. Chronic oxidative stress reduces the respiratory burst response of 
neutrophils from beta-thalassaemia patients. British journal of haematology 2005; 129(3): 
435-41. 
522. More JM, Voelker DR, Silveira LJ, Edwards MG, Chan ED, Bowler RP. Smoking reduces 
surfactant protein D and phospholipids in patients with and without chronic 
obstructive pulmonary disease. BMC pulmonary medicine 2010; 10: 53. 
523. Datla SR, Dusting GJ, Mori TA, Taylor CJ, Croft KD, Jiang F. Induction of heme 
oxygenase-1 in vivo suppresses NADPH oxidase derived oxidative stress. Hypertension 
2007; 50(4): 636-42. 
524. Bates SR, Xu J, Dodia C, Fisher AB. Macrophages primed by overnight culture 
demonstrate a marked stimulation of surfactant protein A degradation. Am J Physiol 
1997; 273(4 Pt 1): L831-9. 
525. Black MJ, Brandt RB. Spectrofluorometric analysis of hydrogen peroxide. Anal Biochem 
1974; 58(1): 246-54. 
526. Nyberg K, Johansson U, Johansson A, Camner P. Phagolysosomal pH in alveolar 
macrophages. Environ Health Perspect 1992; 97: 149-52. 
527. Kobzik L, Godleski JJ, Brain JD. Selective down-regulation of alveolar macrophage 
oxidative response to opsonin-independent phagocytosis. J Immunol 1990; 144(11): 4312-
9. 
528. Ouadrhiri Y, Pilette C, Monteiro RC, Vaerman JP, Sibille Y. Effect of IgA on respiratory 
burst and cytokine release by human alveolar macrophages: role of ERK1/2 mitogen-
activated protein kinases and NF-kappaB. Am J Respir Cell Mol Biol 2002; 26(3): 315-32. 
529. Wu TT, Chen TL, Chen RM. Lipopolysaccharide triggers macrophage activation of 
inflammatory cytokine expression, chemotaxis, phagocytosis, and oxidative ability via a 
toll-like receptor 4-dependent pathway: validated by RNA interference. Toxicol Lett 
2009; 191(2-3): 195-202. 
530. Michel O, Nagy AM, Schroeven M, et al. Dose-response relationship to inhaled 
endotoxin in normal subjects. Am J Respir Crit Care Med 1997; 156(4 Pt 1): 1157-64. 
531. Stone WL, Qui M, Smith M. Lipopolysaccharide enhances the cytotoxicity of 2-
chloroethyl ethyl sulfide. BMC cell biology 2003; 4: 1. 
532. Don Porto Carero A, Hoet PH, Nemery B, Schoeters G. Increased HLA-DR expression 
after exposure of human monocytic cells to air particulates. Clin Exp Allergy 2002; 32(2): 
296-300. 
533. Meyer M, Huaux F, Gavilanes X, et al. Azithromycin reduces exaggerated cytokine 
production by M1 alveolar macrophages in cystic fibrosis. Am J Respir Cell Mol Biol 2009; 
41(5): 590-602. 
534. Krausgruber T, Blazek K, Smallie T, et al. IRF5 promotes inflammatory macrophage 
polarization and TH1-TH17 responses. Nat Immunol 2011; 12(3): 231-8. 
535. Pauly JL, Allison EM, Hurley EL, Nwogu CE, Wallace PK, Paszkiewicz GM. Fluorescent 
human lung macrophages analyzed by spectral confocal laser scanning microscopy and 
multispectral cytometry. Microsc Res Tech 2005; 67(2): 79-89. 
536. Hodge S, Matthews G, Mukaro V, et al. Cigarette smoke-induced changes to alveolar 
macrophage phenotype and function are improved by treatment with procysteine. Am J 
Respir Cell Mol Biol 2011; 44(5): 673-81. 
537. Williams MA, Rangasamy T, Bauer SM, et al. Disruption of the transcription factor Nrf2 
promotes pro-oxidative dendritic cells that stimulate Th2-like immunoresponsiveness 
upon activation by ambient particulate matter. J Immunol 2008; 181(7): 4545-59. 
538. Rangasamy T, Cho CY, Thimmulappa RK, et al. Genetic ablation of Nrf2 enhances 
susceptibility to cigarette smoke-induced emphysema in mice. J Clin Invest 2004; 114(9): 
1248-59. 
539. Starrett W, Blake DJ. Sulforaphane inhibits de novo synthesis of IL-8 and MCP-1 in 
human epithelial cells generated by cigarette smoke extract. Journal of immunotoxicology 
2011; 8(2): 150-8. 
540. Aoki Y, Hashimoto AH, Amanuma K, et al. Enhanced spontaneous and 
benzo(a)pyrene-induced mutations in the lung of Nrf2-deficient gpt delta mice. Cancer 
Res 2007; 67(12): 5643-8. 
541. Yageta Y, Ishii Y, Morishima Y, et al. Role of Nrf2 in host defense against influenza virus 
in cigarette smoke-exposed mice. J Virol 2011; 85(10): 4679-90. 
542. Reddy NM, Suryanarayana V, Kalvakolanu DV, et al. Innate immunity against bacterial 
infection following hyperoxia exposure is impaired in NRF2-deficient mice. J Immunol 
2009; 183(7): 4601-8. 
543. Marzec JM, Christie JD, Reddy SP, et al. Functional polymorphisms in the transcription 
factor NRF2 in humans increase the risk of acute lung injury. FASEB J 2007; 21(9): 2237-
46. 
544. Suzuki M, Betsuyaku T, Ito Y, et al. Down-regulated NF-E2-related factor 2 in 
pulmonary macrophages of aged smokers and patients with chronic obstructive 
pulmonary disease. Am J Respir Cell Mol Biol 2008; 39(6): 673-82. 
545. Hubner RH, Schwartz JD, De Bishnu P, et al. Coordinate control of expression of Nrf2-
modulated genes in the human small airway epithelium is highly responsive to cigarette 
smoking. Mol Med 2009; 15(7-8): 203-19. 
546. Boutten A, Goven D, Boczkowski J, Bonay M. Oxidative stress targets in pulmonary 
emphysema: focus on the Nrf2 pathway. Expert opinion on therapeutic targets 2010; 14(3): 
329-46. 
547. Ishii T, Itoh K, Takahashi S, et al. Transcription factor Nrf2 coordinately regulates a 
group of oxidative stress-inducible genes in macrophages. J Biol Chem 2000; 275(21): 
16023-9. 
548. Krombach F, Munzing S, Allmeling AM, Gerlach JT, Behr J, Dorger M. Cell size of 
alveolar macrophages: an interspecies comparison. Environ Health Perspect 1997; 105 
Suppl 5: 1261-3. 
549. Yasaka T, Mantich NM, Boxer LA, Baehner RL. Functions of human monocyte and 
lymphocyte subsets obtained by countercurrent centrifugal elutriation: differing 
functional capacities of human monocyte subsets. J Immunol 1981; 127(4): 1515-8. 
 
 
